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SUMMARY 
Human cytomegalovirus (HCMV) strain AD169 encodes a single abundant 
1.95kb immediate early (IE) mRNA and a single abundant 2.7kb early RNA. 
The major IE gene (0.756-0.745 map units) was shown in nuclease protection 
experiments to encode a spliced molecule of 1,736 nucleotides (excluding 
the poly (A) tail) consisting of four exons of 121,88,185 and 1,342 
nucleotides. Three introns of 827,114 and 170 nucleotides were located 
near the 5' end of the gene. The structural analysis of the major IE gene 
enabled the amino acid sequence of the major IE polypeptide to be deduced 
from the DNA sequence. The major early gene, which is contained in both 
copies of the HCMV long repeat, was found not to be spliced. A translation 
product of the 2.7kb early RNA has yet to be identified. Reporter genes 
were used in transient DNA transfection experiments to monitor expression 
from HCMV and other viral promoters. HCMV infections trans-activated 
expression from the transfected SV40 early, Rous Sarcoma virus, HSV-1 
thymidine kinase (TK), the HCMV major IE and the HCMV major early 
promoters. Expression from both the HCMV IE and the HSV-1 TK promoters was 
stimulated much more gradually by HCMV than by HSV-1 infections. 
Experiments performed using u. v. -irradiated virus and inhibitors of HCMV 
replication indicated that the transfected IE promoter was stimulated 
primarily by a de novo synthesised HCMV-encoded gene product(s). When the 
concentration of the plasmids IEPlcatIEterm and AccHincat transfected into 
cells was lowered sufficiently, HCMV infection was observed to repress 
expression from the transfected IE promoter. A sequence in the HCMV major 
IE gene between -299 and +69 apparently contains a cis-acting signal which 
responds to an HCMV-induced repressor. Competitive co-transfection 
experiments indicated that an HCMV-induced repressor of IE transcription 
interacts with at least three distinct regions within the IE promoter. 
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INTRODUCTION 
1: 1 Clas, -dýation 
Human Cytomegalovirus (HCMV) is a member of the family Herpesviridae. 
The basic morphology of herpesvirions has been conserved throughout the 
family and is a basis for classification. Herpesvirions contain a single 
icosadeltahedral capsid (110-120nm in diameter), consisting of 162 
capsomeres, enclosed in a condensed protein coat or tegument of variable 
size and an outer lipoprotein envelope (Wildy et 2L, 1960). The capsLd 
contains a linear double-stranded DNA molecule. Characteristically, 
replication of herpesvirus; genomes; and capsid assembly takes place in the 
nuclei of infected cells. 
Herpesviruses have been observed to infect a wide range of host species 
including fungi (Kazama and Schornstein, 1972), crustaceans (Farley 
. 
2t 2ý, 
1972), fish (Wolf and Darlington, 1971), amphibians (Lunger, 1964), birds 
(Churchill and Biggs, 1967) and numerous mammals (Roizman et al ., 1981). 
There are at least fLve human herpesviruses (HSV-1, HSV-2, VZV, HCMV and 
EBV) all of which cause clinically important diseases. 
The Herpesviridae has been divided into three subfamilies primarily on 
the basis of the biological properties of the viruses in vitro and in vivo: 
(a) Alphaherpesvirinae: In vivo alphaherpesviruses usually infect epithelial 
cells giving rise to vesicular lesions. Following primary infection 
alphaherpesviruses frequently persist in a latent form in the neuronal cells 
of ganglia. The latent virus may periodically reactivate giving rise to 
secondary infections. The alphaherpesviruses have a relatively short growth 
cycle (less than 18h) and can exhibit a narrow or wide host range both in 
vitro and in vivo. The genomes of alphaherpesviruses range in size between 
130kb (channel catfish virus; Chousterman et aL, 1979) and 151kb 
(Saimirline herpesvirus 1; Roizman et al., 1981) and typically have a high 
16 
G+C content although values vary from 32% (Canid herpesvirus 1; Plummer et 
ýý, 1969) to 74% (PRV; Honess and Watson, 1977). DNA hybridisation 
experiments have shown that HSV-1, HSV-2, EHV-1, PRV and VZV all share 
significant DNA sequence homology and that homologous regions are arranged 
in a similar order Cessentially colinear") on the genomes of these 
alphaherpesviruses (Davison and Wilkie, 1983). 
(b) Betaherpesvirinae: The betaherpesvirinae contains the cytomegaloviruses of 
man, monkeys, guinea pigs, mouse and other mammals. Characteristically, the 
betaherpesviruses are slow growing, have a restricted host range Lin vitro 
and in A Lvo) and produce both nuclear and cytoplasmic inclusions in infected 
cells. The betaherpesviruses have. reladvely large genomes, ranging in size 
between 144ýb (bovine CMV; Ehlers et al., 1985) and 240kb (murine CMV; 
Mercer et al., 1983) and have a G+C content of between 50% to 60% (Honess, 
1984). 
(c) Gamm aherpesvirinae: The ga mm aherpesviruses have a restricted host range and 
usually replicate in lymphoblastoid cells, although some can lytically 
infect fLbroblast and epithelial ceUs. Gammaherpesviruses can persist in 
cell populations as episomal DNA elements exhibiting restricted gene 
expression. The genomic DNA of this subfamily ranges in size from 105kb 
(Bovid herpesvirus 4; DeVilliers, 1979) to 166kb (Mareks disease virus; Lee 
et 21., 1971). The G+C content of gam maherpesvirus DNA, with the exception 
of the EBV-Iike viruses of old world monkeys (approx. 59%), is relatively 
low (Honess, 1984). 
1: 2 Historical Perspective 
The earliest identification of a HCMV infection has been attributed to 
Ribbert (Ribbert, 1904; Ho, 1982) who in 1881 identified 'protozoan-like' 
ceUs in the kidney of a still-borne foetus. Ribbert appreciated his 
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observations were significant when Jesionek and Kiolenenoglou (1904) 
described the presence of large cells containing intranuclear bodies in the 
kidneys, lungs and liver of an eight month foetus. The 'protozoan-like' 
cells identified by Jesionek and Kiolemenoglou contained an eccentrically 
positioned nucleus with intranuclear inclusions. It is now appreciated that 
these early studies describe fatal cases of congenitally acquired 
cytomegalic inclusion disease (CID). At the time, however, the enlarged 
cells were mistaken for protozoa. 
Goodpasture and Talbot (1921) first coined the term lcytomegalial to 
describe the enlarged cells isolated from the kidneys, lungs and liver of a 
six week old infant at post mortem. The presence of cytomegalic cells in 
more than one organ was interpreted as indicating that the pathogen was 
carried in the blood stream. Goodpasture and Talbot believed that the 
cytomegalia was similar to the effect observed in VZV infected cells and 
was not due to the presence of a protozoan. Von Glahn and Pappenheimer 
(1925), describing the first report of a cytomegalia in the post mortem of 
an adult, suggested that the presence of nuclear inclusions indicated a 
nuclear infection, possibily caused by an agent related to the herpesvirus 
group. 
Jackson (1920) observed that the salivary glands and kidneys of 
apparently healthy laboratory guinea pigs frequently contained cytomegalic 
cells. Extracts prepared from cells exhibiting a cytomegalia were injected 
into the salivary glands of young guinea pigs and cells containing typical 
nuclear inclusion detected in the animals 7 to 15 days post inoculation 
(Cole and Kuttner, 1926). The causative agent of the infection was shown to 
be a virus by its ability to pass through the appropriate filters. When 
extracts containing the virus were injected into animals other than -guinea 
pigs nuclear inclusions were not observed (Cole and Kuttner, 1926); this was 
an early indication of the species-specificity exhibited by members of the 
CMV (betaherpesvirinae) group. 
18 
Li vitro cultivation of guinea pig CMV was first achieved in minced 
fragments of guinea pig tissue which were being maintained in Maitland's 
medium (Andrewes, 1930). Lifected cells containing a single nuclear 
inclusion, initially detected between 48 to 72h p. L, were observed to 
increase in size during the course of an infection. Although the in vitro 
neutralisation of guinea pig CMV by immune sera was demonstrated by Andrewes 
(1930) serial subculture of the virus in vitro was not achieved at this 
tLm e. 
Li the 1950's Dr Margaret Smith, responding to the high incidence of 
CID being reported in infants and young children at post mortem, 
systematically set out to propogate CMV in vitro (reviewed Weller, 1970).. h 
vitro serial subculture of a cytomegalovirus was first achieved with the 
murine Salivary Gland Virus (Smith, 1954). An extract was prepared from the 
salivary glands of an infected mouse and added to murine embryonic tissue 
being cultured in a complex serum-rich medium which contained antibiotics. 
Large, rounded, refractile cells were first detected in the monolayer 
between 6 to 7 days p. L and in the following 2 to 3 days the c. p. e. spread 
throughout the ce-U culture. Murine CMV was serially passaged in vitro and 
then reinoculated into mice where the virus again produced characteristic 
cytomegalic inclusions. Virus titration demonstrated that there was a large 
increase in the number of infectious particles during in vitro passage. A 
similar protocol was then used successfullly to subculture two HCMV isolates 
in human uterine wall tissue (Smith, 1956). 
Working independently two other groups isolated and subcultured HCMV 
shortly after Smith (Weller, 1970). Rowe and co-workers, while culturing 
adenoid tissue removed from young children during surgery, fortuitously 
detected cytomeglia in three of the cultures after incubation periods of 
between 22 to 51 days; one of the isolates (strain AD169) obtained by Rowe 
et ýý (1956) was used in experiments described in this thesis. 
Weller et 
al., (1957) fortuitously isolated HCMV strain Davis using a procedure which 
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was originally designed to culture toxaplasma from lung 
biopsies. The 
similar c. p. e. 's produced by strains AD169 and Davis in tissue culture cells 
were sufficiently distinctive to differentiate the HCMV infections from 
those of VZV or other human herpesviruses (Weller et aL, 1957). 
The three most commonly used laboratory strains of HCMV are strains 
AD169, Davis and Towne. The Towne strain was isolated in 1970 from a two 
month old infant who survived microcephaly and hepatosplenomegaly caused by 
a congenital infection (Plotkin et aL, 1975). 
1: 3 Epidemiology 
The ability to serially culture HCMV in vitro facilitated the 
development of diagnostic techniques necessary to investigate HCMV 
epidemiology. The detection of antibodies directed against HCMV in an 
individual! s blood, using techniques such as complement fixation, is 
evidence of an individual having experienced an infection. Serological 
surveys were undertaken to measure the level of circulating antibody to HCMV 
in different age groups and communities. 
An early epidemiological survey performed in Bethesda (USA) by Rowe and 
co-workers (Rowe et al., 1956) found that the proportion of the population 
with C. F. antibody to HCMV increased with age fro m 14 %, in the 6 to 23 
month age group, to 81%, in the over age 35 years group (table 1: 1). The 
highest rate of seroconversion was seen in babies and infants under age 4 
years. More recent surveys have produced similar results (Stern and Elek, 
1965; Carlstrom and Jalling, 1970). During pregnancy maternal antibody is 
transferred across the placenta into foetal blood. Passive immunity 
conferred by maternal antibody declines during the first six months after 
birth. Passively acquired maternal antibody accounts for the high proportion 
of samples from cord blood (71%) and neonates (29%) which contained 
HCMV-specific CF antibody (Table 1: 1; Rowe et aL, 1956). 
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Sample (age group) 
Cord Blood 
6 weeks 
6-23 months 
2-4 years 
5-9 years 
10-15 years 
18-25 years 
>35 years 
No. Positive/No. Tested 
12/17 (71%) 
5/17 (29%) 
3/21 (14%) 
11/36 (317. ) 
11/33 (33%) 
22/49 (45%) 
52/98 (53%) 
42/52 (81%) 
Table 1: 1: Correlation beteen age and the incidence of 
complement-fixing antibody to HCMV in Bethesda, U. S. A. 
(Rowe et al., 1956). 
A W. H. O. co-ordinated survey, using standardised reagents and 
conditions, monitored the level of CF antibody in 20 to 40 year old healthy 
blood donors in different parts of the world (Krech, 1973). The results 
showed that HCMV is endemic worldwide (Table 1: 2). The high incidence of 
HCMV in countries from the equator to the arctic indicates that climatic 
conditions do not signif-Lcantly affect HCMV transmission. Immunity to HCMV 
is, however, less prevalent in more affluent societies. This is, perhaps, 
most clearly illustrated in Johannesburg where 100% of Bantu negros were 
seropositive as compared with 70% of the white population. In a similar 
study, performed in London, 90% of women were seropositive in a then 
relatively less prosperous im migrant A sian co mm unity co m pare d with 58 % of 
native women (Stern and Elek, 1965). 
Alford et al. (1981) investigated the relationship between 
socioeconomic status and the age distribution of primary infections. The 
study, carried out in Birmingham, USA, found that by child-bearing age 75% 
of women in a low income group were seropositive compared with 35% of women 
91 
Country (Town) Sample'Size % Seropositive 
France (Lyon) 
W. Germany (Freiburg) 
Switzerland (St Gallen) 
USA (Albany) 
Australia (Melbourne) 
USA (Honolulu) 
South Africa (Johannesburg, 
Argrentinia (Buenos Aries) 
Czechoslovakia (Bratislava) 
Trinidad (Port of Spain) 
Mauritius 
USA (Anchorage) 
Hong Kong 
Japan (Sendai) 
Greenland 
Tanzania (Dar Es Salaam) 
Morocco 
Fiji Islands 
Uganda (Entebbe) 
Nigeria (Ibadan) 
South Africa (Johannesburg, 
Bantu Negroes) 
Philippines (Manila) 
India (Chandigarh) 
98 40 
89 42 
105 45 
98 45 
99 54 
145 67 
whites) 96 75 
43 81 
100 83 
99 86 
93 89 
100 94 
99 94 
99 96 
90 98 
117 98 
109 98 
95 100 
143 100 
95 100 
112 100 
89 100 
68 100 
Table 1: 2: Incidence of complement-fixing antibody to HCMV in 
healthy Tlood donors, age 20-40 years, world-wide (from 
Krech, 1983). 
in a middle to high income group. A higher proportion of women in the 
middle to high income group were, therefore, susceptible to primary 
infection during pregnancy. 0.5% of the low income group and 0.9 % of the 
higher income group experienced primary infection during pregnancy (Alford 
et 2L, 1981). Symptomatic congenital HCMV infections are known to occur 
more frequently in the children of mothers experiencing a primary infection 
than in those experiencing a reactivation or secondary infection (see 
section 1: 4). With the improvement in socioeconomic conditions seen in 
industrialised countries there has been a concomitant change in the 
epidemiology of HCMV. In more developed communities, on average, individuals 
are exposed to HCMV infection later in life and consequently a higher 
proportion of mo. thers. in the more developed tommunities experience a primary 
infection during pregnancy. 
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1: 4 Congenital Infection 
The most frequently diagnosed disease caused by HCMV is 
co nge nitally-ac quire d Cytomegalic, Inclusion Disease (CID). HCMV can be 
transmitted, via the placenta, to the foetus from a mother experiencing 
either a primary or secondary infection. Histopathological examination of 
infants with CID invariably reveals the presence of pathognomic cytomeglic 
epithelial cells in the liver, lungs, kidneys, pancreas and/or salivary 
glands. Symptoms associated with CID include petechia, hepatosplenomegaly, 
jaundice, microcephaly, low birth weight, prematurity, inguinial hernias 
and chorioretinitis (Stagno et al., 1984). 
Estimates of the rate of congenital HCMV infection range between 0.28% 
and 2.2% of total births (Peckam et al., 1983). In general the incidence of 
City HAMILTON LONDON 
Size of Cohort 
. 
15,212 14,789 
Congenitally Infected 64 42 
(0.42%) (0.28%) 
Diagnosed CID from 
Overt Symptoms 4/64 1/42 
Profound Bilateral Deafness 2/41 
Profound Unilateral Deafness 3/42 
Mild Bilateral Deafness 1/42 
Mild Unilateral Deafness 1/42 
Total with Sensorineural 
Hearing Loss 7/42 4/42 
Additional Serious Sequelae 
Attributed to Congenital 
HCMV Infection 1/42 3/42 
Serpositive Mothers in 
the Community 44% 56% 
Table 1: 3 Incidence of congenital HCMV infection and HCMV-related 
symptoms in prospective studies carried out in Hamilton, Canada 
(Larke et al., 1980; Saigal et al., 1982) and London (Peckham et 
al. , 19F3 ) 
7. 
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congenital infection is directly related to the proportion of seropositive 
mothers in the population. A series of prospective long-term follow-up 
studies, in which large numbers of neonates were screened, has been 
undertaken to evaluate the full consequeces of CID. The presence of a 
viruria at birth is diagnostic of a congenital infection. Table 1: 3 
summarizes the results of two surveys performed in populations where there 
was a relatively low ratio of seropositive mothers. Only 5/1061 congenitally 
infected neonates were diagnosed as having symptoms of CID. Of these five 
symptomatic cases one (from the London study) developed microcephaly, 
spastic quadroplegia, optical atrophy and bilateral hearing loss; a second 
had profound bilateral deafness and the remaining three cases experienced no 
long term handicap. Previous studies, which had been concerned primarily 
with patient referrals, had found a 20% to 30% fatality rate in 
symptomatically infected neonates with between 90% to 95% experiencing some 
long term complication (reviewed by Stagno, et al., 1984). The improved 
prognosis suggested by the Canadian study was thought to reflect the 
efficient diagnosis of neonates exhibiting milder symptoms of the disease. 
Two out of 101 neonates who were asymptomatic. at birth subsequently 
developed quadraplegic cerebal palsy, hearing loss and additional sequelae. 
The principal finding of the long-term follow-up study was that there was a 
high incidence of sensorineural hearing loss in apparently asymptomatically 
infected children. The Canadian group monitored the health of most of the 
congenitally infected children up to age 5 years; 7 out of 41 children in 
this group exhibited sensorineural hearing loss (Table 1: 3). Extrapolating 
from these figures Hanshaw (1982) estimated there are 100,000 individals in 
the USA alone with impaired hearing resulting from congenital exposure to 
HCMV. Sensorineural deafness had previously been shown to be associated with 
symptomatic congenital HCMV infections (Medearis, 1964; Williamson et al., 
1982). HCMV can establish widespread infections in the epithelial cells of 
the inner ear and infectious virus has been isolated from perilymph removed 
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from the inner ear (Myers and Stool, 1968; Davis, 1969). 
Transplacental HCMV infection takes place in the presence of maternal 
antibody, in a number of cases congenital infections have been detected in 
consecutive pregnancies (Embil et al., 1970; Stagno et 22,,, 1973). Although 
pre-existing maternal immunity does not prevent congenital infection it does 
moderate the pathogenic consequences of the disease. A prospective survey 
undertaken in Birmingham, USA, found that 5/33 congenitally infected babies 
born to mothers experiencing a primary infection exhibited overt symptoms of 
CID as compared with 0/27 congenitally infected children born to mothers 
experiencing a reactivation or secondary infection (Stagno et al., 1982). 
Stagno et al., (1982) observed that women of higher socioeconomic status 
were more susceptible to primary infection during pregnancy than women of 
lower socioeconomic status, who were predominantly seropositive, and that 
their children were consquently more likely to experience overt symptoms of 
CID. 
In Chile, where 98% of the population is seropositive and the rate of 
congenital infection is 1.7%, Stagno et al (1984) were unable to identify a 
single case of CID in autopsy reports or in neonatal referals exhibiting 
potential symptoms of the disease. CID therefore may be a disease found only 
in socioeconomically advanced communities. 
1: 5 Perinatal Infection 
Neonates who experience a perinatal infection do not begin to secrete 
virus in their urine until age 1 to 2 months. The incidence of perinatal 
infection ranges between 8% (Birmingham, USA) to 56% (Japan) in different 
co mm unities (Stagno et al., 1980). The mother appears to be the principal 
source of virus in perinatal infections. In France it was observed in a 
survey of 10 month old children born to seronegative mothers none 
seroconverted (Cabau at al., 1979). 
Breast milk is a signif-Lcant source of virus in perinatal infections. 
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The highest rates of perinatal infection are observed in communities which 
favour breast-feeding, e. g. Japan and Finland. The babies of 28 mothers who 
secreted virus in their milk were studied. In the survey 0/9 babies that 
were bottle fed experienced an HCMV infection as compared with 11/19 that 
were breast fed. 
The second major potential source of perinatal infection is from 
maternal secretions as the baby passes through the birth canal. It is 
estimated that between 11% and 28% of mothers secrete HCMV from the cervix 
at the time of birth (Reynolds et al., 1973). It is difficult to determine 
the rate at which HCMV is transmitted during birth, as opposed to 
immediately before or after, with any certainty. A study performed in 
Birmingham, USA, however, provides indirect evidence that there may be an 
association. The study found that 40% of children born to women secreting 
HCMV fro m the cervix subsequently went on to develop a neonatal infection 
(Reynolds et al., 1973). 
Although HCMV may occasionally cause pneumonitis, long-term studies 
have yet to identify any other disease associated with perinatal infection 
(Granstrom, 1980). Congenital and perinatal HCMV infections frequently give 
rise to chronic infections, in more than 50% of cases virus was stM being 
secreted in urine at age 6 years (Stagno et al., 1984). These chronic 
infections are normally asymptomatic and do not appear to affect normal 
development. 
1: 6 Infectious Mononucleosis 
HCMV is the causative agent of approxim ately 7% of all cases of 
infectious mononucleosis (Klemola, 1973; Horwitz et. al., 1977). Infectious 
mononucleosis is the only disease of immunologically competent adults which 
has been attributed to HCMV. HCMV mononucleosis is characterised by a 
persistant. fever which lasts for 2 to 5 weeks, peripheral blood 
lymphocytosis, abnormal liver functions, mild hepatitis and a 
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heterophile-negative antibody response (Klemola and Kaariniainen, 1965). The 
m-ajority of HCMV mononucleosis cases occur in individuals over age 15 years, 
the syndrome is not normally associated with CID in neonates. 
Humoral antibody production and NK cell function remain intact 
throughout the infection (Rinnaldo et al., 1977). In vitro measurements, 
however, show that the cytotoxic T-lymphocyte response to stimulation with 
concanavalin A, pokeweed mitogen, specific (HSV-1) antigens and allogenic 
cells is diminished (Rinnaldo et al., 1977). Recovery from the disease has 
been correlated with reparation of the CTL blastogenic response (Carney et 
1983). 
A large absolute increase in the number of CD8 + (OKT8+ or cytotoxic, 
suppressor) T-ceUs and a small absolute decrease in the number of CD4 + 
(OKT4+ or cytotoxic helper) T-ceUs is observed in lymphocyte preparations 
from HCMV mononucleosis patients. This causes an inversion of the 
help er: sup pressor T-cell ratLo (Rinnaldo et aL, 1983; Hirsh, 1984). An 
invertion in the help er: sup pressor cell ratio is associated with a reduced 
level of cellular immunity in AIDS patients, although in AIDS patients the 
invertion appears to be caused by a reduction in CD4+ cell numbers. 
The observed increase in suppressor T-cell numbers may not be the sole 
cause of the depressed CTL response. IE plastic-adherent monocytes are 
extracted from the PBL cells of HCMV mononucleosis patients a recovery in 
the CTL blastogenic response is observed. The re-addition of fresh monocytes 
from HCMV mononucleosis patients, although not from normal donors, to the 
cell culture resulted in the CTL response being suppressed again (Rinaldo et 
ýý, 1980). The interaction between HCMV and monocytes may induce the 
synthesis of a factor which suppresses the CTL response (Hirsch, 1984). 
A small proportion of PBL's infected in vitro (1-15%) will express the 
major IE polypeptide. Monocytes were infected most efficiently (10% of the 
monocyte population) with NK cells (6.3%), B-lymphocytes (1.0%), CD4+ (1.6%) 
and CD8+ (3%) cells also being susceptible (Rice et aL, 1984). The 
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expression of late virus antigens was, however, not detected which indicated 
that the infection was abortLve. The majority of large atypical lymphocytes 
observed in mononucleosis patients belong to the CD8+ grouping and cannot be 
stimulated by mitogens (Hirsch, 1984). HCMV has recently been shown to 
replicate in a subpopulation of CD8+ cells which have been stimulated by 
either interleukin 2 or allogeneic lymphocytes (Braun and Reiser, 1986; 
section 1: 24). 
1: 7 latrogenic Infections 
Following the discovery that HCMV was a causative agent of infectious 
mononucleosis the association was made between HCMV and the post perfusLon 
syndrome (Kaariainen et al., 1966). The post perfusion syndrome develops 2 
to 7 weeks after open heart surgery or treatment which involves the 
transfusion of fresh blood. The disease is clinically similar to infectious 
mononucleosis and is accompanied by a rise in titre of antibody to HCMV 
(Kaariainen et al., 1966). 
The transmission of HCMV by blood transfusion can be averted by storing 
blood for 48h (Paloheimo et al., 1968). Ho (1982) compiled statistics from 
12 prospective studies on the incidence of HCMV infection following blood 
transfusion. HCMV infection were detected in 14% of patients who received 
transfusions with 4%, predominantly seronegative, manifesting symptoms. The 
risk of infection was calculated to be approximately 3% per unit of blood 
transfused. HCMV viraemia was extremely rare being detected primarily in 
patients exhibiting clinical symptoms of infectLon (Cheeseman et al., 1979; 
Rinnaldo et al., 1980; Macher et al., 1983). 
HCMV cannot easily be detected in transfused blood; out of a total of 
1448 uniý of transfused blood collected in the USA and the UK none yielded 
infectious HCMV (compiled by Ho, 1982). Attempts to isolate HCMV from 
lymphocytes of healthy, seropositive blood donors have also been 
unsuccessful (Rinnaldo et al., 1978). Transmission of, _HCMV 
in transfused 
28 
blood may depend on the reactivation of latent virus being harboured in 
lymphocytes. The incidence of infection is reduced when lymphocytes are 
removed from the transfused blood (Lang et ýý, 1977) or the blood is stored 
in a manner which reduces lymphocyte viability (Tolkoff-Rubin et a]L, 1978). 
An exceptionally high incidence of HCMV infection has been observed in 
individuals who received transfusions of purified leukocytes (Winston et 
1980). 
Almost exclusively congenital and neonatal infections are acquired from 
the mother. Neonates who are transfused with seropositive blood are an 
exception. A prospective study found that 13.5% of seronegatLve neonates who 
received transfusions of seropositive blood subsequently secreted HCMV in 
urine (Yeager et al., 1981). 40% (4/10) of infected seronegatLve neonates 
died and 10% (1/10) experienced severe symptoms of a systemic HCMV infection 
(Yeager et al., 1981). Passive protection by maternal antibody is important 
in protecting the foetus and newborn children from a potentially life 
threatening HCMV infection. 
HCMV emerged as a major complication in surgical operations following 
the advent of im munosuppressive drug therapy around 1960. Pass et al. (1980) 
estimated that 90% of renal transplant recipients experienced infection by 
HCMV. Approximately 35% of renal transplant recipients experienced a febrile 
self-limiting disease between 30 to 90 days post transplantation but a 
further 2.3% suffered a disseminating fatal infection (Glen, 1981). In 
recent years a co m bination of using less intensive im m unosuppressive therapy 
and reducing the level of im m unosuppression in response to HCMV infections 
has made HCMV less of a problem for renal transplant operations (Betts, 
1982) 
HCMV infections continue to be a major hazard in bone marrow transplant 
operations. Approximately 80% of bone marrow recipients experience an overt 
HCMV inf ection with 20 % experiencing an .HCM 
V-associated pneu m onia. There is 
an 80% mortality rate for bone marrow recipients who 
develop the 
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HCMV-associated pneumonia (Meyers et aL, 1980). Since the level of immuno- 
suppression cannot be modulated in bone marrow transplant recipients in 
response to infection, treatment of the HCMV-associated pneumonia appears to 
be dependent on the development of effective chemotherapy. A promising 
candidate HCMV anti-viral agent is the acyclovir analogue BW B759U (Biron et 
. 
22:, 1985). 
In a prospective study of bone marrow recipients Quinnen et al. (1981; 
1982) observed that failure to survive infection was correlated with: (a) an 
absence of the NK ceU response at the onset of the infection and (b) a 
subsequent failure to activate the HLA restricted CTL response. A reduced 
help er: sup pressor T-cell ratio was observed in both fatal and non-fatal HCMV 
infections (Schroff et al., 1982; Quinnan and Rook, 1982). An effective CTL 
response is also known to be important in renal transplant patients 
experiencing an infection. HCMV infected renal transplant recipients who 
fail to develop a CTL response experience a systematic disease and a 
viraemia which, although rarely fat4 can lead to graft rejection (Schooley 
et ýý, 1983; Quinnan and Rook, 1984). 
1: 8 HCMV and AIDS 
The term AIDS (acquired immunodeficiency syndrome) is used to describe 
patients suffering from at least one life threatening infection or a Kapos: L 
sarcoma resulting from HIV-(human immunodeficiency virus, the causative 
agent of AIDS) induced immunosuppression. HIV lytically infects CD4+ cells 
which have a "helper" function in stimulating the CTL response. AIDS 
severely compromises the cellular immune response which normally copes 
efficiently with HCMV infections. Almost all AIDS patients experience overt 
symptoms of an HCMV infection. Rook et al. (1985) isolated infectious HCMV 
from 54/56 AIDS patients and in 37/56 cases the virus was associated with 
buffy coat cells. Typically severe HCMV infection is seen at a late stage in 
AIDS with a progressive HCMV viraemia being associated with a concomitant 
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decrease in the CTL and NK responses. In a histological study performed at 
autopsies on 15 patients who had succumbed to AIDS there were extensive HCMV 
lesions in both the lungs and adrenal glands in 14 cases (Macher et al., 
1983). Lesions produced by disseminating HCMV infection have been described 
in a wide variety of tissues and organs (Reichert et al., 1985). 
HCMV-induced pneumonia has been reported to be the most frequent cause of 
death in AIDS patients (Reichert et al., 1985). It is not clear if the 
im munosuppressive properties of HC MV infection contributes towards the 
syndrome or if HCMV is purely an opportunistic pathogen. 
1: 9 Oncogenicity 
HCMV is able to morphologically transform cells in culture. Albrecht 
and Rapp (1973) observed that foci of non-contact inhibited cells were 
produced when hamster embryo fibroblasts were infected with uv-irradiated 
virus. Similarly, infection of HEF cells with the slow-growing genital HCMV 
isolate, strain Mj, induced the production of morphologically transformed 
cells (Geder et al., 1976). In both cases cultured cell lines expressed HCMV 
antigens and were found to induce tumour formation when injected into 
animals. Continuous passage of the human cell line resulted in a decrease in 
both the expression of virus antigen and the tumorogenicity of the cells. 
In DNA transfection experiments Nelson et al. (1982) were able to 
reproducibly transform murine NIH 3T3 cells with restriction endonuclease 
digested HCMV strain AD169 genomic DNA and cloned subgenomic fragments. 
11/12 of these transformed cell lines were shown to be able to induce tumour 
formation when injected into BALB/c nude mice (Nelson et al., 1982). The 
major transforming region was mapped to a 490bp DNA fragment in the genome 
of strain AD169 (Nelson et aL, 1984). RNA transcripts of 5.4kb and 6.25kb 
are encoded by this region during the IE, early and late phases of infection 
(Jahn et aL, 1984; Wilkinson et al., 1984). However, the longest ORF 
associated with the transforming sequence would encode a polypeptide of only 
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41 amino acids (Kouzarides et al., 1983; Nelson et al., 1984). Additionally, 
S-1 nuclease mapping experiments indicate that transcripts derived from the 
transforming region are not spliced (Nelson et al., 1984). The mechanism by 
which the 490bp DNA fragment induces transformation is not known. Attempts 
to detect the integrated HCMV sequences in DNA purified from transformed 
cells have so far been unsuccessful (Nelson et al., 1982). 
In a different series of experiments Clanton et al. (1983) identified 
regions within the HCMV strain Towne genome which appeared to share homology 
with transforming regions of HSV-2 DNA. Transfection of normal syrian 
hamster cells with the cloned strain Towne DNA Xbal fragment E (which 
showed limited homology with the HSV-2 1IL111 fragment C) resulted in the 
production of refractile rapidly-growing, immortalised cell colonies. These 
transformed cell lines also induced tumour formation when injected into 
athymic mice. The transforming regions identified within strains AD169 and 
Towne mapped to adjacent fragments on the genomes of their respective 
viruses but were distinct. HCMV strain Towne Xbal fragment E is abundantly 
transcribed during the IE phase of gene expression (Wathen and Stinski, 
1982). 
It has been reported that a number of regions of the HCMV genome shares 
homology with the oncogene v-myc (Gelmann et al., 1983; Spector and 
Vacquier, 1983). Nucleotide sequence analysis has shown, however, that the 
hybridisation between HCMV and myc sequences under low stringency conditions 
was not due to sequence homology, merely nonspecific annealing of GC-rich 
DNA fragments (Kouzarides et al., 1983; Nelson et al., 1984; Rasmussen et 
al., 1985). 
HCMV transforms cells in vitro relatively inefficiently, as compared 
with avian sarcoma virus and avian leukosis virus (Nelson et aL, 1982), but 
the transformed cell lines which are produced are usually tumorogenic. The 
Herpesviridae contains a number of viruses which cause or are strongly 
associated with 
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antibody has been associated with prostatic adenocarcinomas (Kunkel et al., 
1980; Boldogh et al., 1981), cervical cancer (Melnick et al., 1981), colonic 
adenocarcinomas (Hashiro et al., 1979; Roche etý al., 1981) and Kaposi's 
sarcoma (Giraldo et al., 1972; 1975; 1978; Irew et al., 1982). The clinical 
evidence is, however, circumstantial and it has yet to be demonstrated that 
HCMV either causes or contributes directly or indirectly towards tumour 
production in vivo. 
1: 10 The Virion 
The basic morphology of herpesvirions has been conserved throughout the 
group. An herpesvirions contain four distinct structural elements: a core 
containing DNA, an icosohedral capsid (110-120nm in diameter) consisting of 
12 pentameric and 150 hexameric capsomeres, an electron-dense tegument 
region surrounding the capsid and an outer lipoprotein envelope (Fig 1: 1; 
Wildy et 
. 
2L, 1960). The size of herpesvirions can vary signifIcantly 
depending on the amount of tegument protein taken up, HSV-l virions have 
been observed to vary between 120nm to 180nm in diameter (McCombs et al., 
1971). 
A number of features distinguish the virions of HCMV and HSV-1. The 
HCMV core was observed by electron microscopy to be comprised of seven or 
more globular subunits whereas the HSV-1 core was a single continuous 
structure (Smith and DeHarven, 1973). It has recently been reported that 
HCMV may possess a second loose-fitting outer envelope which is easily 
removed by osmotic shock (Farrar and Oram, 1984). Surface projections, or 
spikes, are present on the outer surface of HSV-l envelopes but they have 
yet to be detected on HCMV virions. 
Three different types of enveloped particle are produced during an HCMV 0 
infection: (a) dense bodies; non-infectious, spherical, electron-dense 
particles which contain large amounts of tegument protein (Sarov and Abady, 
1975; Gibson, 1981a), (b) non-infectious enveloped particles (NIEPs) -which 
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Simian CMV 
(Kdaltons) 
HCMV 
(Kdaltons) 
Comments 
205 212 virion protein 
145 153 major capsid protein 
119 149 abundant basic phosphoprotein 
(tegument) 
129 140 non-virion 
122 minor vi rion phosphoprotein 
112 115 . virion 
110. minor virion phosphoprotein. 
94 minor virion phosphoprotein 
88 minor virion phosphoprotein 
78 80 minor virion phosphoprotein 
75 minor virion phosphoprotein 
69 74 abundant tegument phosphoprotein 
(upper matrix protein) maps to 
HindIII Li c and b (a) 
66 69 most abundant tegument phospho- 
protein, (lower matrix protein) 
maps to HindIII L, c and b (a) 
67 abundant tegument phosphoprotein 
protein kinase, maps to 
HindIII D (b) 
53 minor virion phosphoprotein 
51 52 non-virion, nuclear, DNA binding 
protein, maps to HindIII M (c) 
43 minor virion phosphoprotein 
40 42 virion 
38 39 virion 
37 35 abundant non-virion, assembly 
protein, present in B-capsids 
and NIEPs 
34 34 minor capsid protein 
32 32 minor virion 
29 virion phosphoprotein, 
cytoplasmic 
27 minor virion 
24 minor virion phosphoprotein 
Envelope Glycoproteins 
250 
130 in complex with gp52 
95 in complex with gp52 
67 
52 in complex with gp52 and gpl30 
homology with gB of HSV-l and 
EBV, maps to HindIII F (d) 
Table 1: 4: Summary of Simian CMV strain Colburn and HCMV late 
ICSPs modified from Gibson (1983). Sizes of the glycoproteins was 
from HCMV strain AD169 (Farrar and Oram, 1985). Sizes of the 
unglycosylated HCMV protein were from strain 751 (Gibson, 1983) 
except for the 24,43,53,75,88,94,110 and 122 K minor 
phosphoproteins (strain AD169; Roby and Gibson, 1986), the 29 K 
phosphoprotein (strain AD169; Nowak et al., 1984a) and the 67 K 
protein kinase (strain Towne; Davis et al., 1984). The map 
location of the genes encoding the polYPep7ides was described in 
(a) Nowak et al., 1984b, (b) Davis et al., 1984, (c) Mocarski et 
al., 1985b aý-d -(d) Cranage et al., 198-(; -. - 
contain the same proteins as infectious virions plus an additional 35K 
protein (the assembly protein, see section 1: 22) but no DNA (Irmiere and 
Gibson, 1983) and (c) complete virions. 
It has been estimated that HCMV virions contain between 33 to 35 
polypeptides with molecular weights ranging from less than 10K to greater 
than 200K (Sarov and Abady, 1975, Fiala et al., 1976; Kim et al., 1976; 
Stinsk4 1976; Gupta et al., 1977; Stinski, 1977; Gibson, 1981a; Irmiere and 
Gibson, 1983). The composition of different HCMV isolates has been shown to 
be almost identical with respect to the size and number of the constituent 
protein species (Gupta et al., 1977). HCMV polypeptides are usually 
identified by their apparent molecular weights determined by SDS-PAGE. 
Unfortunately this system creates a degree of confusion as the same protein 
species is given a different designation by different groups. The 
terminology adopted in Table 1: 4 will be sustained throughout this thesis. 
Four enzymic activities have been detected in isolated virions: a DNA 
nicking activity (Landini et aL, 1982), a DNA polymerase (Mar et aL, 1981) 
and two distinct protein kinase activities (Mar et aL, 1981; Roby and 
Gibson, 1986). One of the protein kinases specifically phosphorylated 
tegument proteins in an in vitro assay (Mar et aL, 1981; Roby and Gibson, 
1986) while the other was able to phosphorylate an exogenous (casein) 
substrate (Roby and Gibson, 1986). Both protein kinase activities were found 
to be associated with the virion tegument fraction and were biochemically 
distinct from the protein kinase which is induced in HCMV infected ceus 
during the early phase (Michelson et aL, 1984). An abundant 67/68K 
tegument phosphoprotein has been shown to be responsible for one of the 
virion protein kinase activities (Davis and Huang, 1985; Britt and Auger, 
1986). The gene encoding this protein has been mapped on the virus genome 
(Davis et al, 1984) and its DNA sequenced (Davis and Huang, 1985). 
-egument proteins, like those of HSV-1, are The majority of HCMV 't 
phosphorylated (Table 1: 4; Lemaster and Roizman, 1980). Interest 
has 
36 
x CO 
< 
- - 
Z 
x 
< 
LL 
LU 
< 
r"j E 
rr 
> Z 
0 
CO 
Xxx 
5z 
- - j2 
Z U cc - 
U) 
: 
0= m , 
Z-- 
: Ef 
CO 
U- LLJ j 0 
0 
im 
lp 10 
01 
-il -il-k 
0 Co 
0 
0 
x 
n 
LL 
> 
o 
N 
. 
Jc- 
- C x 
CO 
CO -) 
:D 
ui 
-T- 
N 
co 
7- 
LLI 
E 
UJ 
(D 2C 
, Z) = - 
w 
0 z 
C) m 
CO 
> U) : z LL 
0 
3 
0 - - - 
CL - .0 
I-A 
i 
C-0 LU 
x ca K 
0 CV 
N 
0 
0 
R 
0 
0 gn 
14 
00 
Co 
10 
cu 
az 
-4 
tz 
Co «Z: 
Co 
Z Z: 
CL 
u 
E 
0 
cö 
00 
Co 
Q) 
Co 
recently focused on the herpesvirus tegument proteins following the 
demonstration that the HSV-1 Vmw65 tegument protein stimulates transcription 
from HSV-1 IE promoters (Campbell et, al., 1984). It is not yet clear whether 
HCMV encodes a similar trans-acting virion component (Spaete and Mocarski, 
1985b; Stinski and Roehr, 1985). 
1: 11 The Virus Genome 
The molecular cloning of the HCMV DNA has been crucial in studies of 
genome structure and function. Restriction endonuclease cleavage maps have 
been constructed for strains AD169 (Fleckenstein et al., 1982; Greenaway et 
. 
2L, 1982; Oram et al., 1982; Spector et al., 1982; Westrate et al., 1980), 
Davis (DeMarchi, 1981), SG (Westrate et al., 1983) and Towne (LaFemina and 
Hayward, 1980; Thomsen and Stinski, 1981). A detailed restriction 
endonuclease map of strain AD169 is shown in Fig 1: 2. The Hindl1I cloned 
subgenomic DNA fragments used in the construction of this map were also used 
in experiments performed for this thesis. 
The HCMV genome, contained in infectious virions, is a linear double 
stranded DNA molecule of approximately 235kb or 150 x 10 
6 daltons 
(Kilpatrick and Huang, 1977; Demarchi et al., 1978; Geelen et ab 1978; 
Lakeman and Osborn, 1979, Stinski et al., 1979) with an overall G+C content 
of 58% (Crawford and Lee, 1964; Huang et jIL, 1973). Purified full length 
HCMV DNA is infectious when transfected into human embryonic lung cells; 
HCMV replication, therefore, is not absolutely dependent on any enzyme which 
may be carried in infecting virions (Geelen et al., 1978). 
Herpesvirus genomes can be divided into three different classes on the 
basis of their structural organisation (Fig 1: 3; Honess and Watson, 1977). 
The class 1 herpesviruses are the most straightforward; their genomes 
contain direct repeats of DNA elements but are not subject to 
rearrangement, ie. segment inversion, during DNA replication and therfore 
consLst of a single isomeric form of DNA (Fig 1: 3). Three different types of 
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Fie 1: 3: There are three classes of herpesvirus genomes. (a) class 1 
genomes exist in a sinile isomeric form even though they can contain a 
variety of repeated DNA elements as is illustrated for the genomes of 
CCV, HVS and EBV. The GC-rich TR region of HVS is known as H-DNA. (b) 
Class 2 herpesvirus genomes exist in two isomeric forms: the prototype 
(P) orientation and with an inverted short (S) region (the I 
conformation). (c) Both the L (long) and S components of class 
herpesviruses can be inverted relative to each other so that their 
genomes exist in four equimolar isomeric forms: the prototype (P), with 
an inverted short region (I ), with an inverted long region (I L) and 
with both the long and shorý regions inverted (I LS) . The a sequence is 
present in at least one copy at both termini and, in an inverted 
orientation, at the L-S junction. The remainder of the long (TR L and 
IR L) and short 
(TR S and IRS) repeats are made up of a sequence 
designated b or c respectively. The prime sign indicates the sequence 
is inverted. 
class 1 genomes have been identified and are represented in figure 1: 3 by 
channel catfish virus (CCV), herpesvirus saimiri (HVS) and EBV. The CCV 
genome consists of a long unique (U L) region flanked by a repeated sequence, 
both copies of the terminal repeat (TR) being in the same orientation 
(Chousterman et al., 1979). The second type of class 1 genome structure is 
similar to that of CCV except that the TR sequences (H-DNA in Fig 1: 3) 
comprise multiple tandem reiterations of the same short sequence, in the 
case of HVS the repeats are 1.4kb long (Fleckenstein and Desrosier, 1982). 
EBV, representing the third type of class 1 genome, has terminal repeats 
containing reiterated sequences similar to those of HVS plus an additional 
internally repeated element (IR) comprised of multiple reiterations of a 
different repeat. An analysis of the nudeotide sequence of EBV has 
identified further less extensive repeated elements elsewhere on the genome 
(Baer et al., 1984). 
Class 2 herpesvirus genomes contain aUL and a short unique (US) 
region with the US region being flanked by inverted repeats (IR S and TR S). 
The short component (S) of the genome can become inverted, relative to the 
long component (L), during replication thus generating two equimolar 
isomeric forms of genomic DNA (Fig 1: 3). A small proportion of purified 
virion VZV DNA (5%) also has an inverted L component. This subpopulation, 
however, is thought to be generated during the process of DNA packaging 
rather than a structural rearrangement of the VZV genome caused by 
recombination during DNA replication (Davison, 1984). 
The class 3 herpesvirus genomes contain UL and US regions each flanked 
by a different inverted repeat (TR L' IR L; IRS, TRS). The L and S components 
of the genome can invert, relative to each other, during replication which 
results in there being four different isomeric forms of virus DNA (Fig 1: 3). 
The four different isomers are present in equimolar concentrations in virion 
DNA preparations. HCMV, like HSV-1, has a class 3 genomic structure. 
Restriction endonuclease digestion of HCMV virion DNA generates a 
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complex mixture of molar and submolar (derived from the termini and internal 
repeats of the different isomers) DNA fragments. The submolar DNA fragments 
derived from the L-S junctions and both termini exhibit a stepped 
heterogeneity in size which is seen as a DNA 'ladder' following agarose gel 
electrophoresLs (LaFemina and Hayward, 1980; Tamashiro et al., 1982). A 
similar size heterogeneity in the TR L and junction fragments of HSV-l DNA is 
due to the presence of multiple copies of the a sequence; the HSV-1 a 
sequence is a 265bp DNA element which is present in the same orientation at 
both termini of the HSV-1 genome (Wagner and Summers, 1978) and in the 
inverse orientation at the L-S junction (Davison and Wilkie, 1981). The a 
sequence is involved in both the inversion of L and S segments during virus 
DNA replication (Chou and Roizman, 1985) and in the packaging of virus DNA 
into capsids (Mocarski et al., 1985a). 
HybridisatLon experiments demonstratated that the DNA sequence which 
spans the HCMV L-S junction is also present, in an inverted orientation, at 
both termini. The HCMV genome therefore contains a terminal redundancy 
similar to the HSV-1 a region (LaFemina and Hayward, 1983; Tamashiro et al., 
1984). The 553bp a sequence of strains AD169 (Tamashiro et aL, 1984) and 
the 762bp a sequence of strain Towne (Spaete and Mocarski, 1985a) was 
determined by DNA sequence analysis of their L-S junctions. In addition to 
straightforward duplication of the a sequence the genome of strain AD169, 
and to a lesser extent also strain Towne, contains a complex series of a 
variants which appear to have been produced by a combination of deletion and 
recombination events (LaFemina and Hayward, 1983; Tamashiro et al 1984; 
Tamashiro and Spector, 1986; Spaete and Mocarski, 1985a). 
In spite of their size difference the a component of strains AD169 and 
Towne share regions of extensive sequence homology. The a sequences of HCMV 
strains AD169 and Towne both contain direct repeats which are analogous to, 
but do not share homology with, repeats found in the HSV-1 a sequence 
(Davison and Wilkie, 1981). There is, however, a 26bp sequence (CGGGGGGGTGT- 
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TTTTAGCGGGGGGGGGGT) which is identical in strains AD169 and Towne and shares 
significant homology with a sequence contained within the a components of 
HSV-1, HSV-2, VZV, EBV and HVS (Tamashiro et. al, 1984; Spaete and Mocarski, 
1985a; Tamashiro and Spector, 1986). The conserved sequence (the herpes 
pac-2 homology; Deiss et al., 1986) is found between 25 to 35 bases from the 
end of herpesvirus genomes and is thought to represent one of the SLs-acting 
signals which direct the cleavage of concatemeric herpesvirus DNA into unit 
length and packaging into capsids (Spaete and Mocarski, 1985a; Tamashiro and 
Spector, 1986). 
Spaete and Mocarski (1985a) have demonstrated that the 966bp Kpnl/Xbal 
fragment from the HCMV strain Towne L-S junction can functionally complement 
in cis a deletion of the HSV-1 a sequence in an HSV-1 amplicon. HSV-1 
amplicons are eukaryotic plasmid vectors containing an HSV-1 origin of 
replication and a cleavage/packaging (the HSV-1 a sequence) signaL With the 
aid of functions provided by HSV-1 helper virus, the amplicon is replicated 
and packaged into virions as long tandemly repeated molecules of 
concatemeric DNA. The ability of the HCMV a sequence to replace the 
functions provided by the HSV-1 a sequence in HSV-1 amplicons has a number 
of interesting implications. The result implies that (a) the limited 
homology which eyists between the a sequences of HSV-1 and- HCMV may be 
sufficient to delineate the ci-s-acting herpesvirus cleavage-packaging 
signal, (b) the processes involved in the packaging HSV-1 and HCMV DNA have 
been conserved from a common ancestral herpesvirus and (c) HCMV may contain 
additional genes with functional equivalents on the HSV-1 genome (Spaete and 
M ocarski, 1985a). 
In spite of the functional conservation of cleavage-packaging signals 
between HCMV and HSV-1 DNA hybridisation experiments have shown that HCMV 
shares little homology with HSV-1, HSV-2, EBV and nonhuman members of the 
betaherpesvirinae (simian CMV strain Colburn and murine CMV; Huang and 
Pagano, 1974). An analysis of the nucleotide sequence of the HCMV strain 
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AD169 S region was unable to detect any DNA or protein sequence homology 
with other characterised human herpesviruses and indicates that organisation 
of genes within the HCMVUS region is different to that of HSV-1 and VZV 
(Weston and Barrell, 1986). Although the level of sequence homology between 
HCMV and HSV-1 is limited, cross-hybridisation can be detected in conditions 
of low stringency (Clanton et al., 1983). Recently an analysis of the 
nucleotide sequence of HCMV HindIll fragment F has revealed homology at the 
amino acid sequence level between both a glycoprotein (designated gB in 
HSV-1) and the DNA polymerase genes of HSV-1, VZV, EBV and HCMV (Cranage et 
. 
22:, 1986; Kouzarides at al., 1987a). 
A comparison of the restriction endonuclease cleavage patterns of 
clinical isolates (Kilpatzick and Huang, 1977; Huang et aL, 1980) and the 
available restriction endonuclease maps of laboratory strains indicates that 
the HCMV genome has been highly conserved. DNA/DNA reassociation experiments 
have shown that the genomes of strains AD169 and Towne are approximately 90% 
homologous and that the differences are concentrated in defined areas, 
notably the XbaI fragments A, C, G and J of strain AD169 (Pritchett, 1980). 
A region of significant interstrain variability has been mapped within and 
adjacent to the long inverted repeats (LaFemina and Hayward, 1980). In 
strain AD 169 the TRL ad IR L elements are approximately 11.5kb and the IR s 
and TR s elements approximately 
2.5kb (Spector et aL, 1982). The TR L /IR L 
elements of strain Towne are a similar size (LaFemina and Hayward, 1980), 
but those of the Davis (less than 4kb; Demarchi, 1984) and SG (approx. 3kb; 
Westrate et aL, 1983) strains are significantly smaller. It is relevant to 
note that HCMV is the only class 3 betaherpesvirus which has been 
idendaed; bovine (Ehlers et al., 1985), guinea pig (Gao and Isom, 1984), 
murine (Mercer et aL, 1983) and simian strain Colburn (LaFemina and 
Hayward, 1980) CMV's all do not contain inverted internal repeats. In 
evolutionary terms, the HCMV genome may have acquired its internal repeats 
relatively recently. Honess (1984) proposed that the variation in size of 
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the repeats in different HCMV strains im plies that their length is not 
efficiently constrained by selective pressure; in HSV-1 a number of IE genes 
essential for efficient virus replication map in the region of inverted 
repeats and may be instrumental in controlling their sLzes (Whitton and 
Clements, 1984). 
Recently strain AD169 DNA was shown to share limited homology with 
cel-lular DNA of human, owl monkey, chinese hamster but not murine origin. 
The homologous sequences were mapped on the HCMV genome to four distinct 
parts of the UL region and one within the inverted repeats (Ruger et aL, 
1984). Simian CMV strain Colburn also hybridises with cellular DNA. The 
cross-hybridising region of strain Colburn has been sequenced and was shown 
to be caused by repeats of the dinucleotide CA (Jeang and Hayward, 1983). 
The strain Colburn CA-rich sequence is in the same relative position on the 
simian CMV genome as the L-S junction is in HCMV. The significance of the 
homologies between HCMV or simian CMV and cellular DNA is not clear. 
1: 12 Virus Entry Into Permissive Cells 
While characteristically cytomegaloviruses have a relatively slow 
growth cycle, the initial events in an HCMV infection proceed rapidly. 02 
Microglobulin bound to the surface of HCMV virions (McKeating et jL1,, 1987) 
is thought to enable the virion to attach to HLA class 1 molecules on the 
cell surface (Grundy 
. 2t . 
2L, 1987). HCMV enters the ce. 11 by fusion of the 
virion envelope with the outer cell membrane (Iwasaki et al., 1972; Smith 
and DeHarven, 1974). Nucleocapsids stripped of their envelopes migrate 
rapidly to the nucleus where they can be detected, adjacent to the nuclear 
pores, 5 min p. i. (Smith and DeHarven, 1974). Nucleocapsids are not detected 
inside the nucleus at this time, which implies that DNA may be 'injectedt 
directly from the capsid into the nucleus. Virus DNA is detected in the 
nucleus 20 min p. L (Wahren et al.; 1984). Virus infection has an immediate 
effect the cellular morphology; microvilli and large "vesicular 
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protuberances" develop on the cell surface (Garnet, 1979). Stimulat: Lon of 
chromatin activity (Kamata et al., 1978) and the expression of nuclear 
antigen (Michelson-Fiske et al., 1977; Reynolds, 1978) are detected within lh 
P. L 
1: 13 Development of the C. P. E. 
HCMV was named after the c. p. e. it produces. The c. p. e. which first 
appears during the early phase, however, is not a cytomegalia. Between 5-12h 
p. i. permissive cells become increasingly refractile, round up and there is 
a significant contraction in size (Stinski, 1977). At 5h p. L the nucleus 
becomes marginated, irregular in shape and develops a single ring-shaped 
granular inclusion made of a fibrMar material (Calval-lo et al., 1981). The 
onset of the early c. p. e. coincides with an influx of Ca2+ ions into cell 
(Albrecht et al., 1984). The increase in Ca 
2+ 
concentration inside the cell 
appears to be essential for virus replication. Inhibitors of Ca2+ transport, 
such as Verapamil and Papaverine, are able to block the development of the 
early c. p. e. and virus replication (Albrecht et al., 1984). 
During the course of the early phase infected cells continue to 
contract and the nuclear inclusion becomes larger and better defined. By 24h 
p. L the nucleus has adopted a regular reniform shape and is marginated 
(Cavallo, et al., 1981). A large juxtanuclear body, which takes up a 
lipid-staining dye (Sudan IV) can be observed, at this time, with a light 
microscope. When the cells were stained with acridine orange, a nucleic acid 
staining dye, the cytoplasmic vesicle was unstained but was encircled by an 
orange halo of RNA (McAllister et al., 1963). The cytoplasmic vesicle itself 
is composed mainly of golgi apparatus (Iwasaki et al., 1973; Smith and 
DeHarven, 1973). 
The cytoplasmic networks of actLn and intermediate filaments 
dissociate during the first 24h p. i. and do not reform during the late phase 
of infection (Losse et al., 1982; Albrecht et al., 1984). Actin, which 
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continues to be synthesised, becomes associated with the perinuclear region 
(Losse et, al., 1982) whereas protein from the intermediate filaments 
migrates into the nucleus where it appears to become a major component of 
the nuclear inclusion (Albrecht et, al., 1984). 
After 24h pi. infected cells show a gradual but large increase in size 
and the characteristic late phase 'cytomegalia' developes. Infected cells 
become less rounded and by 72-144h p. L taking on an epithelial, shape. Both 
the nucleus and nucleolus expand in line with the rest of the infected cell. 
The fibrillar network of ring-shaped nuclear inclusions spreads through the 
whole of the expanded nucleus as the infection proceeds encircling electron 
translucent areas (Calvallo et al., 1981). 
1: 14 Three Phases of HCMV Gene Expression 
Transcription and replication of the virus genome takes place in the 
nucleus. HCMV operates a cascade system of gene regulation in which an 
increasing number of virus encoded RNA and protein species are synthesised 
during the course of a productive infection (Stinski, 1977; Stinski 1978; 
Wathen et aL, 1981). The HCMV infectious cycle is conventionally divided 
into three phases: immediate early (IE or r), early (or 5) and late (orlt). 
The IE phase encompasses the events occuring after virus infection but 
prior to de novo virus-encoded protein synthe-, ds. Although IE gene 
expressLon is almost completely dependent on unmodified cellular 
transcriptional, RNA-processing and translational systems, a HSV-1 tegument 
protein, taken up by cells during virus adsorption, has been shown to 
stimulate HSV-1 IE transcription (Campbell et al., 1984). It has recently 
been proposed that HCMV virions contains a sLmilar function (Spaete and 
Mocarski, 1985b; Stinski and Roehr, 1985). The transition from IE to early 
phase gene expression occurs rapidly (Blanton and Tevethia, 1981). In order 
to study the IE phase gene products (RNA and protein) cells are infected and 
maintained in the presence of an inhibitor of protein synthesis (such as 
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Fig 1: 4: Histogram showing levels of hybridisation beteen IE, 
early and late phase cytoplasmic poly (A)+ RNA and different 
regions of the HCMV genome (from Wilkinson, 1983). The 
hybridisation was performed against dot blots of cloned HCMV 
HindIII fragments except for the inverted repeat regions where the 
PstI fragment B was used. The level of hybridisation, determined 
by densitometry, was divided by the molecular weight of the 
cloned fragment to give the value plotted. Transcription from 
sequences adjacent to the inverted repeats was not investigated in 
this experiment. The position of HindIII fragments is shown. 
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cycloheximide) for 1h before and up to 12h after infection. Cycloheximide 
prevents the transition from the IE to the early phase by inhibiting ýe novo 
virus-encoded protein synthesis. Treatment with an inhibitor of protein 
synthesis enhances IE transcription and thereby facilitates studies of IE 
gene expression. Enhanced IE protein synthesis is obtained by releasing 
infected ceUs from the translational (cycloheximide) block in the presence 
of an inhibitor of transcription, such as actinomycin D. 
Early phase gene expression extends from the onset of virus encoded 
protein synthesis up until the inidad n of virus DNA replication. Early 
RNA is routinely purified from cells grown in the presence of an inhibitor 
of the virus DNA polymerase (such as PFA) up to 24h pj- 
Late genes are defLned as those expressed after the initiation of virus 
DNA replication. The transition from early to efficient late phase gene 
expressLon takes place by 96h p. L 
The use of metabolic inhibitors helps to delineate the bounderies 
between the different phases of gene expression. Gene products synthesised 
during one phase may continue to be synthesised during subsequent phases. 
A dditionally, the division of the HCMV replicative cycle into the IE, early 
and late phases does not exclude the possibility that specifLc or 
co-ordinated changes in gene regulation occurs at other stages of infection. 
1: 15 IE RNA Transcripts 
An estimated 90% of cytoplasmic poly (A)+ IE RNA is derived from two 
re&Lons of the virus genome; the 20.35kb HindBI fragment E and 6.6kb of 
DNA at the junction of HindEl fragments J and Z (Fig 1: 4; DeMarchi, 1981; 
Wathen and Stinski, 1982; DeMarchi, 1983a; McDonough and Spector, 1983; 
Wilkinson, 1983). The size, number, and in some cases, the orientation of 
transcription of IE RNA species has been determined in experiments in which 
cloned subgenomic DNA fragments were hybridised with 'Northern' transfers 
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Fig 1: 5: The pattern of IE transcription from (a) the HCMV strain 
AD169 genome (Wilkinson et al., 1984) and (b) the HSV-l genome 
(Rixon and Clements, 1982; Perry et al., 1986). HCMV IE RNAs are 
identified by their sizes (kb) whereas HSV-l IE RNAs have been 
given their agreed designations, 1-5. The positions of introns (A) 
in HSV-l transcripts are shown. 
Fig 1: 5; Wathen et aL, 1981; Wathen and Stinský 1982; DeMarchi, 1983c; 
Wilkinson, 1983; Jahn et. al., 1984; Wilkinson et al., 1984). HCMV strain 
I AD 169 encodes at least one major, four middle abundant and ten minor size 
classes of IE RNA (Fig 1: 5). For ease of reference HindDI fragment E has 
been subdivided into IE coding regions 1,2 and 3 as described in Figs 1: 6 
(Stinski et al., 1983) and the HindIII J/Z junction has been designated IE 
coding region 4. 
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IE C oding R egion 1 The m ost abundant IE mRNA encoded by HCMV strains AD 169 
(1.95kb; Wilkinson, 1983; Jahn et al., 1984), Davis (2.2kb; DeMarchi, 1983c) 
and Towne (1.95kb; Wathen and Stinski, 1982) map to the same relatLve 
position, within the UL region, of each genome ([E coding region 1; Fig 
1: 6). The 1.95kb IE transcripts of strains AD169 and Towne have been 
precisely mapped by DNA/RNA hybridisation experiments between 0.762 and 
0.745 map units on their respective virus genomes. Within the IE genes of 
strains AD169 and Towne the orientation of transcription is the same, the 
relative positions of the BamHI, Lstl and Sstl restriction endonuclease 
cleavage sites are similar and the transcriptional initiation sites, 
identified by in vitro transcription experiments, are identical (Stinski et 
1983; Wilkinson, 1983; Thomsen et al., 1984). The strain AD169 and 
Towne major 1.95kb IE mRNAs were shown to be transcribed from at least 
2.85kb of genomic DNA; indicating that in both strains AD169 and Towne at 
least 0.9kb of the initial transcript was excised by splicing. Work 
performed for this thesis (Akrigg Lt ýý, 1985) and by Stenberg et al. 
(1984) has precisely mapped the positions of three introns in the major IE 
genes of strains AD169 and Towne (Fig 1: 6). 
Hybrid selected translation (HST) experiments have been used to 
identify and map some of the products of IE gene expression. In HST 
experiments RNA encoded by a specific gene is selected by hybridisation with 
the appropriate cloned subgeno mic DNA frag m ents im m obilised on a solid 
Fig 1: 6: HCMV IE coding regions 1 to 4. (a) HindIII fragment E 
contains IE coding regions 1 to 3 and (b) IE coding region 4 goes 
across the junction of HindIII fragments J and Z. The splicing 
pattern for the major 1.95 kb IE RNA of strains AD159 and Towne 
are identical (this thesis; Stenberg et al., 1984). The 
transcriptional data for RNAs derived from IE coding region 2 is 
from Stenberg. 2tal., 1985). Although detailed transcriptional 
mapping data for IE coding region 2 of strain AD169 is not 
available it is known to encode IE RNAs of 1.7 kb and 2.25 kb but 
not 1.4 kb (Wilkinson et al., 1984). Data for IE coding regions 3 
and 4 is for strain ADý1-6§-(Wilkinson et al., 1984). The position 
of some BamHI (J), EcoRI HindIII 
T4-. Tand SstI (AL) sites are 
shown. 
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matrix (e. g. a nitrocellulose membrane). Following extensive washing, to 
remove all non-homologous RNA, the annealed mRNA is eluted and translated in 
vitro in a rabbit reticulocyte lysate. The results of experiments performed 
using strains AD169 and Towne IE RNA are detailed in Table 1: 5. HST 
experiments have shown that the major IE polypeptide is the product of IE 
coding region 1 in strains AD169 (Wilkinson et aL, 1984), Davis (DeMarchi, 
1983) and Towne (Stinski et aL, 1983). 
IE Coding Region 2: The pattern of transcription from coding region 2 is 
complex (Figs 1: 5 & 1: 6). The nucleotide sequence region 2 in the Towne 
strain has been determined and a partial characterisation of RNA splicing 
accomplished (Stenberg 
. 
2t ýý, 1985). At least five RNA species (1.1,1.4, 
1.7,1.7 and 2.25kb) have been mapped to IE coding region 2 of strain Towne 
(Stinski et al., 1983; Stenberg 
. 
2t ýý, 1985). The 1.4kb, the spliced 1.7kb 
Virus 
strain 
Towne a Coding region 1 (HST) 
Towne aC oding b region 2 (HST) Towne Coding region 2 (seq) 
Towne 
D16 
c Total d 
(Immunoppt) 
9 A Total (Immunop pt ) 
AD169 e Coding region 1 (HST) 
AD169 e Coding region 2 (HST) 
AD169 e Coding region 4 (HST) 
75 
75 
75 72 68 
78 77 73 
75 
78.5 78 
Polypeptides 
(Kdaltons) 
39 
56 42 21 16.5 
51 48 30 27 
59 39 21 19 
31 
62 59 
51 47 40 
a Stinski et al., 1983. b 
c 
Stenberg et al., 1985. 
d Stinski, 1978. 
e 
Blanton and Tevethia, 1981. 
Wilkinson et al., 1984. 
Table 1: 5: A comparison of IE polypeptides identified by 
immunoprecipitation, hybrid selected translation (HST) and 
predicted from nucleic acid sequencing/nuclease protection studies 
(seq). The existance in vivo of proteins predicted from nucleotide 
sequence/nuclease prTtJ-tion data has yet to be confirmed 
experimentally (Stenberg tt . 21., 
1985). The major IE polypeptides 
are shown in bold type. The major IE coding regions 1 and 2 are in 
the same relative positions on the genomes of strains AD169 and 
Towne as is described in Fig 1: 3. 
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and the 2.25kb mRN As respectively were shown to contain 2,4 and 3 introns 
and to encode polypeptides of 27K, 48K and 51K. Transcription of these three 
spliced mRNA species is thought to be initiated from the major IE gene 
promoter in IE coding region 1 (Stenberg et 2L, 1985). Stenberg et, al. 
(1985) proposed that the translation products of the spliced 1.7kb and 
2.25kb mRNAs both contain a short sequence in common with the amino terminus 
of the major IE polypeptide. Transcription of a second 1.7kb mRNA, which is 
thought to encode a 30K polypeptide, was initiated immediately downstream 
from the major IE gene; using a promoter which overlaps the 3' end of the 
major 1.95kb mRNA coding region. 
In HCMV strain AD169 two middle abundant size classes of IE RNA are 
transcribed from within 0.7kb downstream from the terminus of the major IE 
gene and in the same orientation (Wilkinson et al., 1984); equivalents of 
the strain Towne 1. lkb and 1.4kb IE mRNAs transcribed from coding region 2 
(Fig 1: 6) have, however, not been detected (Jahn et al., 1984; Wilkinson et 
21., 1984). The strain AD169 IE coding region 2 encodes at least four size 
classes of IE protein (Table 1: 5) but only two sLze classes of middle 
abundant RNA; the abundance of the minor 5.2kb, 5.4kb and 6.25kb RNAs was 
too low to be expected to produce detectable products in HST experiments. It 
is possible that more than one IE mRNA of 1.7kb and/or 2.25kb is transcribed 
from strain AD169 IE coding region 2. 
IE Coding Region 3: IE coding region 3 of strain AD169 has been studied in 
detail primarily because it contains a 490bp DNA fragment which has been 
shown to be capable of transforming cells in vitro (Fig 1: 6; Nelson et al., 
1984). The minor 5.4kb and 6.25kb IE RNAs which are transcribed through the 
transforming region (Fig 1: 6) have been shown not to be spliced in the 
region of the transforming DNA fragment (Nelson et al., 1984). The longest 
ORF within the transforming region, as predicted by an analysis of the 
nucleotide sequence (Kouzarides et al., 1983; Nelson et al., 1984), would 
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however encode a polypeptide of only 41 amino acids. The transformation 
process mediated by this region therefore may not be caused by a 
HCMV-encoded protein. 
IE Coding Region 4: In strain AD169 two middle abundant (1.75kb and 3.8kb) 
and one minor (4.8kb) RNA species encoded by IE coding region 4 hybridise 
with DNA probes from both HindIll fragments J and Z (Fig 1: 5). The two 
middle abundant RNAs are transcribed in right to left direction with respect 
to the prototype orientation of the genome (Fig 1: 5; Wilkinson et al., 
1984). 
1: 16 Post-transcriptional Control Over Processing of IE RNA 
Following transcription a poly (A) tail is added to the 3' ends of most 
IE RNAs and in some cases, at least, introns are removed from primary 
transcripts by RNA-splicing (see section 1: 15) before they are transported 
to the cytoplasm. Some IE transcripts, however, have been shown to be 
preferentially retained in the nucleus. The 5.4kb and 6.25kb IE RNAs from 
IE coding region 3 are present in low abundance in IE cytoplasmic poly (A)+ 
RNA but in high abundance in early and late RNA preparations. DeMarchi 
(1983a) observed that RNAs of similar sLzes (4.8kb and 5.2kb) encoded by the 
equivalent region of strain Davis were efficiently transcribed under IE 
conditions but were not transported to the cytoplasm until the early phase. 
RNA synthesised from a region between 0.483-0.553 map units of strain Davis, 
which accounted for 9% of total IE transcription was also not transported to 
the cytoplasm under IE conditions (DeMarchi, 1983a). Since it has yet to be 
determined whether any of the RNAs confined to the nucleus during the IE 
phase encode proteins it is not clear if this phenomenon represents post- 
transcriptional regulation of HCMV gene expression. 
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1: 18 IE Gene Expression 
The HCMV major IE antigen produces a generalised staining pattern over 
the whole of the cell nucleus in im munofluorescence studies (Goldstein et. 
ýý, 1982). Although the major IE polypeptide is associated with the 
nucleus, when infected cells are lysed with the detergent NP40 (which 
solubilises the plasma membrane), between 60% to 90% of the major IE 
polypeptide partitions with the cytoplasmic fraction (Jeang and Gibson, 
1980; Gibson, 1981b). Im mune electron microscopy studies have shown that 
much of the major IE antigen is associated with the outside of the nuclear 
membrane and the perinuclear region (K. Blake, personal communication) 
however some of the major IE polypeptide may penetrate the nuclear membrane 
as it has been reported to be associated with cellular chromatin (S. 
Michelson quoted by Stinski et al., 1983). 
Comparisons made by SDS-PAGE of ICSP's produced using different 
isolates indicates that there is little inter-strain variation in the sizes 
of HCMV proteins (Gupta et al., 1977), additionally the protein profiles of 
HCMV isolates and simian CMV strain Colburn are also very similar (Gibson, 
1983; Table 1: 4). The major IE polypeptide is a noticable exception. Gibson 
(1981b) observed that when directly compared in the same polacrylamide gel 
the major IE polypeptides of strains Colburn, AD169, Davis and Towne had 
apparent molecular weights of 94K, 79K, 78K and 76K respectively. The 
observed differences in the electrophoretic mobilities of these proteins 
were not thought to be caused by post-translational processing as they were 
also apparent when the proteins were translated in vitro (Cameron and 
Preston, 1981). 
Although the apparent molecular weights of the strains AD169 and Towne 
major IE polypeptides differ by 3K their genes are sLmilar (see section 
1: 16) and in other respects the proteins have similar properties. The major 
IE polypeptLdes of strains AD169 and Towne are both phosphorylated (Gibson, 
1981b), share the same isoelectric point and are antigenically related; both 
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proteins are recognised by a monoclonal antibody produced by Goldstein et 
(1982). 
During the course of a productive infection the characteristic nuclear 
staining pattern of the major IE polypeptide can be detected by 
immunofluorence 20-60 min p. L (Michelson-Fiske et al., 1977). Experiments 
in which infected cell proteins were pulse labelled with [ 
35SI-methionine 
showed that the major IE polypeptide is efficiently expressed only during 
the first few hours of a permissive infection (Stinski, 1978; Blanton and 
Tevethia, 1981). The major IE mRNA was present in only trace amounts at 2h 
pi., is relatively abundant at 5h p. L'but by 12h p. L its abundance has 
declined 10 fold to a level which is maintained until the late phase 
(Stenberg and Stinski, 1985). The repression of major IE gene expression 
during the early and late phases is exerted at the level of transcriptional 
initiation (Nelson and Groudine, 1986). Recently DNA transfection studies 
have indicated that the major IE polypeptide may directly or indirectly 
cause transcription from its own gene to be repressed; the major IE gene may 
therefore autoregulate its own expression (Stenberg and Stinski, 1985). 
Because cycloheximide prevents both the shut-off of IE gene expression 
and the transition to early phase it is used experimentally to artificially 
increase the quantity of IE gene products in infected cells. Cycloheximide 
treatment, however, results in a 90% reduction in the yields of total poly 
(A)+ RNA obtained from human embryo fLbroblasts (MRC5 cells; Wilkinson, 
1983). DeMarchi (1983c) has shown that the 2.2kb major IE mRNA of strain 
Davis is much more stable in cycloheximide treated cells than other HCMV 
transcripts. Consequently, cycloheximide treatment can be expected to 
signifLcantly enhance the concentration of the major IE mRNA relative to 
that of other host and virus-coded species in infected cells. 
Convalescent immune sera im m uno precipitated three polypeptides with 
molecular weights of 73K, 77K and 78K in similar abundance from extracts Of 
strain AD169 infected cells prepared 1.5h pi. (Blanton and Tevethia, 1981). 
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The 77K and 78K proteins may correspond to the strain AD169 78K and 78.5K IE 
polypeptLdes mapped to IE coding region 2 by HST (Table 1: 5). Cycloheximide 
treatment for 5h p. L resulted in the subsequent overproduction of the 73K 
(major) IE polypeptide, following cycloheximide release, but did not 
significantly enhance the synthesis of the 77K and 78K polypeptLdes (Blanton 
and Tevethia, 1981). Michelson et al. (1979) also detected three IE 
polypeptLdes of sLmilar size (76K and a doublet of 82K) in HCMV strain 
Mira-infected cells between lh to 3h p. L The 76K strain Mira protein was 
present in both nuclear and cytoplasmic fractions, which is typical of the 
major IE polypeptide, but interestingly the two 82K proteins were detected 
only in the nuclear fractions (Michelson et al., 1979). The largest ORF 
identified so far from the nucleotide sequence of IE coding region 2 (strain 
Towne) would encode a protein of only 51K, synthesised from the spliced 
2.25kb IE mRNA (Fig 1: 6; Stenberg et 
. 
22., 1985). There is so me evidence, 
however, from HST experiments that strain Towne coding region 2 also encodes 
a 75K polypeptide which is distinct from the major IE polypeptide (Stinski 
et al., 1983). 
HST showed that the three RNA species mapped to IE coding region 4 
encoded at least three polypeptides with molecular weights of 40K, 47K and 
51K (Table 1: 5). IE-1.75 which is derived largely from HindIII Z probably 
encodes the 40K protein whereas IE-3.8 which hybridises more strongly with 
Hin, dI11 J may encode the 47K protein (WilIcinson et aL, 1984). 
The translation products of minor IE RNAs transcribed from IE coding 
region 3 and other regions of the HCMV genome have yet to be identified. 
1: 18 Comparison Betweeen HCMV and HSV-l IE Transcription 
The patterns of HCMV and HSV-1 IE transcription is compared in Fig 1: 5. 
In both viruses IE gene expression is restricted to a relatively small 
portion of the virus genome. Four of the five HSV-1 IE genes are clustered 
around the inverted repeats; HSV-1 IE mRNAs 1 and 3 are encoded entirely 
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fro m within the long and short repeat respectively and their genes are 
therefore present in two copies per HSV-l genome. In contrast, the principal 
HCMV IE genes all m ap within the UL region. The available information (see 
section 1: 15) indicates that the structural organisation of the HCMV IE 
genes is complex, transcription initiated from the major IE promoter alone 
may encode four or more mRNA species (Stenberg Lt 22: ý, 1984; A krigg tt 
1985; Stenberg et 21., 1985). Differential RNA splicing is employed by HCMV 
in IE coding regions 1 and 2 to generate a complex series of related 
polypeptide encoded by a combination of different exons. Gene expression 
fro mHCMV IE coding regions 3 and 4 is not yet well characterised but it is 
apparent that in both regions more than one size class of transcript is 
synthesised from the same strand either by an alternative splicing mechanism 
and/or by using more than one transcriptional initiation or polyadenylation 
site (Table 1: 6). 
IE mRNAs-1, -4 and -5 are the only HSV-1 IE transcripts which have been 
shown to be spliced (Perry et ! 21,, 1986; Rixon and Clements, 1982). HSV-1 IE 
gene 1 contains two introns of 767 bases and 136 bases both of which map 
within the coding region for the IE110 protein (Fig 1: 5; Perry . 
2t 
. 
2L, 
1986). IE mRNAs -4 and -5, which are transcribed from the HSV-1 short 
repeats into opposite ends of the US component (Fig 1: 5), both contain a 
single intron in their 5' leader sequences. The promoter, leader and the 
intron sequences of IE mRNAs -4 and -5 are essentiauy identicaL Since the 
H SV-1 intron co mm on to both IE mRNAs -4 and -5 does not contain the 
translational initiation codon 'A U G' and is not always excised during RNA 
processing, its removal may not be essential for gene expressLon (Rixon and 
Clements, 1982). 
The HCMV IE genes differ from those of HSV-1 in (a) their relative 
locations on the virus genomes and (b) the HCMV IE genes, at least in coding 
regions I and 2, use alternative RNA splicing pathways to make more 
elaborate use of the available coding capacity. 
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1: 19 Early Phase Gene Expressign 
The early phase of the HCMV replicative cycle is long relative to that 
of HSV-1. Following a high m. o. L infection, replication of HCMV DNA is not 
detected until 12h p. L and does not reach a maximum until 72-96h p. L 
(Huang et 1973). The efficient expression of both early and late HCMV 
genes is dependent on transcriptional activation by (a) de novo synthesised 
IE gene product(s). The transition from IE to early phase gene expression 
occurs relatively rapidly. By 4-6h p. L IE protein synthesis is already in 
decline and the synthesis of early proteins can be detected (Blanton and 
Tevethia, 1981). DNA/RNA hybridisation experiments have. also detected early 
phase transcription at 4h p. L (DeMarchi et al., 1980). 
The general pattern of transcription observed at 4h p. L is maintained 
until 24h p. L (DeMarchi et al., 1980). Cytoplasmic poly (A)+ RNA isolated 
from strain AD169-infected, PFA-treated cells 24h p. L hybridised weakly 
with most regions of the virus genome but strongly with the long repeat (56% 
of early RNA hybridisation was with TR L 
/IR 0' E3Lnd]Il W (9.5%) and HindEI V 
(3.1%), (Fig 1: 4; Wilkinson, 1983; McDonough and Spector, 1983). HCMV 
encodes a single abundant 2.7kb early RNA from the long repeat region 
(McDonough et al., 1985; this thesis), however the virus does not encode a 
correspondingly abundant virus-encoded early polypeptide. A translation 
product for the abundant 2.7kb early RNA has not been identified. 
Hybridisation experiments performed using whole cell early phase RNA 
have shown that, as during the IE phase, some transcripts encoded by the UL 
component are retained in the nucleus until later in the infectious cycle 
(Wathen and Stinski, 1982; DeMarchi, 1983a). The HCMV major tegument and 
DNA-binding proteins which are synthesdsed only in trace amounts during the 
early phase are major components of the cell in the late phase. Geballe et 
al. (1986a) observed that although the genes for these proteins were not 
transcribed under IE conditions they were transcribed at 4h p. L The genes 
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encoding the HCMV major tegument and DNA-binding protein are transcribed 
during the early phase but, possibly due to post-transcriptional 
regulation, they are expressed as conventional late phase genes. 
1: 20 Late Phase Gene Expression 
The pattern of HCMV gene expression increases in complexity as the 
infection progresses. Hybridisation experiments between cytoplasmic poly 
(A) RNA and cloned HCMV DNA fragments indicate that during the late phase 
most regions of the virus genome are being expressed (Fig 1: 4; DeMarchi et 
ýý, 1980; DeMarchi, 1981; Wathen and Stinski, 1982; McDonough and Spector, 
1983; Wilkinson, 1983). A systematic experiment in which cloned XbaI DNA 
fragments representing the complete strain Towne genome were hybridised with 
Northern transfers of late RNA identified more than 85 virus-encoded RNA 
transcripts (Wathen and Stinski, 1982). HCMV is known to encodes a large 
number of late proteins (Table 1: 3). The potential coding capacity of the 
235kb HCMV genome is considerable but recently some progress has been made 
towards unraveUing the complexities of late phase gene expression. 
The cloning vectorXgtll was designed to select for the expression of 
short open reading frames (ORFs) cloned upstream from the bacterial 
ý-galactos: Ldase gene. The inserted short ORF is expressed as a fused protein 
covalently linked to G--galactosidase. Mocarski et al. (1985b) shotgun cloned 
short sonicated fragments of HCMV DNA intoXgtll. One of the clones 
generated expressed a protein recognised by the monoclonal antibodies CH 
13-2 and CH 16-1 (Pereira et al., 1982). The cloned DNA fragment was shown 
to be derived from HCMV Hind11I M (strain AD169). HST experiments 
demonstrated that a 5kb mRNA transcribed from Hind]I[ M encoded a 50K 
polypeptide which was im m uno precipitated by a mixture of CH 13-2 and CH 
16-1 (Mocarski et al., 1985b). The 50K polypeptide was identi: ELed as being 
the (52K) DNA-binding protein characterised by Gibson (1983; Table 1: 4). 
Nowak et al. (1984b) used a series of overlapping cosmid clones 
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spanning the entire strain AD169 genome in HST experiments. 
Im munprecipitation of the in vitro translation products with monoclonal 
antibodies enabled the genes encoding the 69K (65K according to Nowak et 
2j., 1984b) and 74K (71K) major tegument, or lower and upper matrix, 
proteins to be mapped. Both proteins were encoded by (a) 4kb mRNA(s) 
transcribed in a left to right orientation (with respect to the prototype 
orientation of the genome; see Fig 1: 2) from HindEI fragments L, c and b. 
The mechanism by which the two tegument proteins were encoded by the same 
region of DNA was not ascertained. The proteins, however, were antigenically 
distinct which suggests that they do not share extensive amino acid 
sequence. Nowak et al. (1984b) also identifLed the approximate map locations 
of a large number of additional polypeptides, some of which co-migrated wth 
virion components, in these HST experiments. It was not possible, however, 
to definitively identify additional translation products from their size 
alone. 
Davis et aL (1984) mapped an abundant 1.9kb late mRNA within the 
strain Towne EcoRI fragment G (in strain AD169 the transcript maps to within 
Hindlll D and BSBI X). The late gene was cloned into a eukaryotic 
expression vector (based on the SV40 origin of replication) and transfected 
into COS cells. The expression of a 67K phosphoprotein was detected in the 
transfected cells using a monoclonal antibody (Davis et al., 1984). The 67K 
phosphoprotein was identified as a component of the virion tegument and 
co-purif-Led with a protein kinase activity. The nucleotide sequence of this 
gene was determined (Davis and Huang., 1985). 
Mach et, al. (1986) recently detected the expression of a short fragment 
of the gp52 structural gene cloned into Xgtll using a polyvalent antiserum 
raised to gp52 in rabbit. The gp52 structural gene was thereby shown to be 
located within HindIII fragment F. An analysis of the nucleotide sequence of 
Hind1IE F identified an ORF for a potential glycoprotein which shared a 
significant level of amino acid homology with the glycoprotein B's of HSV-1 
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and EBV (Cranage et al., 1986). Gp52 is produced by the proteolytLc cleavage 
of a larger precursor molecule and shares amino acid sequence homology with 
glycoproteins encoded by other herpesviruses. 
The nucleotide sequence of HindIE F also predicted an ORF which 
exhibited significant homology with the DNA polymerase genes of other 
sequenced herpesviruses (Kouzarides et al., 1987b). The entire HCMV genome 
is currently being sequenced. Many of the proteins involved in the mechanics 
of virion replication (e. g. the DNA polymerase, DNA cleavage and packaging 
enzymes, capsid and other virion proteins) appear to have been conserved 
across the herpesvirus group. A comparison of the HCMV DNA sequence with the 
known sequences of HSV-1, VZV and EBV may identify further conserved 
herpesvirus proteins and assist in determining the functions of additional 
HCMV genes. 
1: 21 HCMV DNA Replication 
HCMV encodes its own DNA polymerase (Huang, 1975) which has been mapped 
on the genome of strain AD169 within the HindIII fragment F (Kouzarides et 
21., 1987b). In biochemical tests the HCMV DNA polymerase has Eimilar 
properties to the cellular cc-DNA polymerases which are involved in DNA 
replication as opposed to repair (Hirai and Watanabe, 1976). The HCMV DNA 
polymerase is PAA and aphidocolin sensitive, resistant to high 
concentrations of 2', 3' ddTTP and functions optimally in high salt 
concentrations (Huang, 1975a; 1975b; Nishiyama et al., 1983). A 3' to 51 
exonuclease activity, which is also PAA sensitive, is associated with the 
virus DNA polymerase (Nishiyama et al., 1983). 
HCMV DNA replication is first detected 12h p. L, increases to reach an 
initial peak of activity at 24h pi., then declines and rises again to its 
maximum level during the late phase, 72-96h p. L (Stinski, 1978). Although 
the replicative cycle of HSV-1 and HCMV in human fibroblasts takes 8h and 4 
days respectively (Smith and DeHarven, 1973) many of the processes involved 
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in virus DNA replication and encapsidatLon appear to be very similar. During 
the early stages of a permissive or semi-permissive infection the HCMV 
genome circularises (LaFemina and Hayward, 1983) due to an interaction 
between the complementary a sequences present as direct repeats at each 
terminus of the genome (Fig. 1: 3). Circularisation of the HCMV genome, a 
property shared with other herpesviruses, is PAA-sensitive and may therefore 
be dependent on a function of the virus-encoded DNA polymerase. 
Like other herpesviruses (Spear and Roizman, 1980), the HCMV genome is 
probably replicated according to the rolling circle model which would result 
in virus DNA being synthesised in long concatemers. HCMV DNA purified from 
late phase infected cells has been shown to contain a high concentration of 
L-S joint fragments and relatively few terminal fragments which implies that 
the genome is replicated either in long concatemers or DNA circles (LaFemina 
and Hayward, 1983). Additionally the HCMV a sequence can substitute for the 
HSV-1 a sequence function in HSV-l amplicons (Spaete and Mocarsk4 1985a; 
section 1: 11). The a sequence provides the cis acting signal which directs 
the cleavage of concatemeric DNA into unit lengths which occurs during 
packaging into capsids. 
Replication of cellular DNA is inhibited in permissive cells by 10h 
p. L, even in the presence of PAA (DeMarchi, 1983b). This result is 
apparently in conflict with a previous observation that HCMV infections 
stimulate cellular DNA replication (St Jeor et. al., 1974). DeMarchi and 
Kaplan (1977) have suggested that HCMV may stimulate cellular DNA 
replication only in cells abortively infected by defective virions. 
1: 22 Virus Maturation 
The continued synthesis of host cell proteins throughout the HCMV 
replicatLve cycle makes the identification of virus encoded proteins more 
difficult. The majority of late phase ICSPs, which have been identified, 
co-migrate in SDS-polyacrylamide gels with components of purified virions 
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(Stinski, 1977). Late phase virus-encoded protein synthesis is, therefore, 
believed to be primarily associated with vixion production. The initial 
stages in the construction of HCMV virus particles take place in the 
nucleus. 
In detailed studies of the sLmian CMV strain Colburn replicatLve cycle 
Gibson (1981a) identified two forms of immature virus particle in infected 
cell nuclei. The 'type A' particles are empty virus capsids containing 28K, 
34K and 145K virion proteins in a ratio of 1: 3: 7 respectively (Gibson, 
1981a). 'Type B' particles contain all the A-capsid proteins plus two 
additional phosphoproteins of 37K and 45K and also virus DNA. Since the 37K 
and 45K phosphoproteins: are not processed into mature virions, it has been 
proposed that these "assembly proteins! ' play a role in nucleocapsid 
maturation (Gibson, 1981a). Tryptic hydrolysis of the 37K and 45K proteins 
indicates that the two proteins are very similar and probably share a mino 
acid sequences (Gibson, 1981a). The CMV assembly proteins and the HSV-1 38K 
(VP22a) capsid-associated protein are unusual in that they fluoresce pink 
when stained with coomassie brilliant blue. The cause of the fluorescence is 
not understood but its existence suggests there may be a functional 
relationship between the CMV and HSV-1 capsid-associated proteins (Gibson, 
1981a). A temperature-sensitive HSV-1 mutant (17tsVP1201) contains a defect 
which prevents the processing of VP22a (38K) from a 40K precursor protein. 
In HSV-1 17tsVP1201-infected cells, at the non-permissive temperature, viral 
DNA is replicated and nucleocapsLds are produced but the nucleocapsids do 
not package the viral genome; a functional VP22a protein is therefore 
required for packaging HSV-1 DNA (Preston et al., 1983). 
Immediately following the initiation of virus DNA replication simian 
CMV strain Colburn induces the synthesis of a 51K DNA-binding protein 
(Gibson et aL, 1981a). The DNA-binding protein is phosphorylated, 
positively charged and localised in the nucleus of infected cells. In 
certain circumstances the 51K protein can be found associated with 
B-capsid 
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particles, which suggests it is involved in virus maturation. However, the 
51K DNA-binding protein, like the assembly proteins, is not incorporated 
into mature virions (Gibson et al., 1981a). Since both empty and filled 
capsids are associated with nuclear inclusions in infected cells, the 
packaging of HCMV DNA into nucleocapsid particles is thought to take place 
at the nuclear inclusions (Becker et al., 1965; McGavran and Smith, 1965; 
Cavallo et al., 1981). HCMV DNA preparations made from virus stocks enriched 
for defective particles contain a high proportion of subgenomic DNA 
molecules, the majority of which were approximately 60 x 106 and 100 x 10 
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daltons; (Stinski et al., 1979). The presence of these relatively short DNA 
molecules in mature virions suggests that the mechanism responsible for 
cleaving and packaging concatenated virus DNA is not be suictly dependent 
on HCMV capsid particles being fil1ed with genomic length units of DNA. 
The mechanism involved in packaging viral DNA may have been conserved 
throughout the Herpesviridae. HSV-l also manufactures A- and B-capsid 
particles in infected cells with a similar size and protein composition to 
those of simian CMV (Gibson and Roizman, 1972; Gibson, 1981a). The 
capsid-associated proteins of HSV-1 and CMV have similar properties (Gibson, 
1981a), there is a region of DNA sequence homology within the cleavage and 
packaging signals (a sequences) of HCMV and HSV-1 (see section 1: 11; 
Tamishiro et al., 1984) and the HCMV L-S junction can complement the 
cis-signal (contained in the a sequence) for cleavage and packaging DNA in 
an HSV-1 amplicon (see section 1: 11; Spaete and Mocarski, 1985a). 
Nucleocapsids become coated with tegument protein in passing from the 
nuclear inclusion to the nuclear envelope (McGavran and Smith, 1965). The 
most abundant HCMV polypeptide, both in infected cells, and purified virions 
is the 69K major tegument, or lower matrix, protein (Stinski, 1976). The 69K 
tegument protein also accounts for 95% of the mass of dense bodies (Irmiere 
and Gibson, 1983). Immunofluorescence studies show that the 69K protein is 
found in the nucleoplasm of infected cells but it is not associated with the 
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nuclear inclusions (Weiner et al., 1985). This observation is consistant 
with nucleocapsids acquiring their coating of tegument protein after leaving 
the nuclear inclusion. In infected cells both the 69K tegument protein and 
the 153K major capsid protein are associated with the nuclear skeleton, or 
matrix (Yamauchi et al., 1985). The early stages of virion maturation appear 
to involve an ordered interaction between virion proteins and the fibrillar 
protein networks contained in the infected cell nucleus. 
There are three major (including the 69K tegument protein) and nine 
minor phosphoproteins in mature virions, none of which are components of the 
nucleocapsid (Table 1: 4; Roby and Gibson, 1986). The extensive 
phoshorylation of tegument proteins may be related to virion maturation. The 
tegument of mature HCMV vixions contains two distinct protein kinase 
activities, one of which specifically phosphorylates tegument proteins in 
vitro (Mar et al., 1981; Roby and Gibson, 1986). Recent reports have shown 
the protein kinase to be a 67K/68K viAon protein which, although abundant, 
is distinct from the 69K major tegument protein (Davis and Huang, 1985; 
Britt and Auger, 1986). 
HCMV virions have been shown to contain the polyamines spermine and 
spermidine (Gibson et al., 1984). Treatment of infected celIs with difluoro- 
methylornithine (DFMO), an anologue of ornithine which inhibits polyamine 
synthesis, causes a reduction in the yields of both infectious virions and 
NIEPs (Gibson et al., 1984). Since NIEPs do not contain DNA it was 
proposed that polyamines have a role in the maturation of HCMV enveloped 
particles other than neutralising the charge on DNA; polyamines may possibly 
be required to neutralise charged phosphoproteins during the assembly of the 
HCMV tegument (Roby and Gibson, 1986). While spermine and spermidine are 
also both present in HSV-1 virions, only spermine is found in the 
nucleocapsid where it is presumed to be involved in neutralising the charged 
phosphate groups on tightly packaged virus DNA. Spermidine, consequently, 
must be associated either with the HSV-1 tegument region or the envelope 
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(McCormick, 1978). 
Immature virus particles bud through the nuclear membrane into the 
cytoplasm (Smith and DeHarven, 1973; Severi et al., 1979). According to the 
model proposed by Severi et al. the passage of the virus particle out of the 
nucleus occurs in two stages. Initially the virus particles bud through the 
inner nuclear membrane acquiring a temporary envelope in the process. The 
envelope, containing the virus particle, then fuses with the outer nuclear 
membrane and th. e naked particle is ejected into the cytoplasm (Severi et 
j2L, 1979). The presence of non-enveloped virus particles within the 
cytoplasm (Smith and DeHarven, 1973; Severi et al., 1979) was interpreted as 
indicating that the mature vixion does not obtain an envelope from the 
nucleus. This model, however is not universally accepted (Gibson, 1981a; 
Farrar and Oram, 1984). Farrar and Oram (1984) proposed that the HCMV virion 
contains two envelopes and that the inner envelope is probably derived from 
the nuclear membrane. 
The final phase of virion maturation takes place in the cytoplasmic 
vesicle which is composed mainly of golgi apparatus (McABister et aL. 
1963; Smith and DeHarven, 1973). The proteins associated with the virion 
envelopes are predominantly glycosylated (Stinskiý 1977). The five 
glycoproteins which have been identified in the strain AD169 outer virion 
envelope have apparent molecular weights of 52K, 67K, 95K, 130K and 250K 
(Table 1: 4; Farrar and Oram, 1984). In purified extracts, the 52K 
glycoprotein was found to be linked by disulphide bonding to the 95K or the 
130K glycoproteins to produce a series of high molecular weight protein 
complexes (Farrar and Greenaway, 1986). Polyvalent sera and monoclonal 
antibodies have been raised against HCMV glycoproteins. It is clear from 
immunofluorescence studies that the glycoproteins are predominantly 
associated with the cytoplasmic vesicle and the plasma membrane (Pereira et 
jLL, 1982; Nowak et al., 1984; Law et al., 1985). 
HCMV acquires its outer envelope, containing the membrane 
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glycoproteins, by budding through the membranes of the golgi and the plasma 
membrane (Farrar and Oram, 1984). A 28K/29K unglycosylated virion 
phosphoprotein was shown, by immunofluorescence, to be found associated with 
the cytoplasmic inclusion but not the nucleus of infected cells (Nowak et 
1984; Re et al., 1985). The 28K/29K phosphoprotein is not a surface 
component of the virion (Nowak et al., 1984). In the maturation process 
which takes place at the cytoplasmic vesicle the virion acquires at least 
one unglycosylated protein. 
Numerous glycoprotein species have been detected in infected cells in 
addition to the five shown to be contained in the mature virion (Pereira et 
ýý, 1982; Pereira et al., 1984; SuDivan-Tailyour and Garnett, 1986). Many 
of these glycoprotein species are generated by varying degrees of 
glycosylation combined with proteolytic cleavage of four antigenically 
distinct precursor molecules (Pereira et al., 1984). A monoclonal antibody 
raised to the 52K glycoprotein (gp52) recognises at least seven size classes 
of protein in infected cells (Pereira et al., 1984). While the in vitro 
translation product of gp52 mRNA has an apparent molecular weight of 95K, 
the size of the protein in infected cells is both increased due 
glycosylation and reduced as a consequence of proteolytic cleavage to 
ultimately generate a protein with an apparent molecular weight of 52K 
(Pereira et al., 1984; Cranage et al., 1986; Mach et al., 1986). 
The induction of an immune response directed against the virion surface 
Qlvcoproteins may be important in eliciting protection against HCMV 
infections in vivo (Gibson and Irmiere, 1984). Polyvalent sera and a number 
of the monoclonal antibodies raised to HCMV glycoproteins have been shown to 
be capable of neutralising HCMV infections in vitro (Pereira et al., 1982; 
Furukawa et. al., 1984; Rasmussen et al., 1985; Cranage et al., 1986). 
Furukawa et al. (1984) observed that crude extracts of HCMV envelopes 
elicited both the humoral, and cell-mediated immune response in guinea pigs. 
It may be possible to develope an effective subunit vaccine based on the 
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glycoproteins contained in HCMV outer envelope (Gibson and Irmiere, 1984). 
1: 23 Effects of HCMV Infection on Host Cell Metabolism 
Chromatin: On entering the nucleus HCMV DNA becomes associated with 
chromatin (St Jeor et al., 1982). Kamata et aL (1978) detected rapid 
changes in chromatin structure in HCMV-infected ceUs by measuring the 
circular dichroism and ethidium bromide binding capacity of purified 
chromatin. A small increase in ethidium bromide binding to chromatin was 
detected within lh p. L As the infection proceeds there is a steady increase 
in the level of ethidium bromide binding up to 24h p. L after which time the 
level gradually declines. The circular dichroism measurements of chromatin, 
in contrast, had declined by lh p. i. but returned to the original level by 
12h p. L and continued to increase up until 48h p. L Experiments using 
u. v. -inactivated virus and an inhibitor of protein synthesis indicated that 
the observed effects were dependent on de novo virus-encoded protein 
synthesis. Since a change in chromatin structure was detected by Ih p.: L an 
IE gene product is probably involved. 
In order to identify the factors responsible for inducing the observed 
effects protein was stripped off chromatin purified from infected cells, 
fractionated on DNA-cellulose and added back to chromatin extracted from 
uninfected cells. The virus-induced factors responsible for increasing 
ethidium bromide binding and affecting changes in circular dichroism 
measurements were eluted from DNA-cellulose in different fractions, 
chromatin structure in HCMV-infected cells is therefore affected by at least 
two distinct factors. The magnitude of the observed effects suggested that 
HCMV induces a change in total cellular chromatin and not merely that 
portion associated with virus DNA (Kamata et aL, 1978). In support of these 
observation Kierszenbaum and Huang (1978), in electron microscopy studies, 
have identified abnormal nucleosome structures in HCMV-infected cells 18h 
P. L 
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Cell DNA Synthesis HCMV can stimulate semiconservative DNA replication in 
, 
both permissive human embryo fibroblasts (HEF) and non-permissive Vero cells 
whose growth has been arrested using media with a low serum content (St Jeor 
et al., 1974). Additionally, cellular DNA replication is stimulated during 
the non-productive infection of rabbit kidney cells which express early HCMV 
antigens (DeMarchi, 1983b). In actively growing HEF cells, however, cellular 
DNA replication is stimulated efficiently only in cells which do not express 
HCMV antigens (DeMarchi and Kaplan, 1977). DeMarchi (1983b) suggests that 
the stimulation of cellular DNA in productively infected HEF cells may be 
repressed by an early gene function which is not expressed during the 
non-productive infection of rabbit kidney cells. 
Gonczol and Plotkin (1984) have identLELed a growth factor (CMV-GF) 
which is released from either permissive or non-permissive cells exposed to 
infection by HCMV. CMV-GF is synthesised by cells infected with 
u. v. ý-Inactivated virus and is therefore thought to be encoded by the host 
cell. Microtubule depolymerisation occurs in cells during the early phase of 
HCMV infections (section 1: 13) and Taxol, a compound which stabilises 
microtubules, has been shown to inhibit both the stimulation of cellular DNA 
replication in HCMV-infected cell monolayers and mitogenic stimulation by 
CMV-GF (Albrecht et al., 1984; Gonczol and Plotkin, 1984). The mechanism by 
which infection with HCMV and CMV-GF both stimulate cellular DNA synthesis 
involves the disruption of microtubules and consequently may possibly be 
related. 
Transcriptional Stimulation: There is a transient reduction of up to 50% in 
the the level of newly synthesised RNA entering the cytoplasm between 1 to 
10h p. L (Garnett, 1979). However, the rate of total cellular RNA synthesis 
is increased by 18h p. L and reaches a level 3 times higher than uninfected 
controls by 60h pi. (Tanaka et al., 1975). The concentrations of the 4S, 
18S and 28S rRNAs is 10 fold higher and cytoplasmic poly (A) 
+RNA only 2.4 
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fold higher in late phase HCM V-inf ected cells than in uninf ected controls 
(Tanaka et al., 1975; Wilkinson, 1983). Hybridisation of pulse-labelled RNA 
with HCMV DNA has shown that only 0.6% of RNA synthesised between 0-2h. p. L 
and 1.8% of RNA synthesised between 28-30h p. L is virus-encoded (Chua et 
al., 1981). 
Infection with HCMV stimulates the activity of the cellular RNA 
polymerases 14 1[ and III (in an in vitro assay) by factors of six-, 
sixteen- and three-fold respectively (Tanaka et al., 1978). The stimulation 
of endogenous RNA polymerase activities must be induced by a protein 
synthesised during the first 6h p. L since the transcriptional activation 
induced by HCMV infection is inhibited if cells are treated during the first 
six hours of an infection with either cycloheximide or actinomycin D (Tanaka 
et 21., 1978). Actinomycin D treatment of early infected cells also inhibits 
the subsequent replication of the virus (Landini et al., 1979). 
The activation of cellular transcriptional processes is an unusual and 
distinctive feature of HCMV infections. 
Protein Synthesis: Cellular encoded polypeptLdes continue to be synthesised 
throughout the HCMV replicative cycle. Only 10-30% of early and 50-60% of 
late phase protein synthesis is attributable to virus-encoded polypeptLdes 
(Stinski, 1977). There is a transient reduction of greater than 50% in the 
level of total protein synthesis in infected cells during the first 20h pi. 
(Stinski, 1977; Garnett, 1979), followed by an increase from 22h p. L to 
reach the peak rate of synthesis between 30-32h p. L Translational activity 
then declines but is subsequently re-stimulated and a second peak is seen 
between 42-60h p-L (Stinski, 1977). Although transcription is greatly 
enhanced during the late phase of HCMV infections, suprisingly even at peak 
levels (32h and 60h p. L) protein synthesis is only slightly greater in 
infected cells than in uninfected controls (Stinski, 1977). Experiments 
performed in parallel with inactivated virus (irradiated with u. v. light or 
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neutralised with antibody) indicated that de novo HCMV gene expression was 
not required for the suppression of early phase protein synthesis but it was 
necessary for the subsequent translational activation observed during the 
late phase. 
HCMV has been shown to stimulate either the synthesis or the activity 
of a number of specific cellular proteins (Table 1: 6). Although HCMV does 
not encode a thymidine kinase enzyme (TK), virus infection efficiently 
stimulates the activity of both cellular (cytosol and mitochondrial) TK 
enzymes. The stimulation of TK activity in the cytosol can be detected by 
12h p. L and reaches a maximum level (10-12 times that of uninfected control 
Activated Polypeptide Host References 
or Polyamine Encoded 
TK nucleus & Zavada et al., 1976 
mitochondria Estes &77uýang, 1977 
Plasminogen Activator Yes Yaminishi & Rapp, 
Factor 1979 
Ornithine Decarboxylase Yes Isom, 1979 
Spermine & Spermidine Yes Tyms & Williamson, 
1980 
RNA polymerases I, II, Yes Tanaka et al., 1978 
& III 
Ig G binding protein ? Sakuma et al., 1977 
Falcierl-J-al., 
1980 
Gonczol et al., 1981 
Murayma -ý-t T1., 1986 
CMV-GF (Growth Factor) Yes Gonczol and Plotkin, 
1984 
Repressed Polypeptide 
Fibronectin Yes Ihara et al., 1982 
Table 1: 6: Effect of HCMV infection on expression of specific 
cellular proteins and polyamines. 
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cells) at 48h p. L (Estes and Huang, 1977). In uninfected ceUs regulation 
of TK expression is dependent on the cell cycle. TK activity is stimulated 
late in the G1 phase immediately prior to cellular DNA replication (Liu et 
ýý, 1985). Ornithine decarboxylase (Table 1: 6) is also normaUy induced 
during the G1 phase in uninfected cells (Isom, 1979). The induction of 
enzymes associated with the cellular late Gl/S phase may be essential for 
HCMV replication. Inhibiting host cell transcription by treatment with 
actinomycin D prior to infection has been shown to block HCMV, but not 
HSV-1, replication in early phase gene expressLon, this result suggests 
that HCMV replication is particularly dependent on host cell functions 
(Landini et aL, 1979). 
It has yet to be determined whether the HCMV induced IgG Fc receptor 
protein is virus or host cell encoded. The Fc receptor is a 42K glycoprotein 
(Sakuma et aL, 1977; Gonczol et aL, 1981) which is synthesised at both the 
early and late phases during infection (Falcieri et aL, 1980). 
One cellular protein whose synthesis is known to be inhibited by HCMV 
is fibronectin. Fibronectin is a large structural polypeptide present on the 
cell surface which is important in determining cellular morphology. 
Inhibition of fibronectin synthesis requires virus-encoded protein synthesis 
and is detected by 6h pi. Im munofluorescence stuýdies show that by 6h p. L 
the : ELbronectin lattice on the cell surface on the cell surface has already 
become distorted. Inhibition of fibronectin synthesis may be involved in the 
production of the early c. p. e. (1hara et al., 1982). 
1: 24 HCMV Infection in Permissive, Semi-Permissive and Non-Permissive Cells 
Characteristically cytomegaloviruses replicate efficiently only in 
cells of the normal host or a closely related species (Table 1: 7). For 
example murine Ba1b/c-3T3 cells (LaFemina and Hayward, 1983), mink lung 
fibroblasts (Hart and Norval, 1981) and bovine embryonic fibroblasts 
(Waner 
and Weller, 1974) are totally non-permissive to 
HCMV replication. The host 
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cell specificity of the betaherpesviriniae is, however, not absolute. 
Limited HCMV replication and maturation is tolerated by certain non-human 
cell lines; these are classed as a semi-permissive infections. Rabbit lung 
fibroblasts (Farber et al., 1979; Hart and Norval, 1981) and simian vero 
cells (Waner and Weller, 1974) have been shown to be semi-permissive for 
HCMV replication (Table 1: 7). Yields of infectious virus obtained from 
rabbit fibroblasts are significantly less (10,000 fold) than those from 
human fibroblasts (Hart and Norval, 1981). 
The progress of virus infectLon in semi- and non-permissLve ceEs has 
been investigated. In non-permissive murine Ba1b/c-3T3 cells the HCMV genome 
fails to circularise following infection and virus-encoded protein synthesis 
is largely restricted to overproducing the major IE polypeptide (LaFemina 
and Hayward, 1983). RNAs purified from baby mouse kidney, rabbit kidney, 
African green monkey and Vero cells 36h p. L were hybridised with Southern 
transfers (Southern, 1975) of restriction endonuclease digested HCMV genomic 
DNA (DeMarchi 1983a; 1983c; 1984). The hybridisation results indicated that 
in both non- and semi-permissive cell types although virus transcription 
Permissive Semi-permissive- Non-permissive 
Non-human None 
Human Fibroblasts 
Epithelial cells 
Differentiated EC 
cells 
Some Stimulated 
T-lymphocytes 
Rabbit Fibroblasts 
Vero cells 
Persistantly- 
infected fibro- 
blasts 
293 cells 
Murine Balb/c-3T3 
Mink Lung Fibroblasts 
Bovine Embryonic 
Fibroblasts 
EC cells 
Most PBLs 
Hela cells 
Table 1: 7: Susceptibility of different cell types to infection with HCMV 
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progresses to the early phase the region encoding the major IE gene, 
normally repressed at this stage of a permissive infection, was still being 
expressed. Since the pattern of HCMV transcription in each non-human cell 
line at 36h p. i. was distinctive, DeMarchi (1984) suggested that the 
progress of the sequential cascade activation of HCMV gene expression may be 
dependent on many factors encoded by the host cell. 
Not all human cells support HCMV replication. Human embryonal carcinoma 
(EC) cell lines fail to express even the major IE polypeptide following 
infection (Gonczol et aL, 1984). Since HCMV DNA has been shown to enter the 
nuclei of infected EC cells, the infection would appear to be blocked at the 
level of IE gene expression (Gonczol et aL, 1985). Retinoic acid can be 
used to induce EC cells to differentiate into a van-ety of different cell 
types. Following infection, differentiated EC cells are able both to express 
the HCMV major IE polypeptide and to support virus replication (Gonczol et 
ýý, 1984). Undifferentiated EC cells have been shown to contain a factor 
which can complement mutations in the adenovirus Ela gene (Imperiale et aL, 
1984). In addition to stimulating transcription from adenovirus promoters, 
the Ela gene product is known to repress transcription from promoters 
containing enhancer elements (Borrelli et aL, 1984). The Ela gene product 
and a repressor present in EC cells appear to negatively regulate enhancer 
activity in an identical fashion (Hen et aL, 1986). Since the HCMV major IE 
promoter is known to contain an enhancer element (Boshart et aL, 1985), the 
Ela-like factor present in EC cells may be responsible for inhibiting HCMV 
IE gene expression. 
Hela cells also do not support expression of the HCMV major IE 
polypeptide following infection although the major IE antigen is expressed 
if its gene is introduced into the cell by DNA transfection (Fig 3: 7). Hela 
is an im mortalised cell line which has been selected for efficient growth in 
vitro. It is not known at what stage the infection of Hela cells is blocked; 
during virus adsorption, transport of the virus genome into the nucleus or 
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the expression of the IE gene itself. 
HCMV replicates most rapidly and gives the highest yields when cultured 
in human embryonic fibroblasts (HEF's), consequently in the laboratory HCMV 
is invariably isolated and propagated in HEF cells. In vivo, however, the 
cytomegalic inclusions characteristic of HCMV infections are most frequently 
observed in cells of epithelial origin (Knowles, 1976). Cultivation of HCMV 
in vitro in epithelial cells has been described but replication is slower 
and less efficient than in : ELbroblasts (St. Jeor and Rapp, 1973; Knowles, 
1976; Vonka et al., 1976). 
1: 25 Latency 
HCMV, like other herpesviruses, can reactivate after long periods of 
apparent latency (Huang et ýý, 1980). The mechanism by which HCMV 
establishes and is subsequently re-activated from the latent state is not 
known. However, it has been shown that HCMV infections of certain human cell 
types are non-productive (Table 1: 7). These non-productive infections 
represent a possible mechanism by which the virus may persist in infected 
cells undetected by im mune surveillance in vivo. 
The relationship between HCMV and the cells of the immune system is of 
great clinical importance. Mononuclear cells taken from asymptomatic, 
seropositive individuals have been shown to contain HCMV IE RNA (Schrier et 
ýý, 1985) and infectious virus can be isolated from the buffy coat material 
of patients experiencing an overt infection. In vitro, peripheral blood 
lymphocytes (PBL) can be infected more efficiently with recent HCMV isolates 
than with high passage, laboratory-adapted strains (Rice et al., 1984). 
However, even using recent HCMV isolat s, less than 15% of PBLs exposed to 
infectLon express the major IE antigen; expression of the major IE antigen 
was detected in monocytes, B-lymphocytes, natural killer, CD4+ and CD8+ 
cells (Rice et al., 1984; Schrier et aL, 1985). The in vitro infection of 
PBLs observed by these workers appeared to be blocked at an early stage of 
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the HCMV replicative cycle since neither late antigen expression nor 
infectious virus was detected. More recently it has been shown that a small 
proportion (approximately 0.05%) of cells in a mixed lymphocyte population 
could produce infectious HCMV when they were stimulated by either 
interleukin 2 or allogeneic mixed lymphocytes (Braun and Reiser, 1986). 
Immunofluorescence studies indicated that the majority of HCMV replication 
was taking place in CD8+ (cytotoxic suppressor T) cells (Braun and Reiser, 
1986). Since mitogenic stimulation by phytohae m agglutinin did not induce the 
permissive state in T lymphocytes some factor other than rapid cell growth 
appears to be required, possibly some factor involved in cellular 
differentiation. Reiser et al. (1986) have also recently shown that bone 
marrow stem cells can support HCMV replication if they are cultivated. in 
vitro for 3 weeks prior to infection, possibly during growth in vitro the 
cells undergo a differentiation step which permits virus replication. In 
Avo, lymphocytes may support a level of virus replication and may have an 
important role in both the long-term maintenance (latency) and in the 
dissemination of infection. 
Mocarski and Stinski (1979) observed that following productive, 
cytolytic infection of human fibroblasts a small number of cells survived. 
These cells were cultured. All the resulting cell lines produced were 
observed to contain multiple copies of the HCMV genome and 30% of the cell 
lines secreted infectious virus. Interestingly, cultures which initLally 
produced virus could be converted to a non-producing state by adding 
anti-HCMV sera to the growth media. When these cells were further 
subcultured in the absence of antisera they reverted to producing virus. The 
mechanisms involved in HCMV persistance in a sub-population of infected 
fibroblasts and the suppression of virus replication by humoral antibody is 
not understood. 
The identification and characterisation of the HCMV gene products 
involved in regulating gene expressLon may ultimately be important in 
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under-standing how latency is modulated. 
1: 26 Gene Regulation in Herpesviruses 
The regulation of gene expression has been studied more intensively and 
is better characterised in cells infected with HSV-l than with any other 
herpesvirus. HSV-l exerts its earliest effects on gene expression before the 
virion enters the cell. Kemp Lt 
. 
2L (1986) demonstrated that the binding of 
the virion to its receptor on the cell surface was sufficient to stimulate 
transcription from at least two cellular genes. An additional subset of 
cellular genes are stimulated following virus absorption in the presence of 
an inhibitor of protein synthesis (Kemp ýLt 
. 
2L, 1986). During the course of 
productive infections even though a small number of cellular genes are 
either induced or continue to be expressed (Notarianni and Preston, 1982; 
LaThangue et al., 1984) the vast majority of cellular macromolecular 
synthesis is repressed (Roizman et al., 1965); this situation in HSV-1 
infected cells is in contrast to the marked stimulation of cellular RNA and 
protein synthesis observed during HCMV infections (section 1: 23). 
In the absence of de novo virus-encoded protein synthesis only five 
HSV-l IE genes are transcribed (Fig 1: 5); expression from the promoter of IE 
gene 3 has been studied in greatest detail. The IE gene 3 promoter contains 
an upstream regulatory region which, like an enhancer element, stimulates 
transcription in cis from heterologous promoters relatively independently of 
orientation or distance but, unlike conventional enhancers, does not 
function effectively when inserted downstream of the promoter (Cordingley et 
21., 1983; Lang et 1984; Preston and Tannahill, 1984). More detailed 
analysis of the IE gene 3 enhancer-like element demonstrated that at least 
three seperable, non-homologous elements contribute towards its activity 
(Bzik and Preston, 1986). 
Transcription from HSV-l IE genes is also stimulated in trans by a 
structural component of the virion, a 53,342 dalton (Vmw 65) tegument 
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phosphoprotein (Batterson and R oiz m an, 1983; C ordingley q ýý, 1983; 
Campbell et aL, 1984; Dalrymple . 
2t 
. 
2L, 1985; Pellet et aL, 1985). The 
presence in cis of the consensus sequence TAATGARAT, which is present in at 
least one copy in all nine sequenced HSV-1 and HSV-2 IE promoters, by itself 
can be suff-Lcient to confer on a heterologous promoter the capability for 
its expression to be induced by the virion trans-activator. The level of 
stimulation is, however, greater when a GA-rich sequence, adjacent to. the 
TAATGARAT consensus in the IE gene 3 promoter, is also present (Gaffney fit 
2L, 1985; Bzik and Preston, 1986). At present it is not clear whether HCMV 
virions contain a trans-activator of IE transcription; at least one 
alphaherpesvirus, PRV, has recently been shown not to (Campbell and Preston, 
1987). 
A function of herpesvirus IE gene expression in permissive cell systems 
is the sequential transcriptional activation of early genes. Transient DNA 
transfectLon studies have identif-Led two HSV-1 IE genes involved in 
stimulating early gene expression. In co-transfection experiments cloned DNA 
fragments, containing IE gene 3, stimulated expression from the HSV-1 early 
promoters for the gD, TK and Vmw 38 structural genes but repressed 
expression from its own promoter and that of IE gene 1 (Everett, 1984; 
O'Hare and Hayward, 1985a; 1985b). In similar experiments IE gene 1 alone 
also stimulated expression from HSV-1 early promoters and, in transfections 
using IE genes 1 and 3 together, the two trans-activators acted 
synergistically. Unlike IE gene 3, however, IE gene 1 stimulates expression 
from HSV-1 IE promoters (O'Hare and Hayward, 1985b). HSV-1 IE gene 
expression is therefore stimulated by the virion component, Vmw65, the 
product of IE gene 1 (VmwllO) and repressed by the product of IE gene 3 
(V mw 175). 
Recent studies have shown that IE gene 2, which encodes Vmw63, is 
essential for virus growth; temperature-sensitive mutants in IE gene 2 
permit virus DNA replication but are restricted in late phase gene 
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expression (Sacks et aL, 1985). In DNA transfection experiments the 
product of IE gene 2 (Vmw63) was shown to stimulate expression from the 
promoter for the HSV-1 late gene encoding the major capsid protein, but not 
from the early promoters of the gD and TK genes, and only when used in the 
combination with HSV-1 IE genes 1 and 3 (Everett, 1986). 
A number of temperature-sensitive mutants of IE gene 3 have been 
produced, the best characterised of which is probably HSV-1 TsK. TsK 
contains a single base substitution in the coding region of Vmw175 which, at 
the nonpermissive temperature, causes IE RNAs and IE proteins to be 
overproduced in infected ceUs and prevents the transition to early and late 
phase gene expression (Marsden et al., 1976; Watson and Clements, 1978; 
Davison et al., 1984). While expression 'of a functLonal. Vmw175 protein is 
essential for virus replication, the expression of VmwllO without a 
functional Vmw175 is insufficient to activate signifLcant early phase 
transcription (DeLuca et al., 1985). During productive infections Vmw175 
associates with foci of replicating HSV-l DNA in the cell nucleus (Randall 
and Dinwoodie, 1986). Recent evidence indicates that Vmw175 binds directly, 
or indirectly in combination with a cellular intermediate, specifLcally to 
DNA sequences in HSV-1 IE promoters to suppress expression and to early 
promoters to stimulate expression (Beard et al., 1986; Faber and Wilcox, 
1986; Kristie and Roizman, 1986a; 1986b). Recently, a mutant with a deletion 
in both copies of IE gene I has been constructed which is able to replicate 
without helper functions but it produces relatively low yields of infectious 
virus which have a high particle to p. f. u. ratio (Stow and Stow, 1986). Stow 
and Stow (1986) suggest that at low m. oi. VmwllO-mediated stimulation of 
IE gene 3 transcription may be required to induce sufficient production of 
Vmw175 to activate early phase gene expression. 
Expression from the HSV-1 gD and 6-globin promoter in transfected cells 
can be stimulated by infection with HSV-1, HSV-2, VZV, HCMV, 
Equine 
herpesvirus-1 and adenovirus-2 and in co-transfection experiments 
by IE 
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coding regions from HSV-1, HSV-2, PRV and HCMV (Everett and Dunlop, 1984; 
Everett, 1984). The HCMV strain AD169 genome trans-acting function was 
encoded by HindBI E, which contains IE coding regLons 1,2 and 3 (Fig 1: 6); 
when IE coding region 1 was used by itself however the level of 
transcriptional activation from the gD promoter was "scarcely detectable" 
(Everett, 1984). Spector and Tevethia (1986) have also shown that an HCMV 
DNA fragment containing IE coding regions 1 and 2 can complement an 
adenovirus-5 mutant with a deleted Ela gene sufficiently to permit 
adenovirus replication. HCMV IE coding region 1 and 2, but not IE coding 
region 1 alone, therefore encodes at least one trans-activating functLon 
which stLmulates transcription in an apparently non-specific fashion. 
1: 27 Objectives 
The primary objective of this study was to perform a detailed 
structural analysis on the major IE gene and the abundantly transcribed 
early gene, which maps within TR L AR L' of strain AD 169 as a basis for 
investigating HCMV gene regulation. Reporter genes were cloned downstream 
and under the control of the IE and early promoters and the novel constructs 
used to investigate (a) activation of expression from the IE promoter by a 
- virion component, (b) the negative regulation of the IE promoter which 
occurs during the early and late phases and (c) the delayed activation of 
early gene expression. 
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MATERIALS AND METHODS 
2: 1 Cells, Cell Culture and Thfection With Virus 
MRC5 is a well-characterised human diploid embryo lung fibroblastic 
cell line which supports efficient HCMV replication. MRC5 cells were 
generously provided by Mr P. Wilton-Smith and were used between passage 
levels 18 to 28. In contrast Hela cells are an established human epithelial 
cell line which do not support HCMV replication. The strain of Hela cells 
(kindly supplied by Dr R. Everett, originally from Dr W. Schaffner) used can 
be efficiently transfected with DNA. 
Cells were routinely maintained in 75 cm 
2 
and 175 cm2 plastic flasks. 
Tissue culture media, used throughout, contained 6% foetal bovine serum 
(Imperial Laboratories), 100 jig/ml kanamycin sulphate (Winthrop 
Laboratories) and 3.7 g/l NaHCO 3 in Dulbecco's modified Eagle's medium 
(Imperial Laboratories). Cells were passaged by washing once with PBS (1.8 
g/l NaCl; 0.22 g/l KC1; 1.14 g/l Na 2 HPO 4; 0.27 g/l KH 2PO41 pH7.4), and 
removed from solid support in 2% (w/v) trypsin; 5% (w/v) NaHCO 3; 5% (w/v) 
EDTA in PBS. Unless otherwise stated, MRC5 and Hela cells were passaged at a 
ratio of 1: 3 and 1: 10 respectively. Cell cultures were gassed with 5% CO 2 in 
air prior to incubation at 37 0 C. Plastic tissue culture roller bottles, 
flasks and petri dishes were supplied by Corning Glass Works and Nunc. 
Tissue culture cells were enumerated using a haemacytometer (Weber 
Scientific, Lancing) following dilution in a solution containing Trypan blue 
(0.02%) in saline (0.85% w/v NaCl) as a vital stain. 
HCMV strain AD169 was provided by Dr J. Booth, St Georges Hospital, 
London and HSV-1 TK- (strain MDK5M) by Dr A. C. Minson, Cambridge University. 
To produce virus stock, MRC5 cells were infected with HCMV M-01 
P. f. u. /cell) when 80% confluent, media was replaced at two weeks pi. and 
virus harvested from 3 weeks p. L, depending on the development of the 
characteristic HCMV c. p. e. Since strain AD169 virions are efficiently 
released into the supernatant, virus was harvested in the culture media. 
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Usually two or more harvests were taken at two to three day intervals. 
Cellular debris was removed by centrifugation (1000 rpm for 10 min in a 
Beckman TJ6 centrifuge) and the virus stored in culture supernatant at 
-700C. 
Hela cells (80% confluent) were infected with HSV-1 TK- at a m. o. L of 
0.1 p. f. u. /celL Cells and media were removed 2-3 days p. L at which time 
100% of cells exhibited c. p. e. The suspension was treated to three rounds of 
freezing (-700C) and thawing to lyse the infected cells. Cellular debris 
was removed by centrifugation (10 min at 1000 rpm in a Beckman TJ6 
centrifuge) and virus stored in culture supernatant at -70 
0 C. 
HCMV and HSV-1 were both titrated in MRC5 cells. 200 pl aliquots of 
ten-fold serial dilutions of virus were was added in parallel to 10 wells 
(15 mm diameter; Nunc) containing 80% confluent MRC5 cells. Virus was left 
for 1h at 37 0C to be adsorbed by the cells, the inoculum was removed, cells 
washed once with 2 ml culture medium and 2 ml of medium was then added to 
the cells. HSV-1 infected cells were incubated for 1 week p. L and 
HCMV-infected cells for 4 weeks p. L Culture media was changed on 
HCMV-infected cells 2 weeks p. L Cells were examined for the presence of a 
c. p. e. and virus infectivity calculated by a Spearman-Karber endpoint 
determination (Finney, 1971). 
U. V. -irradiation of HCMV stocks was performed using a purpose-built 
apparatus. 10 ml of virus was pipetted into a 100 mm petri dish which was 
placed on a rocking table situated 300 mm from the u. v. light source. The 
gentle rocking motion of the table ensured that the virus suspension was 
evenly irradiated. The u. v. -light source delivered 1.77 mW/cm2 which is 
equivalent to 17.7 0/ mm2 per second. Sa m ples fro m the sa meHCMV stock 
(titred at 2x 10 
7 
p. f. u. /ml) was irradiated for Os, 10s (177 10/mm 
2 ), 30s 
(531 0/m m2), 90s (1.59 mJ/m m2), 5 min (5.31 mJ/m m 
2), 15 min (15.93 mJ/mm 
2 
and 45 min (47.7 mj/m m2 ). 2 ml of each irradiated virus sample was 
innoculated on to two 50 mm dishes containing MRC5 cells. One dish was 
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incubated for up to 4 weeks as a test for virus infectivity. CeUs in the 
second dish were tested 6h pi. by im m unoflgorescence for the expression of 
the major IE antigen. 
2: 2 Im munofluorescence 
CeUs used for im munofluorescence experiments were grown on 6mmx 22 
mm coverslips. At the appropriate time coverslips were taken from the tissue 
culture dish and placed in a purpose-built rack which was immersed in PBS 
for 30s to remove surplus media. CeUs were then fLxed on to the coverslips 
by immersLon in acetone (-20 0Q for 5 min. Coverslips were occasionally 
stored at -20 
0C in this state. 
Antibodies used in the antigen recognition stage included a monoclonal 
antibody against the major IE antigen (L14, kindly provided by Dr J. 
Nelson), a pool of 10 human convalescent sera which recognised the IE 
nuclear antigen (kindly provided by Ms K. Blake) and hyperimmune guinea pig 
sera raised to the lassa virus nucleocapsid protein (kindly provided by Dr 
G. Lloyd). The monoclonal antibody L14, which was derived from ascitic fluid 
was used at a dilution of 1: 500 (with PBS), other antibodies were diluted 
1: 20 with PBS before use. In the first stage of antigen recognition 100 P1 
of the antibody was applied to the fixed cells and incubated for 30 min at 
0 37 C in a moist chamber. The coverslips were then washed in 250 ml of PBS 
for 30 min at 37 0 C, drained, and 100 pl of the second (fluorescent tagged) 
antibody applied. Antibodies used in this stage included 
rhodamine-conjugated goat anti: -mouse IgG, FITC-conjugated goat anti-guinea 
pig and FITC-conjugated goat anti-human IgG (ICN Biomedicals). The 
conju gated antibodies were all diluted 1: 20 with PBS before use. 
In double-im m unofluorescence experim ents, the m onoclonal antibody L 14 
and the guinea pig anti-lasssa sera were mixed and used in parallel during 
the antigen recognition stage. Likewise the rhodamine-conjugated anti-mouse 
and the FITC-conjugated anti-guinea pig sera were used together in the 
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second stage of the reaction. 
Finally, coverslips were washed for 30 min in PBS at 370C and dried 
before being mounted on glass slides in 90% glyceroL Photographs were taken 
using a Leitz Dialux 20EB microscope with appropriate filters and 
attachments. 
2: 3 RNA Purification 
In order. to minimise degradation of RNA by ribonuclease during 
extraction all glassware, centrifuge tubes and, where practical, reagents 
were thoroughly cleaned and autoclaved. An steps, except for 
phenol/chloroform extractions, were carried out between 0-40C with all 
reagents and apparatus being precooled before use. 
The protocol used was based on an extraction method described by Dunn 
and Sambrook (1980). Media was decanted from the cell monolayer which was 
then washed once with PBS. Cells were harvested in PBS by rolling 3mm 
diameter glass beads over the surface and centrifuged at 1000 rpm for 10 min 
(Sorvall. GSA rotor, Sorvall RC5B centrifuge). The pellet resuspended in 10 
volumes TNE buffer (0.15M NaCl-, 1mM EDTA; O. 1M Tris-HC1, pH 7.5), containing 
20 mg/ml placental ribonuclease inhibitor (Sigma), and left for 10 min to 
equilibrate. Cells were lysed by the addition of Nonidet P40 (NP40) to a 
final concentration of 1% (v/v) and vortexing vigorously for 30s. The 
extract was cleared of nuclei and cellular debris by centrifugation at 
10,000 rpm for 20 min (Sorvall SS34 rotor). The supernatant was then 
adjusted to 0.27. (w/v) with SDS and to lmM with EDTA followed by extraction 
with phenol (BDH chromatography grade phenol equilibrated with lmM EDTA; 
0.5M Tris--HCI, pH 8.0). Phenol extraction was repeated twice more followed 
by extraction twice with chloroform alone. Total cytoplasmic RNA was 
precipitated by the addition of 2 volumes of ethanol, stored overnight at 
-20 
0C and recovered by centrifugation at 12,000 rpm for 20 min in a Sorvall 
SS34 rotor. The RNA pellet was dried and resuspended in distilled water 
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containing 2.5 jig/ml placental ribonuclease inhibitor. 
In some cases poly (A)+ RNA was purifLed from total cytoplasmic RNA by 
chromatography on oligo(dT) cellulose columns. Total cytoplasmic RNA was 
dissolved in binding buffer (0.5M NaC34 lmM EDTA; 0.5% (w/v) SDS; lOmM 
Tris-HC1, pH 7.5) and passed three times through a column (70 mm x: 90 mm 
diameter) containing oligo(dT) cellulose (Collaborative Research). The 
column was washed with 10 ml of binding buffer and poly(A)+ RNA eluted in 
lmM EDTA; 0.05% (w/v) SDS; lOmM Tri---HC1, pH 7.5. 
The concentration of RNA solutions was determined using a scanning 
spectro photo meter (Beckman DU8), 40 pg/ml of RNA has an absorbance at 260 nm 
of approximately one unit. 
2: 4 DNA Transfection of Eukaryotic. Cells 
The CaPO 4 DNA transfection methodology was developed by Graham and 
Van der Eb (1973). 20 ýLg of plasmid DNA was dissolved in 420 VI of TEP 
(0.5mM EDTA; 1mM Tris, pH 7.5) and pipetted into a 10 ml plastic Falcon 
tube. The Falcon tube was gently vortexed as 60 pl of 2M Ca C12 was added 
dropwise to the DNA solution. The resulting mixture was then added 
dropwise to a Falcon tube containing 480 pl of 2x HBS (280mM NaCl, - 50mM 
HEPES; 1.5mM Na 2 HPO 41 pH 7.12) with gentle vortexing. The precipitate was 
allowed to form for 30 min before being added to cells. 
Cells were seeded in petri dishes 24h before transfection to produce 
monolayers which were 80% confluent. The amount of the transfection 
mixture added to the cells was dependent on the size of the petXi dish 
used. 20 ýtg of DNAw as added to 100 mm dia. m eter dishes, 5 pg to 50 mm 
dia m eter dishes and 2 ýLg to 35 mm dia m eter dishes. W hen a large nu m ber of 
identical transfections were performed in parallel the transfection 
mixtures were produced using the same quantities of reagents as described 
above, although in order to standardise the experiments the mixtures were 
pooled before being distributed to the cells. 
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The precipitate was applied directly to the tissue culture 
suprernatant and left 18h for the DNA to be taken up by the ceUs after 
which the media was discarded, the monolayers washed once with TBS buffer 
(137mM NaCl; 5mM KC1; 0.7mM CaC12; 0.6mM Na 2 HPO 4; 25mM Tris--HC1, pH7.4), 
once with complete media, then complete media was added and the ceDs 
incubated further. In experiments in which transfected ceus were 
subjected to virus infection this was performed 6h after the media had 
been replenished, ie. 24h post transfection. 
2: 5 Bacterial Strains, Plasmids and Media 
The bacterial strains used were: 
E. coli K12 JM101: F', a(l1c, Lro), 211, supE, ! 2LaD36, proAB, qýIq, 
Z AM 15, (Messing et 21., 1981). 
E. coli K12 HB101: F-, hsdS20 (r7, m-), recA13, ara-14, proA2, IacYl, 
Z! ýIK2, rspL20 (S m r), 2Lvl-5, mt1-1, auRE44, (Boyer et al., 1969). 
E. coli strain HB101 was used preferentia. 11y for propagating 
Plasmids, the recA13 genotype makes it less likely for plasmids to be 
involved in a recombination event in this host. E. coli JM101 was used for 
growth of the 'male-specific' M13 phage. Additionally, the defective 
phenotype of the lac gene in E. coli JM101 made it a suitable host for use 
in DNA cloning experiments which involved insertional inactivation of a 
plasmid or phage bourne lacZ gene to identify recombinants. 
Details of the HCMV recombinant DNA gene bank and its construction 
are given in Oram et al. (1982) and Greenaway et j2j, (1982). The plasmid 
cloning vectors pUC8, pUC18 and pUC19 were obtained from BRL. pMTL21b, a 
plasmid based on the 'pUC' series of vectors but containing additional 
unique cloning sites, was a kind gift of Dr N. Minton. pCAT and pSV2cat 
(Gorman et al., 1982a) were obtained courtesy of Dr D. Gaffney, and 
pRSVcat (Gorman et al., 1982b) obtained courtesy of Dr A. Lehmann. pMD102 
(Everett et al., 1983) and IEP11assaterm (unpublished) were provided by 
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Drs R. D. Everett and C. Clegg respectively. IEPlcatIEterm, AccHincat, 
SV2catIEterm, pVUIITK1,0.7TK1,1/34TK1 and 0.7-1/34TK1 were all provided 
by Dr A. Akrigg. The plasmid pT23 contains the HCMV PstI fragment B tailed 
into the Pstl site of pAT153 (Akrigg and Wilkinson, unpublished). 
The M13 phage vectors M13mp8 and M13mpll were obtained from BRL. DNA 
fragments. subc1oned from the major IE gene into M13mp8 which were used in 
nuclease protection studies on the HCMV major IE gene (Table 3: 1) were 
provided by Dr A. Akrigg. M13mpll(1/39) was provided by Dr P. J. Greenaway. 
Bacteria were grown either in L-broth (10 g bacto-tryptone, 5g 
bacto-yeast extract and 10 g NaCl per litre, pH 7.5) or YT-broth (10 g 
bacto-tryptone, 10 g bacto-yeast extract and 5g NaCl per litre, pH 7.5). 
For L-agar and YT-agar 15g per litre of bacto-agar was added to L-broth 
and YT-broth respectively. M13 phage plaques were grown on a bacterial 
lawn in H-top agar (10 g bacto-tryptone, 8g NaCl and 8g agar per 
litre) overlays; the overlays were poured on plates containing YT-agar. 
In antibiotic selection experiments ampicillin was used at a final 
concentration of 50 pg/ml when recombinants were being selected following 
transformation but at 100 pg/ml at all subsequent stages. Tetracycline was 
used at a concentration of 20 ýig/ml. The chromogenic substrate X-gal 
(5-bromo-4-chloro-3-indoyl-, 3-galactoside), which turns blue when 
hydrolysed by ý-galactosidase, was used at a final concentration of 0.02% 
(w/v) together with 50jiM IPTG (iso-propyl-. 3-D-thio-galactopyranoside). 
2: 6 Restriction Endonuclease Digestion and The Electrophoresis of DNA in 
Agarose and Polyacrylamide Gels 
DNA was digested with restriction endonucleases using buffers and 
conditions recommended by the manufacturers (BCL or BRL). The products of 
restriction endonuclease digestion were analysed by electrophoresis in an 
appropriate gel system. 1% horizontal agarose gels (100 mm x 100 mm x 10 
mm) prepared in 1x TBE buffer (0.089M Tris base; 0.089M boric acid; 
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0.002M EDTA, pH 8.0) were used routinely for rapid analysis. When 
necessary, 1% vertical agarose gels (200 mmx 200 mmx 15 m m) were used to 
resolve closely migrating fragments or to obtain more accurate molecular 
weight determinations. Vertical agarose gels were prepared in 1xE buffer 
(20mM sodium acetate; lmM EDTA; 40mM Tris-HC1, pH 8.2). 
DNA fragments less than 200bp long were analysed using a vertical 6% 
polyacryla mide gel (200 mm high x 150 mm wide x3mm thick). 6% (w/v) 
acrylamide; 0.16% (w/v) NX-bis--m ethylene acrylamide in 1xF buffer 
(20mM MOPS; 1mM EDTA; 5mM sodium acetate, pH 7.0) was degassed under 
vacuum and polymerised by the addition of 0.025% TEMED and 0.2% (w/v) 
ammonium persulphate immediately before the gel was poured. 
Samples were applied to weUs in 5% loading buffer (0.025% bromphenol 
blue; 0.05 % xylene cyanol FF in the appropriate electrophoresis buffer 
and electrophores-is performed in 1x TBE (horizontal agarose gels) for Ih 
at 60 volts, 1xE (vertical agarose gels) for 16 h at 20 volts or 1xF 
buffer (vertical acrylamide gels) for 2.5h at 80 volts. DNA was stained by 
im mersLng the gels for 20 min in a solution containing 1 jig/ml ethidium 
bromide dissolved in the appropriate running buffer. DNA stained with 
ethidium bromide was visualised using a u. v. (302 nm) transMuminator. 
HindBI digested Xvirus DNA (BRL) and HaeIII digested OX174 virus DNA 
(BRQ were used as molecular weight standards. 
2: 7 Recovery of DNA Fragments From Gels 
Individual DNA fragments were excised from both agarose and 
acrylamide gels using a scalpel. Each gel fragment was placed into a 
dialysis bag containing 0.3 ml of 1x TBE buffer which was then sealed and 
put in a electrophoresis tank, submerged in 1x TBE and subjected to 
electrophore-, -zds at 40 volts for 20 min. DNA electroeluted from the gel is 
unable to penetrate the membrane of the dialysis bag. Electrophoresis 
buffer containing eluted DNA was removed from dialysis bags, extracted 
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twice with phenol, twice with chloroform and precipitated with two volumes 
of ethanol. Precipitated DNA was recovered by centrifugation, dried and 
dissolved in TE buffer (10 mM Tris-HC1; lmM EDTA, pH 7.5). 
2: 8 Phosphatase Treatment of DNA Fragments 
Restriction endonuclease cleaved DNA fragments were treated with 
phosphatase to remove 5' terminal phosphate groups. In recombinant DNA 
experiments restriction endonuclease digested plasmid vector DNA was 
invariably treated with phosphatase. The removal of both terminal 
phosphate groups makes circularisation of the vector dependent upon its 3' 
terminal hydroxl groups forming phosphodiester bonds with the 5' phosphate 
groups of a foreign DNA fragment. Phosphatase treatment thereby increases 
the proportion of plasmids generated in a cloning experiment which contain 
inserts. DNA fragments destined to be 5' end-labelled with [, y_32 P]ATP 
using polynucleotide kinase were also treated with phosphatase. 
Following digestion with restriction endonucleases DNA was 
precipitated with ethanol, recovered by centrifugation, dried and 
dissolved in 1mM MgC1 2; 0" mM ZnC12; 1mM spermidine; 50mM Tris, pH 9.0. 
Bacterial alkaline phoshatase (BAP; BRL) was added at a concentration of 
75 units per pg of DNA and the reaction incubated at 65 0C for 30 min. The 
reaction products were subjected to electrophoresis in agarose gels and 
the desired DNA fragments recovered by electroelution. When phosphatased 
DNA fragments were not subjected to electrophoresis, BAP was inactivited 
by extracting the sample three times with phenol and twice with 
chloroform. The DNA fragment was then recovered by ethanol precipitation. 
2: 9 Ligation of DNA Fragments 
Linearised vector DNA (plasmid or M13 double stranded DNA) was 
covalently linked at both ends to the DNA fragment being cloned resulting 
in the formation of circular DNA molecules which are capable of being 
90 
replicated in E. coli. The enzyme used to catalyse the formation of 
phosphodiester bonds between the vector and the insert was T4 DNA ligase 
(BCL). A 1: 1 ratio of insert to vector molecules was used unless the 
vector was not phosphatased in which case the ratio was 2: 1, or blunt 
ended DNA fragments were being used in which case the ratio was 4: 1. The 
total DNA concentration in 4gation reactions was kept below 20 ýLg/ml to 
minimise the formation of concatemeric structures. DNA was dissolved in 
21.5 VI TE buffer and 2.5 pI of 10 x ligase buffer (10mM ATP; 50mM MgC12 
50mM dithiotreitol; 50mM Tris-HCI, pH 7.5) added. The reaction was started 
by the addition of 1 pl (1 unit) of T4 DNA ligase and incubated overnight 
at 16 0 C. 
2: 10 Transformation of Escherichla coli 
E. coli was transformed with plasmid DNA according to the method of 
Kushner (1978). Overnight cultures of E. coli were diluted 1: 100 in 
L-broth and incubated with shaking until they reached an OD 650 of 0.2. 
Bacteria from 1.5 ml of culture were pelleted by centrifugation in a 
microfuge (3 min) and resuspended in 1.0 ml of IOmM RbC12; lOmM MOPS, pH 
7.0, (0 0 Q. The suspension was immediately centrifuged for 3 min in an 
eppendorf microfuge, the supernatant discarded and the bacterial pellet 
resuspended in 1 ml of 1OmM RbC12; 50mM CaC12; 1OOmM MOPS, pH 6.5, (Buffer 
B). E. coli were maintained in suspension (on ice) for 30 min before being 
pelleted and resuspended in 0.2 ml of Buffer B (00Q. 0.2 ýLg, or less, of 
DNA was added and the bacterial suspension incubated on ice for 30 min and 
then given a heat shock (43.5 0C for 30s). 1 ml of L-broth was added and 
the culture incubated at 37 0C for 1h to permit expression of the 
antibiotic resistance markers encoded by transforming plasmids. Aliquots 
of the transformed culture were spread on L-agar plates containing the 
appropriate antibiotic (50 ýig/ml of ampicMin or 20 ýIg/ml Of 
tetracycline). Individual colonies of transformed E. coli were obtained by 
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incubating the plates at 370C overnight. 
2: 11 PI-asmid Purification From Small Culture Volumes 
Purffication of plasmid DNA on a small scale was performed according 
to the method of Birnboim and Doly (1979). Plasmid-containing E. c 
picked from a single colony, was grown in 5 ml of L-broth (containing 
appropriate antibiotics) overnight at 370C in a shaking incubator. 1.5 ml 
of the culture was centrifuged for 3 min in a microfuge, the bacterial 
peUet resuspended in 100 pl solution of 2m g/ ml lysozy me (Sig m a, 10 mM 
EDTA; 50mM glucose; 25mM TrIs-HC1, pH 8.0 and incubated for 30 min at 00C. 
Following bacterial lysis, DNA was denatured by adding 200 pI of 0.2M 
NaOH; 1% (w/v) SDS (5 min at 00 C). The addition of 150 pI 3M sodium 
acetate (pH 4.8) for 60 min at OOC results in plasmid 'snap-back' into a 
DNA duplex whereas mismatch during renaturation E. coli chromosomal DNA 
results in it being precipipitated. Precipitated chromosomal DNA was 
pelleted by centrifugation (5 min in an Eppendorf microfuge). Plasmid DNA 
in the supernatant was precipitated with three volumes of ethanol at -200C 
for 30 min, recovered by centrifugation, dissolved in 200 a 0.3M sodium 
acetate, pH 4.8, and precipitated again with three volumes of ethanoL 
Finally the dried ethanol precipitate was dissolved in 100 pl of O. 1mM 
EDTA; 10mM Tri--HC]4 pH 7.5. 
Small scale plasmid preparations were used primarily in screening 
bacteria for the presence of cloned inserts in recombinant DNA 
experiments. DNase-free RNase was routinely added during restriction 
endonuclease cleavage of these DNA preparations to digest contaminating 
RNA which otherwise would conceal DNA fragments less than lkb. 
2: 12 Plasmid Purification From Large Culture Volumes 
Large scale purification of plasmid DNA was performed according to 
the method of Clewell and Heliýski (1969). Plasmid-containing E. coli 
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picked from individual colonies were grown in 5 ml of L-broth (containing 
the appropriate antibiotic) at 370C overnight in a shaking incubator. The 
overnight cultures were used to inoculate 200 ml of L-broth, also 
containing the appropriate antibiotic, which was then incubated at 370C 
with shaking until the OD 650 reached 1.0, at this stage chloramphenicol 
was added to a concentration of 150 pg/mL After a further 12h incubation 
bacteria were harvested by centrifugation at 7000 rpm, 40C for 10 min in a 
Sorvall GSA rotor and resuspended in 2 ml of 25% (w/v) sucrose; 50mM 
Tris-HC1, (pH 8.0). 0.3ml of 20 mg/ml lysozyme (Sigma) in 0.25M EDTA was 
added and the suspension left for 5 min at 00C after which 2 ml of 0.25M 
EDTA was added and the suspension left a further 5 min at OOC. The cells 
were then lysed by the addition of 3 ml 1. % (w/v) Brij 58 (Atlas Chemical 
Industries); 0.5% (w/v) sodium deoxycholate; lm M EDTA; 10m M Tris-HCl (pH 
8.0) and pipetting vigorously up and down three times in a 10 ml pipette. 
The lysate was left on ice for 20 min and then centrifuged at 15,000 rpm, 
40C for 45 min (Sorvall SS34 rotor). The supernatant was decanted, its 
volume measured and 0.95 g/ml CsCl and 200 ýtg/ml ethidium bromide added. 
Plasmid was separated from chromosomal DNA by equilibrium gradient 
centrifugation at 38,000 rpm for 60h (Beckman L5-65B ultracentrifuge, Ti 
50 rotor). After centrifugation tubes were examined under u. v. light 
(wavelength 366 nm) and the lower fluorescent band containing plasmid DNA 
was harvested using a2 ml syringe with a 3/8 inch 21G needle. The upper 
band contains mainly chromosomal DNA. 
Plasmid DNA was extracted three times with propan-2-ol (saturated 
with CsCl and H2 0) to remove the ethidium bromide and dialysed three times 
for 4h against 200 volumes of TE buffer. The absorbance of plasmid 
preparations was measured at 260 nm (Pye Unicam SP6-550 spe ctro photo meter) 
to determine the DNA concentratLon (50 pg/ml of DNA has an absorbance at 
260 nm of approximately 1.0). 
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2: 13 Nick Translation of DNA 
High specific activity radiolabelled DNA hybridisation probes were 
produced in vitro by nick translation (Rigby et, . 
21:, 1977). 
1 jig of DNA was dissolved in a 50 pl, reaction mixture containing 10 
PCi [=_32P] dATP (410 Ci/m mol; A mersham International); 15pM dCTP; 1511M 
dGTP; 15pM. dTTP; 50m M NaCl; 10m M MgC12; 100m M Tris-HC1, pH7.5). Bovine 
pancreatic deoxyribonuclease (Sigma) was added to a final concentration of 
1 pg/ ml- to plas mid DNA (although not to HCMVDN A) to introduce single 
stranded nicks which are required for DNA polymerase 1 to initiate 
replization; puri: ELed HCMV DNA is already nicked. After being held for 10 
min at room temperature 5 units of DNA polymerase 1 (BRL) was added and 
the reaction incubated at 15 0C for 2h. Unincorporated isotope was removed 
by chromatography through a Sephadex G-50 column. Radiolabelled DNA was 
eluted in the void volume. 
2: 14 Form aldehyde-A garose Gel Electrophoresis and The Transfer of RNA to 
Nitrocellul se Membranes 
RNA samples were dissolved in 1xF buffer containing 2.2M 
formaldehyde and 50% recrystalised formamide (Casey and Davidson, 1977) 
and heated at 60 0C for 5 min to fu. 4y denature RNA. After cooling the 
sample was mixed at a ratio of 5: 1 with sample buffer (15% (w/v) Ficoll; 
0.25% (w/v) bromophenol. blue) and applied to a vertical denaturing 
agarose-formaldehyde gel. 1% agarose gels were prepared in 1xF buffer 
and 2.2M formaldehyde, formaldehyde being added when the melted agarose 
solution had cooled to 60 0C (Lehrach et al., 1977). Molecular weight 
markers included E. coli 16S and 23S rRNA (1541 and 3000 bases 
respectively, Brosius et al., 1978; supplied by BDH) and human 18S and 28S 
rRNA (1740 and 4850 bases each; Loening et . 2L, 
1969; Welleaur and Dawid, 
1973) prepared from MRC5 cells. 1xF buffer, without formaldehyde, was 
used as the running buffer and electrophoresis carTied out at 
50 volts for 
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16h. RNA was stained by immersing the in the gel for lh in 1 pg/ml 
ethidium bromide dissolved in 1xF buffer and visualised using a u. v. 
transillu minator. 
RNA was transferred from formaldehyde agarose gels to nitrocellulose 
according to the method of Thomas (1980), this procedure is commonly 
refer-red to as a 'Northern Transfer'. After being destained the gel was 
placed horizontally on a wick (four sheets of Whatman 3MM paper) connected 
to a reservoir containing 20 x SSC (3M NaCl; 0.3M sodium citrate, pH 7.0). 
A nitrocellulose membrane (Schleicher and Schuell) was wetted with H20, 
equilibrated in 20 x SSC and carefully placed on the gel. A 10 cm stack of 
blotting paper was placed on top of the nitrocellulose and held in place 
with a weight. The apparatus was left for 48h for the RNA to be blotted on 
to the membrane. The membrane was then removed, dried and baked for 2h 
under vacuum at 80 0 C. 
2: 15 Filter Hybridisation Conditions 
Hybridisation of radiolabelled DNA probes with RNA immobil-Ised on 
nitrocel-lulose membranes was performed using conditions described by 
DeMarchi (1981). Nitrocellulose membranes were immersed in 50% (v/v) 
formamide in 2x SSC and then placed in plastic bags containing 20 ml. of 
hybridisation buffer (43% (v/v) formamide; 0.5 mg/ml denatured salmon 
sperm DNA (Sigma); 2x SSC; 0.5% (w/v) SDS). The bags were sealed and the 
membranes prehybridised for 4h at 450C. When necessary hybridisation 
6 
probes were denatured by boiling for 5 min, cooled rapidly on ice and 10 
c. p. m. (Cerenkov) of radiolabelled DNA added to make up a final volume of 
5 ml. 1x hybridisation buffer. The prehybridisation buffer was replaced 
with the hybridisation solution containing the probe, the bag was sealed 
and hybridisation performed at 420C for 16h. Membranes were then washed 
(at room temperature) three times in 50% (v/v) formamide; 2x SSC, twice 
in 2x SSC, dried and subjected to autoradiography. 
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2: 16 End-labelling DNA Fragments 
DNA fragments used in nuclease protection experiments were 5' 
end-labelled with py _ý32 P]ATP and polynucleotide kinase or 3' end-labelled 
with [. _32p ]dATP and the Klenow DNA polymerase. All DNA fragments were 
isolated from agarose gels by electroelution before being end-labeffied. 
. 
DNA-fragments destined to be 5' end-labelled were treated with 
phosphatase (sectLon 2: 8) prior to agarose gel electrophoresis. Following 
electroelution DNA fragments were recovered by ethanol precipitation, 
dissolved in 25 jil TE buffer and desalted by chromatography through a 
smaU (100 pl) Sephadex G50 column to remove inhibitors of polynucleotide 
kinase. DNA in the void volume from the column was recovered by ethanol 
precipitation and dissolved in a 20 pl solution containing 10mM MgC12; 
O. 1mM EDTA; O. 1mM spermidine; 5mM dithiothreitol, 50mM Tris--HC1 (pH 7.5) 
and 50 ý, Cj py 
J2 P]ATP (3000 Ci/mmol; A mersham InternatLonal). 10 units of 
T4 polynucleotide kinase (BRL) were added and the reaction incubated at 
37 0C for 1 h. 
DNA fragments were 3' end-labelled by using the Klenow polymerase to 
synthesise DNA complementary to the short protruding -single-stranded 5' 
sequence generated during cleavage of DNA with some restriction 
endonucleases. DNA fragments., recovered from gels, were dissolved in a 
20 lil solution containing 15jiM dCTP; 15jiM dGTP; 15ýffl dTTP; lOmM MgC12; 
50 mMNa Cl; 50 mM Tris-H Cl (p H 7.5) and 10 tlCi [, ýr . _ý32 P1dATP (410 Ci/m mol; 
Amersham International). 1 unit of Klenow DNA polymerase (BCL) was added 
and the reaction incubated at 200C for 30 min. 
Unincorporated label was removed from end-labelled DNA by Sephadex 
G50 chromatography. 
2: 17 Preparation of M 13 Phage ssD NA Templates 
50 pl from an overnight culture of E. coli JM101 was added to 5 ml of 
YT-broth and infected with M13 phage picked from a single plaque. 
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Following incubation for 6h at 370C 1.5 ml of the phage-infected culture 
was centrifuged for 5 min. in an Eppendorf microfuge. The culture 
supernatant, containing mature M13 'phage released during the infection, 
was removed to a fresh 1.5 ml Eppendorf tube and the pellet containing 
infected bacterial cells discarded. 150 pl of 20% (w/v) PEG; 2.5M NaCl was 
added to the supernatant, incubated at 200C for 10 min and the phage, 
precipitated by PEG, was recovered by centrifugation (5 min in an 
Eppendorf microfuge). Care was taken to ensure complete removal of the 
supernatant before the pellet was resuspended in 100 pl of 0.3M Na Acetate 
(pH 4.8). The suspension was then extracted twice with phenol (50 pl), 
twice with chloroform (100 pl) and finally precipitated with 0.5 ml of 
ethanol (-70 0C for 30 min). -M 13 phage ssD NA was then recovered by 
centrifugation, dried and dissolved in 30 4 of TE buffer. 
2: 18 DNA Sequencing Reaction 
ssDNA templates prepared from M13 phage were sequenced by the 
dideoxynucleotide chain termination method of Sanger 
-et -aL 
(1977). Prior 
to the sequencing reaction a synthetic oligonucleotide primer is annealed 
to a complementary sequence on the M13 ssDNA template immediately 5' to 
the clustered cloning sites. A mixture of 5 pI template DNA (see section 
2: 17), 1 pl l7n oligonucleotide primer (0.2pM, Collaborative Research), 
and 1 pl TM buffer (50mM MgC12; 100mM Tris-HC1, pH 8.5) were made up to a 
final volume of 10 pl with water. The sample was incubated in a 60 0C oven 
for lh to permit the efficient hybridisation of the primer to the 
te m plate. 
Four different reactions are involved in sequencing each template, 
one for each nucleotide in DNA. Four stock solutions of nucleotide 
triphosphates were prepared, each containing a different 
dideoxynucleotide. A' contained 12ýýM dCTP; 125ýM dGTP; 125ýtM dTTP; l5jiM 
ddATP, C' contained 6.25ýiM dCTP; *125pM dGTP; 125ýiM dTTP; 
404M ddCTP, G' 
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contained 125ýLM dCTP; 6.25pM dGTP; 125pM dTTP; 80ýM ddGTP, and T' 
contained 125pM dCTP; 125pM dGTP; 6.25jiM dTTP; 2504M ddTTP. 
Immediately before use 14 of the Klenow polymerase (1 unit, BRL) 
and 1 01 (10 11Cj) of [,,, 
j2P]dATP (410 Ci/mmol; A mersham International) was 
added to 10 pl of the hybridised template-primer solution at OOC. 2 V1 of 
the resulting mixture was pipetted inside and near the top of four 1.5 ml 
Eppendorf tubes. 2 V1 of solution A', C', G' and T' were each added to one 
of the tubes which were then centrifuged (5s) in an Eppendorf microfuge. 
The sequencing reaction begins when the solutions mix at the bottom of the 
tubes. Tubes were incubated for 15 min (20 0 C) and then 2 pl of a 
nucleotide triphosphate chase solution (0.25mM dATP; 0.25mM dCTP; 0.25mM 
dGTP; 0.25mM dTTP) was added and the reaction incubated for a further 10 
min (20 0 Q. 2 pl of sa m ple buff er (2 ml 0.5M EDTA, 0.1 g bromophenol blue, 
0.1 g xylene cyanol FF added to 100 ml of deionised formamide) was added 
to each tube and the samples boiled for 3 min, to denature DNA, before 
being applied to a sequencing gel. 
Electrophoresis was carried out in a 0.3 mm (thick) x 200 mm (wide) x 
400 mm (high) vertical 6% polyacryla mide gel. 1 litre of sequencing gel 
solution contains 150 ml of a 40% acrylamide stock solution (38% 
acrylamide; 2% bis-acrylamide), 460 g of urea and 100 ml of 10 x TBE 
buffer. 70 pl of ammonium persulphate and 70 pl of TEMED were added to 50 
ml of (degassed) sequencing gel solution immediately before the gel was 
poured. Sequencing gels were electrophoresed at 1200 volts for 
approximately 2h. The electrophoresis apparatus was supplied by Raven 
Scientific and the power supply was an LKB model 2197. 
Following electrophoresis the gels were immersed in fLxing solution 
(10% acetic acid; 10% methanol; 80% water) and dried by gently blotting 
with paper towels. The gel was covered with Saran Wrap before being 
subjected to autoradiography at room temperature. 
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2: 19 Mapping of RNA Transcripts in Nuclease Protection Studies 
Structural analysis of the major IE mRNA was performed using the 
nuclease mapping technique of Berk and Sharp (1977) as modified by Weaver 
and Weissman (1979). When this technique was used DNA was either 5' 
end-labelled with [. y _32 P]ATP using T4 polynucleotide kinase or 3' 
end-labelled with [=- 
32 P]dATP using the Klenow DNA polymerase (section 
2: 16). 
Nuclease mapping studies were also carried out with ssDNA probes 
prepared from M13 subclones (Farrell et al. (1983). Radiolabelled DNA 
complementary to the M13 cloned insert was synthesised using essentially 
the same protocol described for the DNA sequencing reaction (section 2: 18) 
except that dideoxynucleotides were not used. The nucleotide triphosphate 
solution used comprised 125pM dCTP; 125ýiM dGTP; 125jiM dTTP and 20 pCi 
E. J2 P]dATP (410 Ci/mmol, A mersham International). The nucleotide 
triphosphate chase solution was added as in the DNA sequencing reaction 
(section 2: 18). Following the in vitro DNA radio-Jabel1ing reaction the 
mixture was diluted with distMed water (15 4) and heated to 1000C for 5 
min to denature the partial DNA duplex. The strands were separated by 
electophoresis in a 1% agarose gel and the faster- migrating radiolabelled 
strand recovered by electroelution (section 2: 7). 
Radiolabelled DNA probes were mixed with the appropriate RNA samples 
and precipitated with ethanol. The precipitate was resuspended in 20 pl 
80% (v/v) recrystalised formamide; OAM NaCl; 0.001M EDTA; 0.04M PIPES (pH 
6.4) (H-buffer), heated to 700C for 5 min and the solution incubated for 4 
or 16h at 42 0 C, unless otherwise stated in the text. The solution was then 
diluted 15 fold with mung bean nuclease buffer (0.03M Na acetate (pH 4.6); 
0.05M NaCl; 0.001M Zn C12) or exonuclease VII buffer (0.067M KP04 pH7.9); 
0.083M EDTA). Mung bean nuclease (100 units, P. L. Biochemicals) or 
exonuclease VII (2 units, BRQ was added and the reactions incubated at 
37 0C for 60 min. When practical exonuclease VII treated samples were 
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desalted by chromatoraphy through a Sephadex G50 column. Nucleic acids 
were precipipated with ethanol, recovered by centrifugation, dried, 
dissolved in TE buffer and analysed by electrophoresis either in 
denaturing form aldehyde-agarose gels or DNA sequencing gels. 
2: 20 Primer Extension Analysis of RNA Transcripts 
The transcriptional start site of the HCMV major early gene was 
identified in a primer extension experiment. DNA complementary to the 
cloned insert in M13mpll(1/39) was synthesised using essentially the same 
protocol described for the DNA sequencing reaction (section 2: 18) except 
that dideoxynucleotides were not used. The nucleotide triphosphate 
solution used comprised 1,254M dCTP; 125pM dGTP; 1254M dTTP and 10 ýXi 
[. _32 PIdATP (410 Ci/mmol, Amersham Liternational). The chase nucleotide 
solution was added, as in the DNA sequencing reaction, to obtain maximum 
extension of the newly synthesised strand. The synthesised DNA duplex was 
digested with IXmaEL denatured by boiling in the presence of 50% (v/v) 
formamide (3 min) and single-stranded DNA fragments separated by 
electrophoresis in a 6% acrylamide-urea sequencing gel. The radiolabelled 
103n ssDNA primer was detected by autoradiography and recovered by 
electroelution (section 2: 7). 
10 ýig of total cytoplasmic RNA (or tRNA) was hybridised for 4h at 
400C with 12,000 cpm (Cerenkov) of primer DNA in 30 4 of 80% (v/v) 
formamide; OAM NaCl; lmM EDTA; 0.04M PIPES (pH 6.4). Nucleic acid was 
precipitated with ethanol and redissolved in a 20 pl solution containing 
2.5 units/ml placental ribonuclease inhibitor (Sigma); lmM dATP; lmM dCTP; 
lmM dGTP; lmM dTTP; 50mM KC1; lOmM MgC12; lOmM dithiothreitol; 50mM 
Tris-HC1 (pH 8.0). Reverse transcriptase (25 units, Anglian Biotechnology) 
was added and the reaction incubated at 420C for 30 min. The reaction 
products were recovered by ethanol precipitation, separated by 
electrophoresis in a DNA sequencing gel. Autoradiography was performed at 
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room temperature for 16h. 
2: 21 Autoradiography 
Autoradiography was performed by placing Kodak X-Omat RP film against 
the sample in a light-tight box at room temperature for the period of time 
necessary for optimal exposure of the fIlm. In DNA/RNA hybridisation 
experiments a Dupont Cronex Lightning plus intensifying screen was also 
placed on top of the film and in this case the ffim was exposed at -700C. 
The film was developed in Kodak LX 24 developer (5 min at 200C), rinsed in 
water for 1 min, immersed in Kodak FX 40 fixer (5 min at 20 0 Q, washed in 
running water (30 min) and dried. 
2: 22 Assay for Thymidine Kinase Activity in Transfected Cells 
Thymidine Idnase (TK) activity in transfected cells was measured 
essentially according to the method described by Cordingley et 
. 
21, (1983). 
Cells monolayers were rinsed once with 1x PBS and then scraped off 35 mm 
or 50 mm diameter petri dishes using the flexible end of a fine-tipped 
pastette directly into either 300 pl or 400 V1 of TK extraction buffer (1% 
(v/v) NP40; 10mM KC1; 1mM MgClý; 1mM m ercapto ethanol; 10mM MgC12; 
Tris-HC1, pH 7.5) Cells were lysed by vortexing vigorously for 30s and 
then nuclei and cellular debris was removed by centrifugation in a MSE 
microfuge (high speed for 5 min). The cellular extract was stored at -800C 
unt3l assayed. 
The TK enzyme assay consisted of 10 pl of cell extract; 5mM ATP; 50jiM 
dTTP; 10 pCi of [5 1_3 H]thymidine (40 Ci/mmol; A mersham International); 
10MM MgC'2; 100mM NaPO 4' pH 6.0 in a final volume of 50 pL The reaction 
was incubated at 30 0C for 4h before being stopped by the addition of 10 pl 
of 2mM thy midine and heating to 1000C for 2 min. 45 pl of the reaction 
mixture was spotted on to 15 mm square piece of Whatman DE81 paper. The 
filter paper was washed three tLmes in 4mM ammonium formate, pH 4.0, at 
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37 0 C, twice in ethanol, twice in ether and dried. The amount of 
phosphorylated (3 H]thymidine bound to Whatman DE81 paper was counted in 5 
ml of scintMation fluid using a Hewlett Packard Tri Carb 8000 
scintiMtion counter. 
2: 23 Assay for Chloramphenicol Acetyltransferase Activity in Transfected Cells 
Chloramphenicol acetyltransf erase (CAT) in transfected ceUs was 
measured according to the method described by Gorman et aL (1982a). 
Monolayers were rinsed once with 1 x: PBS and the ceUs scraped off the 
petri dish, using the flexible end of a fine-tipped pastette, into 0.5 ml 
of PBS. Cells were pelleted by low speed centrifugation in a MSE microfuge 
(I min) and resuspended in 100 a of 0.25M Tris-HC1 (pH 7.5). The cells 
were lysed by the addition of NP40 to a final concentration of 1%, 
vortexing vigorously for 30s and exposing to one round of freezing (-80 0 C) 
and thawing. Nuclei and cellular debris were removed by high speed 
centrifugation in a MSE microfuge (3 min). Cellular extracts were stored 
at -800C until assayed. 
The CAT enzyme assay contained 20 pl of cell extract; 0.5 ýXi of 
14 C]chloramphenicol (50 mCi/mmol; Amersham International) and 100 4 of 
0.25M Tris-HC1 (pH 7.5) in a final volume of 160 pL The reaction was 
started by the addition of 20 44mM acetyl coenzy meA (Sig m a) and 
incubated for between 20 min to 2h at 370C. The reaction was stopped by 
adding 0.7 ml of ethyl acetate (-200C) and vortexing vigorously; ethyl 
acetate also serves to extract chloramphenicol from the aqueous phase. The 
organic phase was removed to an eppendorf tube and dried down in a vacuum 
desiccator. The dried product was redissolved in 20 pl of ethyl acetate 
and spotted on to thin-layer sMca gel chromatography (TLC) plates 
(Merck). The TLC plates were suspended above 100 mi of 957. chloroform; 
5% 
methanol in a chromatography tank for 10 min, to allow the silica gel 
to 
equilibrate. The foot of the TLC plate was then placed 
in the solvent 
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which was allowed to ascend the plate by capilliary action for 
45 min. 
Choramphenicol and its three acetylated forms (the products of the 
reaction) were visualised by autoradiography of the TLC plate. 
Quantitative results were obtained by scraping the silica gel off relevant 
regions of the plate into scintillation fluid and measuring their 
radioactivity using a Hewlett Packard Tri Carb 8000 scintillation counter. 
2: 24 Assay of Protein Concentration 
Values for the protein concentrations of cellular extracts were 
obtained using the method of Bradford (1976). 100 mg of CoomassLe 
Brilliant Blue G-250 (BDH) was dissolved in 50 ml of methanol and filtered 
through Whatman 3MM paper. 100 ml of 957. orthophosphoric acid and 200 ml 
of water was added to the filtrate. This concentrated stock solution was 
then diluted 1: 5 for use. 100 pl of each sample asssayed was added to 5 ml 
of the diluted dye and gently mixed. After 10 min the increase in 
absorbance at 595 nm was measured. The protein concentration of samples 
were calculated by comparing the OD 595 with values derived from a 
standard. A standard curve was prepared for each assay performed using 
bovine serum albumin at varying concentrations between 25 pg/ml to 2 
mg/mL 
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RESULTS 
3: 1 Structural An2jy. 2! 2 of the Ma: jor IE Gene 
HCMV encodes a highly abundant 1.95kb IE mRNA which is transcribed fro m 
between 0.756-0.745 map units with respect to the prototype orientation of 
the strain AD169 genome (Figs 1: 5,1: 6 and 3.1). The coding region for the 
1.95kb IE RNA has been shown by RNA/DNA hybridisation experiments to extend 
for at least 2.9kb; this result was interpreted as indicating that the 
major IE gene may contain in excess of 0.95kb of intron sequence (Wilkinson, 
1983; Wilkinson et al., 1984). In order to precisely map the 5' and 3' ends 
of the major IE gene and identify the locations of splice sites nuclease 
protection studies were performed usLng the technique of Berk and Sharp 
(1977) as modified by Weaver and Weissman (1979) and Farrell et al. 
(1983). The structural analysis of the major HCMV IE gene was carried out in 
combination with the determination of its nucleotide sequence, which was 
performed by Dr A. Akrigg. The complete nucleotide sequence of the strain 
AD169 major IE gene has now been ascertained and is shown in appendix 2 
(Akrigg et 2Lý, 1985). 
Mapping the 3' Terminus: Previous studies had suggested that transcription 
of the 1.95kb major IE mRNA extends a short distance past the BamHI site at 
0.745 map units (Fig 3: 1); the BamHI/PstI fragment BP-4 (0.742-0.745 map 
units, Fig 3: 1) hybridises weakly with a 1.95kb RNA which co-migrates with 
and is transcribed from the same strand as the major IE RNA (Wilkinson et 
1984). Additionally, HST experiments showed that a polypeptide, which 
co-migrated with the major IE protein on SDS-PA GE, is translated from -an IE 
mRNA selected by the recombinant plasmid. EHB2, EHB2 contains sequences 
between 0.726-0.745 map units (Fig 3: 1; Wilkinson et al., 1984). Mung, bean 
nuclease protection experiments were therefore performed to determine how 
far downstream of the BamHI sLte the major IE gene extends. 
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The plasmid EHB2 was digested with both BamHI and PstI and 
electrophoresed in a 1% agarose geL The 675bp DNA fragment BP-4 (Fig 3: 1) 
was electroeluted from the gel and 3' end-labeUed using [. _. ý32P]dATP and the 
Klenow DNA polymerase. 5 pg of either total cytoplasmic IE RNA or tRNA was 
mixed with the radiolabelled DNA probe and precipitated with ethanol. The 
dried precipitates were then dissolved in 120 pl of H buffer and divided 
into six 20 pl aliquots. The samples were incubated first at 65 0C for 5 
minutes to denature the double-stranded DNA probe and then for 4h at the 
temperatures detailed in Fig 3: 2 to permit the formation of DNA: RNA hybrids. 
After treatment with mung bean nuclease the samples were electrophoresed in 
a denaturing acrylamide gel which was then subjected to autoradiography. A 
EHB2 EH Bl 
4 1-95 Kb 
v IF it 
4 OKb 
M 13 BqIIA 
Probes SonS 
B P-4 
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Probes 
1. "111111111111 
0 CL !! 0f. 00j; ce In f» N C) CY CY m ýr Ir in tn tn 0 ul u) Co 0 r- E t- N r- N e, 
00000000 
Fig 3: 1: The map location of hybridistion probes used in nuclease 
protection studies on the 1.95kb major IE RNA. End-labelled probes 
(*-) were prepared from the recombinant plasmids EHB1 and EHB2 
(Greenaway et al., 1982). EHB1 contains the HindIII/BamHI fragment 
(0.745-0.764 map units) and EHB2 the BamHI fragment (0.726-0.745 map 
units) cloned into the appropriate sites in the vector pAT153. The 
relative location on the HCMV genome of ssDNA probes prepared from 
recombinant M13 phage (-*) is indicated as are the positions of 
relevant BamH1 M), ý&lI (V), ý&M Q), ýlaI (*), EcoRI 
M), HindIII 
(, L), Pýt-I (V), PvUII (Y), §StI (V) and Laq. J (1) restriction 
endonuclease cleavage sites. 
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Fig 3: 2: Mapping the 3' end of the major IE gene. Total cytoplasmic IE 
RNA (IE) or tRNA (t) were hybridised in H buffer with the 675 bp 5' 
end-labelled DNA fragment BP-4 at 20 
0 C, 37 0 C, 42 0 C, 46 0C and 50 0C as 
indicated. Following digestion with mung bean nuclease samples were 
electrophoresed in a 7M urea, 67. acrylamide denaturing gel. The top 
band (675n) was produced by reassociated DNA duplex molecules which are 
resistant to mung bean nuclease digestion. The lower band (90n) is 
produced by the 1.95kb TE RNA hybridising to the 3' end-labelled DNA 
strand and thereby protecting it against nuclease digestion. 
small radiolabelled nuclease-protected fragment of approximately 90n was 
observed in the samples incubated at 37,42,46, and 500C. In order to 
obtain a more accurate evaluation of the size of the nuclease-protected 
fragment the experiment was repeated (with a hybridisation temperature of 
460C) and the sample electrophoresed in a DNA sequencing gel (section 2: 18). 
IE mRNA protected an end-labelled DNA fragment of precisely 90n (Fig 3: 3). 
This result located the 3' end of the major IE gene as being 90n downstream 
from the BamHl site (0.745 map units). A consensus polyadenylation signal 
(AAUAAA; Proudfoot and Brownlee, 1976) is present in the characteristic 
position 22-28n upstream from the 3' end of the transcript (Akrigg et al., 
1985). 
IdentLELcatLon of the Transcriptional Start Site: The 4.2kb BamHI/EcoRI DNA 
fragment between 0.745-0.762 map units was excised from the plasmid, EHB1 
(Fig 3: 1), radiolabelled at its 5' ends (using [, y _32 P]ATP and 
polynucleotide kinase) and hybridised with IE RNA in H buffer as described 
in section 2: 16 and 2: 19. Samples containing the RNA: DNA hybrids were 
divided into two equal aliquots and treated with either exonuclease VII or 
mung bean nuclease. The nuclease digested samples were then electrophoresed 
in a denaturing agarose gel (Fig 3: 4). Protected fragments of 1.4,1.7,1.9 
and 2.9kb were detected fo-Uowing digestion with exonuclease VII whereas a 
sLngle fragment of 1.4kb was detected in the mung bean nuclease treated 
sample (Table 3: 1). 
Since the BamHI site lies within the coding regLon of the gene the 5' 
radiolabelled end of the co m ple m entary DNA probe is protected fro mm ung bean 
nuclease and exonuclease VII digestion by hybridisation with the major IE 
RNA. Exonuclease VII progressively digested the ssDNA component of RNA: DNA 
hybrids starting from the 3' unlabelled end of the probe. Exonuclease VII 
digestion was expected to generate a single size class of end-labelled DNA 
fragments which would defLne the distance between the transcriptional start 
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Fig Lane DNA Fragment Map Units 32P-Radiolabel Enzyme Size of Protected 
Fragment 
3: 4 -1 BamHI-EcoRI 6.745-0.762 5' end Exonuclease VII 2.9,1.9.1.7.1.4 kb 
3: 4 3 Mung Bean 1.4 kb 
Nuclease 
3: 4 5 2gl. II-ClaI 0.747-0.759 5' end Exonuclease VII 2.4,1.4,1.2,0.8 kb 
3: 4 7 it it to Mung Bean 0.8 kb 
Nuclease 
3: 3& 1 Pstl-BamHI 0.742-0.745 3' end Mung Bean 90n 
3: 2 - (PB7-) Nuclease 
3: 3 2 ISH-ýBSH 0.756-0.757 Primer Extension Mung Bean 69n 
(BglI A) Nuclease 
3: 3 3 Sonicated 0.755-0.757 Primer Extension Mung Bean 121n 
(SonB) Nuclease 
3: 3 8 PVUII-PVUII 0.751-0.753 Primef Extension Exonuclease VII 275n 
3: 3 4 of ft Primer Extension Mung Bean 88,73n 
Nuclease 
3: 3 9 PstI-PstI 0.751-0.752 Primer Extension Exonuclease VII 242n 
3: 3 5 It it Primer Extension Mung Bean 88,40n 
Nuclease 
3: 3 6 TaqI-PstI 0.750-0.751 Primer Extension Mung Bean 151n 
Nuclease 
3: 3 7 TaqI-la! II 0.749-0.750 Primer Extension Mung Bean 166n 
Nuclease 
Table 3: 1: Protected fragments obtained by nuclease digestion of IE RNA/DNA hybrids. 
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166n- 
151 n- 
121n- 
90n- 
88 n- 
73n- 
69n- 
I 
I 
NOW -275n 
-242n 
via 
40n- 
123456789 
Fig 3: 3: Fine mapping of the major IE gene in nuclease protection 
experiments. Table 3: 1 gives details of DNA fragments, the method by 
which each fragment was radiolabelled and the nuclease used to digest 
DNA/RNA hybrids for lanes 1-9. Samples were electrophoresed in a 
denaturing 6% acrylamide DNA sequencing gel. The figure is a composite 
of results obtained using more than one gel. Molecular weight estimates 
were obtained from DNA sequencing tracks run in parallel. Nuclease 
protected fragments were not detected in control samples in which total 
cytoplasimic RNA from uninfected MRC5 cells was used. 
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Fig 3: 4: Mapping the 5' end of exons within the major IE gene. RNA and 
end-labelled DNA fragments were hybridised at 42 0C in H buffer before 
being treated with either mung bean nuclease or exonuclease VII and 
electrophoresed through a 1% formaldehyde-agarose gel. Total 
cytoplasmic IE RNA was used in lanes 1,3,5 and 7, and total 
cytoplasmic RNA from uninfected MRC5 cells was used in lanes 2,4,6 
and 8. Details of the DNA fragments used are given in Table 3: 1 and Fig 
3: 1. Molecular weight estimates were made from HindIII digest of 
bacteriophage X DNA. 
site and the Bam HI site. The ability of exonuclease VII digestion to 
generate four discrete bands (Fig 3: 4) may be caused either by a low level 
of contaminating endonuclease activity nicking the single stranded DNA loops 
of intron sequences generated in the hybrid molecules or alternadvely there 
may be some instability in RNA/DNA hybrids involving short exons. The data 
indicates that intron/exon junctions exist 1.4,1.7 and 1.9kb upstream from 
the BamH1 site (0.745 map units) and that transcription is initiated 2.9kb 
upstrea m. 
When the ýýClal fragment (0.747-0.762 map units) was used for this 
analysis exonuclease VII protected fragments of 0.8,1.2,1.4 and 2.4kb were 
generated (Fig 3: 4; Table 3: 1). Since the ILS11I site is 475bp upstream of 
the BamHI site, the positions of the transcriptional initlad n site and 
intron/exon junctions calculated using probes labelled at the ýýR[ and 
BamHI sites are in good agreement. In vitro transcription experiments have 
also mapped the transcriptional start site to approximately 2.5kb upstream 
of the ý&III site (0.747 map units), (Wilkinson, 1983). 
Fine Mapping of Exons: The positions of exons in the major IE gene did not 
coincide with suitable restriction endonuclease cleavage sites which would 
facilitate their being mapped using the technique of Weaver and Weissman 
(1979), as used above. The nucleotide sequence analysis of the major IE gene 
generated a large number of characterised recombinant M13 clones containing 
DNA fragments produced using a variety of restxiction enzymes and by 
sonication. The preparation of radiolabelled ssDNA probes from recombinant 
M13 clones for use in nuclease protection experiments is relatively 
straightforward (section 2: 19). Fig 3: 1 shows the relative postions on the 
HCMV genome of DNA fragments, cloned into M13 phage, which were used to 
the exons in the m ajor IE gene. 
The first (nearest the promoter) exon was mapped using the overlapping 
cloned. D N. A frag m ents aLII A (0.756-0.757 m ap units) and SonB (0.755-0.757 
ill 
map units). Single major nuclease protected fragments of 69n and 121n were 
obtained with 2211 A and SonB respectively (Fig 3: 3; Table 3: 1). Since the 
DNA sequence in ý&11 A is also completely contained within SonB, it follows 
that that transcription is initiated 69bp upstream from the end of aLlI A. 
Transcription was therefore shown to be initiated 15bp downstream from from 
the SstI site at 0.756 map units at a base now designated +1 (Fig 3: 1). With 
respect to this transcriptional start site SonB and 2LII A extend from bases 
-320 to +147 and -299 to +69 respectively. The first exon, which is 
completely contained in SonB, is therefore 121bp long. A typical consensus 
TATA box homology is found 23n upstream from the transcriptional start site 
(Akrigg et 
. 
2L, 1985). 
The positions of the second and third exons were mapped using the 0.4kb 
. 
EXLAI fragment (0.751-0.753 map unts) and its 242bp component PstI fragment 
(0.751-0.752; Fig 3: 1). Hybridisation followed by mung bean nuclease or 
exonuclease VIE digestion produced the protected bands seen in Fig 3: 3 lanes 
4,5,8 and 9 (see also Table 3: 1). The presence of minor bands, 
particularly with smaller protected fragments, was probably due to 
'breathing' at the ends of hybrid molecules. The size of the DNA fragments 
protected by exonuclease VII digestion differed in sLze by 33n with the two 
probes as did the smaller protected fragments in the mung bean nuclease 
digests (Table 3: 1). Since the distance between the downstream ends of the 
short PstI and Pvu1I fragments is also 33bp, the position of the start of 
the second exon was located by the exonuclease digests to 242n and 275n 
upstream of the PstI and Pvu1I (0.751 map units) sites respectively at +948. 
The length of the second exon was estimated from the mung bean nuclease 
digest (larger fragments) to be 88n and the start of the third exon located 
approximately 40n and 73n upstream from the PstI and Pvu]I (0.751 map units) 
sites respectively (Fig 3: 1). 
The position of the remaining intron was deduced using the ja 
fragment (0.750-0.751 map units) and the la_qI-. IagI fragment (0.749-0.750 map 
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units) which was produced by partial DNA digestion (Fig 3: 1); digestion with 
mung bean nuclease gave single major protected fragments of 151n and 166n 
respectively (Fig 3: 3; Table 3: 1). It follows, therefore, that the TaqI PstI 
fragment contains 151n of exon three and the Iacý-Ia I fragment 166n of exon 
four. 
The relative position and sequences surrounding the splice sites is 
illustrated in Fig 3: 5. The sequences at the intron donor and acceptor 
splice sites were found to conform to the consensus sequences identif-Led by 
Mount (1982). The exact position of the splice sites was subsequently 
confirmed by sequencing an almost full length cDNA clone derived from the 
1.95kb major IE RNA (Akrigg et ýý, 1985). 
4,32 1 
1342n 185n 88n 121n 
170n 114n 827n 
ExoN INTRON EXON 
1 GAC 5TAAGT ----- TG CA 2 
2 AC(GTACGT TTTA GCC 3 
3 TC TAAGT ----- T T TACA TCA 4 
c A A 
A( T AGT 
tG 
G 
bcL 
T El . 
ýTpN A 
Fig 3: 5: The lengths of the four exons (thick bars) and three introns 
of the I major IE gene are shown in the above abbreviated physical map. 
The sequences surrounding the splice junctions are compared with the 
consensus sequences of Mount (1982). IaRIII (41), 29111 
(? ), LstI (V) and 
. 
astI (v) restriction endonuclease cleavage sites are shown. 
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3: 2 IE Gene Expression in Transfected CeUs 
The .. -D NA sequence and structural analysds ot, the 
HCMVm ajor IE gene was 
performed primarily to identify the amino acid sequence of the major IE 
protein, but also to identify the IE promoter with a view to investigating 
IE transcriptional regulation. The nucleotLde sequence of the IE promoter 
contains a number of interesting features (Akrigg et . 
2L, 1985). Within 
513bp upstream of the transcriptional start site, in addition to the 
consensus TATA box, there are two copies of a GC-rich 21bp repeat, a 18bp 
and 19bp repeat are represented four times each and a 16bp repeat is present 
three tLmes. Each of the 19bp repeats contains a copy of a CAAT box homology 
and includes palindromic sequences (Thomsen et al., 1984; Akrigg Lt 2L-, 
1985). An interaction between the two 19bp repeats nearest to the TATA box 
could hypothetically form a stem loop structure with a stem of 18-19bp and a 
loop of 51n (Thomsen et al., 1984). Potential enhancer core sequences 
, AAA (TGG TTT; Weiher et al., 1983) exist in the complementary strand of the 
promoter at -93 to -98, -156 to -161 and -412 to -417 (Akrigg et al., 1985). 
The IE promoter of strain AD169 has recently been shown experimentally to 
contain the most powerful 'enhancer' element so far identLELed, some three 
to fLve fold stronger than the SV40 enhancer (Boshart et al., 1985). The IE 
promoter also contains a number of potential Sp-1 factor binding sites 
(GGGCGG; Gidoni et al., 1984) and has recently been shown experimentally to 
bind nuclear factor 1 (Hennighausen and Fleckenstein, 1986). 
The mechanisms involved in the control of eukaryotic gene expression 
can be readily investigated in vitro in transient DNA transfection 
experiments. Using the transfection technique described in section 2: 4 any 
DNA fragment can be introduced into tissue culture cells and the expression 
of specific gene products obtained in a proportion of cells in a transfected 
monolayer. In a preliminary experiment to test whether the HCMV IE promoters 
would function in transfection experiments recombinant plasmids containing 
the IE genes were transfected into cells and the expression of virus 
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antigens assayed by im munofluorescence. 
The plasmid EHB1 (Fig 3: 1), which contains all but the last 90 bp of 
the major IE gene (IE coding region 1; Fig 1: 6), was transfected into Hela 
cells. Forty-eight hours post transfection the cell were assayed by 
immunofluorescence using convalescent sera. Fig 3: 6a shows the nuclear 
fluorescence detected in EHBl-transfected cells which is similar to the 
characteristic pattern produced by HCMV IE antigen during productive 
infections (Michelson-Fiske et 2L, 1977). 
The HCMVDNA frag m ent ýLIII K contains all of IE coding region 2 but 
does not include the major IE promoter (Fig 1: 6). 2. &M fragment K was 
excised from the recombinant clone containing HindIII E and recloned into 
the unique BamHI site in pSV2neo (Southern and Berg, 1982) to generate the 
plasmid pBGK. When transfected into Hela cells the plasmid pBGK induced the 
synthesis of a compartmentalised nuclear-associated antigen which is 
manifested as the unusual doughnut-shaped fluorescence seen in Fig 3: 7b. 
Expression was not detected from transfected DNA when plasmids containing IE 
coding regLons 3 (EHB3; Greenaway 
. 
2t 21., 1982) and 4 (EcoRI Q; Oram et al., 
1982) were used. 
The regulation of expression from the major IE promoter may be 
important in determining the fate of HCMV infections. The main objective of 
the experiment was to test whether IE promoters would function when 
transfected into cells. The positive result obtained with the plasmid E HB1 
provided a basis for going on to use the DNA transfection technique to study 
transcriptional regulation of the major IE promoter. In addition to the 
major 1.95kb IE RNA, the transcription of many of the RNAs derived from IE 
coding region 2 has been shown to be initiated from the major IE promoter 
(Stenberg et 21., 1985). The detection of antigen expression in cells 
transfected with HCMV ý&111 fragment K implies that there is also an 
efficient constitutive promoter within IE coding region 2 of strain AD169. 
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a) 
b) 
Fig 3: 6: Hela cells transf ected with (a) EHB1 and (b) pBG"K. Indirect 
immunofluorescence was performed using human convalescent antisera as 
the first antibody and FITC conjugated goat anti-human sera as the CD 
second antibody. 
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3: 3 Construction of IEP1 and IEPTK1 
The ability. of the HCMV IE pro m oter to direct transcription in DNA 
transfection experiments provides a convenient system for the detailed 
investigation of IE transcriptional regulation. The level of transcription 
from eukaryotic promoters can be measured indirectly in transient DNA 
transfectLon studies if the structural gene for an assayable enzyme, such as 
thymidine kinase (TK) or chloramphenicol acetyl transferase (CAT), is cloned 
in the appropriate orientation and position downstream of the promoter. 
The recombinant bacteriophage M13mp8(LQI A), which was used in 
nuclease-protection experiments (section 3: 1), contains IE promoter 
sequences between bases -299 to +69 (Fig 3: 1). !! 111 fragment A contains 
most, although not all, of the repeated elements present in the IE 
promoter-regulatory region, the TATA box consensus, the transcriptional 
start site and 69n of leader sequence (Akrigg et . 
22., 1985). The 5' proximal 
translational initiation codon is contained in the second exon and, 
therefore, is not in ýýff A (Akrigg Lt. 21L, 1985). The II fragment A was 
excised from M13mp8(BSIIA) by cleavage of the flanking fcoRI and HindBI 
sites and recloned between the unique EcoRI and Hind11I sites in pUC8 as 
described in Fig 3: 7a to generate the plasmid IEP1. IEP1 is a convenient 
vector for use in eukaryotic expression studies. The series of unique 
restriction endonuclease cleavage sites downstream of the promoter 
fascilitates the cloning of heterologous structural genes under its control, 
while the unique upstream EcoRI site readily allows the IE promoter to be 
excised from IEPI and recloned into a different environment. 
In order to assay expression from the IE promoter in transfection 
experiments the HSV-1 TK structural gene was excised from the plasmid M2 
(Wilkie et al., 1979) on a PýIWBamHI fragment and was inserted into the 
BamH1 site in IEP1 to generate the plasmid IEPTK1 (Fig 3: 7b). The LSIII 
site is situated within the leader sequence of the TK gene so it is 
envisaged that translation of the enzyme should be initiated naturally. HCMV 
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Fig 3: 7: The construction of plasmids IEPI and IEPTK1. (a) IEP1. 
MmpT(ý&lI A) and pUC8 were cleaved with EcoRI and HindIII and 
fractionated on a 1% agarose gel. The 398bp fragment containing ý&H A 
and the larger (approximately 2.7kb) fragment were recovered from 
M13mp8(BglI A) and pUC8 digested DNA, respectively, by electroelution. 
The two purified fragments were ligated and transformed into E. coli 
JM101. (b) IEPTK1. The TK structural gene was excised from the plasmid 
pM2 (Wilkie et al., 1979) on a 2.75kb (approximately) DNA fragment and 
ligated withý-'Bffaým-HI-cleaved, phosphatase-treated IEPI DNA. The ligated 
DNA was transformed into E. coli HB101 and plasmid DNA produced from 
transformants according to the method of Birmboim and Doly (1979; 
section 2: 11). Plasmid DNA was cleaved with restriction endonucleases 
to screen for a recombinant plasmid containing the TK gene inserted in 
the appropriate orientation, as shown above. 
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does not appear to encode its own TK gene although virus infection does 
stimulate the expression of cellular TKs. The activity of the cellular 
enzymes can be specif: Lcally inhibited in enzyme assays by including dTTP in 
the reaction. 
TK 
+2aco 
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3: 5 Expression From IEPTK2 in Transfected CeUs 
While -the - IE prom oter-regulatory sequence present in IEPTKl is 
sufficient to ensure constitutLve expression of the TK structural gene, it 
extends only to 299bp upstream from the transcriptional start site. IEPTKl 
may therefore lack important regulatory elements, e. g. the plasmid contains 
neither a complete copy of the promoter-associated 21bp repeat (Akrigg . 
2t 
ýý, 1985) nor the far upstream sequences which may be associate4 with the 
induction of transcription in differentiating EC cells (Nelson and Groudine, 
1986). 
To investigate the possibility that promoter sequences upstream of 
position -299 are necessary for the transcriptional repression of the major 
IE promoter during the early and late phases of the HCMV infectious 
replicative cycle the plasmids IEP2 and IEPTK2 were constructed as described 
in Fig 3: 9. IEPTK2 is identical to IEPTKl except that it contains an 
additional approximately 1.55kb of sequence upstream from the IE promoter. 
The presence of the additional upstream promoter sequence in IEPTK2, 
relative to IEPTK1, did not significantly influence the temporal regulation 
of expression from the IE promoter (Table 3: 3; Fig 3: 10). Using an input 
m. o. L of 1 p. f. u. /cell HCMV infection did not affect the level of TK 
expression from either IEPTKl or IEPTK2 appreciably at 24h p. L (Figs 3: 8 & 
3: 10). In uninfected cells the level of expression from both plasmids 
gradually decreased with time during the later stages of the experiments, 
whereas in cells infected by HCMV expression from IEPTKl and IEPTK2 was 
stimulated reaching a maximum level between 72-96h p. L after which point 
expression again declined. 
In the context of the conditions used in these experiments the 
presence of the addidonal 5' promoter-regulatory sequence in IEPTK2 
reladve to IEPTKl did not confer on the transfected IE promoter the ability 
to be repressed by inf ection with HCMV. 
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Fig 3: 8: Effect of HCMV infection an expression from IEMI. A, 
IEP1-transfected cells; A, IEPl-transfected, RM-infected cells; 0, 
,. x IEPTKI-transfected, HCMV-infected cells. IEPTKI-transfected cells, 9 
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24 48 96 144 
be immune to the effects of the repressor(s) which normally negatively 
regulates transcription of the major IE gene during the early and late 
phases of productive HCMV infections and to be stimulated by virus-induced 
trans-activating functions. The increase in TK enzyme activity in 
IEPTK1-transfected, HCMV-infected cells was clearly not due to virus 
infection stimulating the expression of cellular TK genes; this was shown by 
the low levels of TK activity detected in control cells which were 
transfected with vector DNA (IEPl) and infected with HCMV (Table 3: 2; Fig 
3: 8). 
The inability of infection with HCMV to repress transcription from 
IEPTKI. in transfected ceUs could be expLained if the IE prom oter-regulatory 
element contained in IEPTKl did not containing the cis-acting signal 
required for transcriptLonal repression. 
Time 
Pete 
(h) 
PAO 
IEP1 
48 24 2,496 
72 48 3,496 
120 96 5,194 
168 144 4,909 
IEP1+ 
HCMV 
IEPTK1 IEPTK1+ 
HCMV 
2,525 10,681 10,631 
3,429 18,869 33,885 
2,939 10,615 120,147 
3,192 7,076 68,814 
Table 3: 2: Assay of TK enzyme activity in IEPTK1-transfected 
cells. Each sample was assayed three times, the average calculated 
and the value obtained by assaying TK extraction buffer (5,646) 
subtracted. Results are given as c. p. m. /10jil of cell extract. HCMV 
infections were performed at a m. o. i. of 1 p. f. u. /cell. 
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Fig 3: 9: Construction of IEP2 and IEPTK2. (a) IEP2. EHB1 and IEPl were 
Ta-chdigested with both EcoRI and SstI and DNA fragments generated 
fractionated by electrophoresis in a 1% agarose gel. The 1.85kb 
EcoRI/SstI fragment (0.753-0.762 map units) was recovered from EHB1 
Ti-g-ested DNA and the 2.7kb EcoRI/SstI fragment recovered from IEPI 
tiiopsted DNA bv electroelution. The two fragments were liRated and 
transformed into E. coli HB101. The net effect 
extend the 5' IE promoter-regulatory sequence 
1.55kb (approximately). (b) The same methodology 
HSV-1 TK gene into IEP2 as was used tý insert 
3: 7b). ýamHI 4P), LcoRI HindIII P 
sites are shown. 
of 
in 
wa 
it 
StI 
this cloning was to 
IEPl an additional 
s used to insert the 
intb IEP1 (see Fig 
(A) and SstI (A ) 
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3: 5 Expression From IEPTK2 in Transfected CeUs 
While the IE prom oter-regulatory sequence present in IEPTK1 is 
sufficient to ensure constitutive expression of the TK structural gene, it 
extends only to 299bp upstream from the transcriptional start site. IEPTK1 
may therefore lack important regulatory elements, e. g. the plasmid contains 
neither a complete copy of the promoter-associated 21bp repeat (Akrigg 
. 
2t 
ýý, 1985) nor the far upstream sequences which may be associated with the 
induction of transcription in differentiating EC cells (Nelson and Groudine, 
1986). 
To investigate the possibility that promoter sequences upstream of 
position -299 are necessary for the transcriptional repression of the major 
IE promoter during the early and late phases of the HCMV infectious 
replicatLve cycle the plasmids IEP2 and IEPTK2 were constructed as described 
in Fig 3: 9. IEPTK2 is identical to IEPTKI except that it contains an 
additional approximately 1.55kb of sequence upstream from the IE promoter. 
The presence of the additional upstream promoter sequence in IEPTK2, 
relative to IEPTK1, did not significantly influence the temporal regulation 
of expression from the IE promoter (Table 3: 3; Fig 3: 10). Using an input 
m. o.: L of 1 p. f. u. /cell HCMV infection did not affect the level of TK 
expression from either IEPTK1 or IEPTK2 appreciably at 24h p. L (Figs 3: 8 & 
3: 10). In uninfected cells the level of expression from both plasmids 
gradually decreased with time during the later stages of the experiments, 
whereas in cells infected by HCMV expression from IEPTK1 and IEPTK2 was 
stimulated reaching a maximum level between 72-96h. p. L after which point 
expression again declined. 
In the context of the conditions used. in these experiments the 
presence of the additional 5' prom oter-regulatory sequence in IEPTK2 
relative to IEPTK1 did not confer on the transfected IE promoter the ability 
to be repressed by infection with HCMV. 
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Fig 3: 10: Ef f ect of HCMV inf ection on expression f rom IEPTK2. 
IEPI-transfected cells; 0, IEPTK2-transfected cells; X 
IEPTK2-transfected, HCMV-infected cells. 
0 24 72 120 
Time (h) IEP1 IEPTK2 IEPTK2+ 
P. te PAO HCMV 
24 0 15,787 44,237 
48 24 22,446 81,320 79,453 
96 72 21,892 37,194 132,748 
144 120 19,951 25,768 115,705 
Table 3: 3: Assay of TK enzyme activity in IEPTK2-transfected 
cells. Each sample was assayed three times, the average calculated 
and the value obtained by assaying TK extraction buffer (19,361) 
subtracted. Results are given as c. p. m. /10 jil of cell extract. 
HCMV infections were performed at a m. o. i. of 1 p. f. u. /cell. 
3: 6 The Effect of UN. Arradiated HCMV on Expression From IEPTKI 
The transcription of a number of HSV-1 IE genes has been shown to be 
stimulated by a 65K phosphoprotein component of the tegument (Campbell et 
2Lý, 1984) which enters the cell during the infectious process. The HSV-1 
and HCMV vixions contain proteins with sLmilar molecular weights and 
biochemical properties (section 1: 10 & 1: 22). In order to investigate 
whether the observed stimulation of IEPTKl expression induced by HCMV 
infection of transfected cells was caused by a virion component or a de novo 
synthesised virus-encoded gene product IEPTKl transfected cells were 
infected in parallel with either viable HCMV or virus which had been 
inactivated by irradiation with u. v. -light. At low dosage, u. v. -light 
cross-links thymidine dimers in the virus genome which prevents both HCMV 
replication and transciption but not virus adsorption into cells (Hirai et 
ýý, 1977). 
As described in section 2: 1,10 ml aliquots of a stock solution of 
virus were irradiated at 1770 PW/cm2 with u. v. -light for Os, 10s (177 
ýLj/ mM2), 30s (531 pJ/ mm2), 90s (1.59 mj/m m2 ), 5 min (5.31 m J/ mm2), 15 min 
(15.9 mJ/m m2) and 45 min (47.7 mJ/m m2). Stocks of irradiated virus were then 
126 
stored in 1 ml volumes at -70 
OC until required. The virus sample which had 
not been exposed to irradiation (0s) was titrated and shown to have an 
inf ectivity of 2x 10 
7 
p. f. u. /mL Each of the irradiated virus stocks (2 ml) 
was used to infect monolayers of MRC5 cells (in 50 mm petri dishes) which 
were then monitored for both plaque formation and the expression of the 
major IE polypeptide. Virus samples receiving less than 5.31 mJ/mm 
2 
all 
produced a gross c. p. e. in MRC5 cells by 2 weeks pýL Virus samples 
receiving 5.31 mj/mm2 or more were unable to induce plaque formation by 4 
weeks p. L Expression of the HCMV IE antigen (6h pýL) was detected in 
im munofluorescence experiments using a monoclonal antibody to the major IE 
protein (section 2: 2). Nearly 100% of ceDs in monolayers infected with 
virus exposed to 0,177 and 531 10/m m2 of u. v. light expressed the nuclear 
antigen compared to 20% of celh infected with virus exposed to 1.59 mJ/mm 
2 
and 0% of cells infected with virus exposed to 5.31 mJ/mm 
2 
or m ore. 
Irradiation with u. v. light for 5 min was sufficient to destroy the ability 
of the virus inoculum to induce either plaque formation or the synthesis of 
the major IE antigen. Since the object of irradiating the virus was to 
inhibit de novo virus-encoded gene expression the inactivation of IE antigen 
expression is more directly relevant to the experiment than the loss of 
virus inf ectivity. 
In order to maximise the transcriptional stimulation from the IE 
promoter high m. o. L's (2 or 20 p. f. u. /cell), or the equivalent volume of 
irradiated virus, were used to infect cells transfected with IEPTK1. In this 
series of experiments stimulation of IEPTKl expression by HCMV infection was 
apparent by 24h p. L; expression being stimulated more strongly at this time 
with the higher m.. o. L (Table 3: 4; Fig 3: 11). The peak levels of IEPTKl 
expression produced using a m. oi. of 2 or 20 p. f. u. /ce. U were similar and 
occurred during the late phase (72h pi. ) of the infection (Fig 3: 11). 
Irradiating virus with u. v. -light for 5 min (5.3 mJ/m m2) prior to 
infection significantly reduced the stimulation of IEPTKl expression, 
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Time (h p. i. ) 
Sample 0 24 48 72 144 
IEP1 
IEPTK1 
IEPTK1 +2 
p. f. u. /cell HCMV 
IEPTK1 + 20 
p. f. u. /cell HCMV 
IEPTK1 +2 
"p. f. u. "/cell HCMV 
5.31 mJ/mm 
2 
IEPTK1 + 20 
"p. f. u. "/cell HCMV 2 
5.31 mJ/mm 
736 2,304 
266,496 123,051 32,308 31,641 18,558 
295,643 334,007 705,099 320,267 
447,384 695,152 829,345 269,551 
173,674 55,811 43,268 11,036 
240,746 89,360 66,782 41,021 
IEPTK1 + 20 97,942 24,793 24,392 15,734 
ftp. f. u. "/cell HCMV 
47.7 mJ/mm 
2 
Table 3: 4: Assay of TK enzyme assay in IEPTK1-transfected cells, effect 
u. v. -irradiated HCMV on expression from the IE promoter. Duplicate 
samples were each assayed three times, the averages calculated and the 
value obtained by assaying TK -extraction buffer (14,983) subtracted. 
Results are given as an average value of TK activity in cpm/10 pl of 
cell extract. Samples giving values over 200,000 cpm were diluted and 
re-assayed to be brought into the linear range of the reaction. The 
amount of virus added to different samples is indicated. Where 
u. v. -treated HCMV was used the inoculum is described in terms of the 
infectivity of the equivalent volume of non-irradiated virus 
(11p. f u. "/cell) and the extent of exposure to u. v. light indicated. 
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Fig 3: 11: Effect of infection with u. v. -irradiated HCMV on expression 
from IEPTK1. All samples were from IEPTK1-transfected cells. 0 , 
uninfected; A, infected with 2 p. f. u. /cell of HCMV; X, infected with 20 
p. f. u. /cell; A, infected 2 
with the equivalent of 2 p. f. u. /cell 
inactivated with 5.31 mJ/mm of u. v. light; 0, infected with the 
equivalent of 20 p. f. u. /cell inactivated with 5.31 mJ/rmn 
2 
infected 
2 
with the equivalent of 20 p. f. u. /cell inactivated with 47.7 mJ/mm 
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-24 0 24 48 72 . 144 Time PA(h) 
especially during the later stages (from 48h p. L) of the experiment (Fig 
3: 11). Infection with u. vi-irradiated (5.3 mj/mm2 ) virus did, however, 
produce a small (up to three fold) dosage-dependent increase in expression 
(Table 3: 4; Fig 3: 11). The infection of IEPTK1-transfected cells with virus 
which been irradiated with u. vi-light for 45 min (47.7 mJ/m m2) did not 
detectably stimulate expression from the IE promoter; prolonged exposure to 
u. v. -light may prevent virus adsorption/infection by damaging components of 
the virion other than DNA. 
The observed results are consistent with there being: (a) a 
(u. v. -resistant) structural component of the HCMV virion which stimulates 
the IE promoter and (b) a de novo synthesdsed HCMV-encoded trans-activator 
which stimulates the IE promoter in transfected cells. Since most of the 
stimulation in IEPTKl expression was destroyed by u. v. -irradiating the virus 
prior to infection inactivated, the trans-activator would appear to exert 
the greater effect on the transfected IE promoter. 
Although the expression of the IE polypeptide was not detected in cells 
infected with u. v. -irradiated (5 min) virus it is possible that limited 
undetected virus-encoded gene expression may have resulted in the de novo 
synthesis of a trans-activator function identical to that produced by 
infection with non-irradiated virus. The level of stimulation produced by 
u. vArradiated virus, however, remains constant during the time course 
(between 2-3 fold with the higher concentration of inactivated virus) and 
does not increase during the late phase as is the case with non-irradiated 
virus (Fig 3: 11). The stimulation produced by irradiated virus was not 
caused by the presence in the inoculum of the HCMV-induced growth factor 
(Gonczcl and Plotkin, 1984; see section 3: 8). 
During permissive HCMV infections transcription from the IE promoter is 
normally repressed after 6h p. L The stimulation of IEPTKI expression during 
the late phase of infection suggests that the transfected IE promoter is not 
efficiently repressed by the HCMV-induced repressor of IE transcription. 
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Fig 3: 12: Effect of HSV-1 TK- infection on expression from IEPTK1. A, 
pVUTK1-transfected cells; 0, IEPTK1-transfected cells; Xj 
IEPTK1-transfected, HCMV-infected cells; *, IEPTK1-transfected, HSV-1 
infected cells. 
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3: 7 HSV-1 Infection Rapidly Stimulates IEPTK1 Expression 
HSV-: -I rdutants with a defective TK gene have been shown to replicate 
efficiently in actively growing tissue culture cells (Jamieson et. al., 
1974). The availabilty of such mutants made it possible to investigate the 
effects of HSV-1 infection on expression from IEPTK1 in transfected ce. Us. 
In this series of experiments the plasmid pVUTKl (kindly provided by Dr 
A. Akrigg) was included as a negative control. pVUTKl contains the HSV-l TK 
gene, under the contcl of its own promoter, excised from the recombinant 
plasmid M2 (Wilkie et al., 1979) on a Pvu]I-generated DNA fragment and 
inserted into the unique Hincil site in pUC19. The level of TK enzyme 
activity detected in extracts from pVUTK1-transfected cells was slightly 
above the background levels of the assay (Table 3: 5). HSV-l TK- infection of 
IEPTKI-transfected cells induced a slight increase in expression from the 
HCMV IE promoter as early as 3h p. L, an approximately two-fold stimulation 
at 8h p. i. and an approximately six-fold stimulation at 24h pýL By 48h 
Time pVUTK1 IEPTK1 IEPTK1 IEPTK1 
(h p. i. ) + HCMV + HSV-l 
0 5,007 12,093 
3 3,648 14,315 8,020 17,725 
8 4,048 11,336 13,433 26,924 
24 3,510 8,001 32,525 46,785 
48 4,419 9,803 72,779 - 
Table 3: 5 Assay of TK enzyme activity in IEPTK1-transfected cells 
infected with either HCMV or HSV-1. Duplicate samples were assayed 
three times each, the average calculated and the value obtained by 
assaying TK extraction buffer (4,002) subtracted. Results are 
expressed as an average value of TK activity in cpm/10 41 of cell 
extract. An input m. o. i. of 4 p. f. u. /cell was used for both 
viruses. 
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p. L the HSV-1 infection had destroyed the cell monolayer so it was not 
possible to take meaningful samples. The HCMV IE promoter in transfected 
cells is stimulated by HSV-1 encoded trans-activating proteins and appears 
to escape negative regulation by the repressors of HSV-1 IE gene expression. 
In an experiment performed in parallel, IEPTK1-transfected cells were 
infected with HCMV using a similar m. o. i. HCMV-induced stimulation of 
expression from the HCMV IE promoter was not detected, however, until 24h 
p.: L (Table 3: 5; Fig 3: 13), indeed at 3h p. i. HCMV infection produced a 
transient reduction in IEPTK1 expression. Although HCMV stimulated 
expression from IEPTKl more slowly than HSV-1 TK - higher levels of IEPTKI 
expression were detected in HCMV-infected cells. 
3: 8 Stimulation of IEPTKI Expression: The Effects of Metabolic Inhibitors and 
Heat Treatment of Virus 
2-Deoxy-D-glucose and phosphonoformate (PFA) inhibit the growth of HCMV 
during the early phase of the replicative cycle. 2-Deoxy-D-glucose, a sugar 
analogue, inhibits HCMV DNA replication although not the synthesis of the 
viral DNA polymerase (Weder and Radsak, 1981) and PFA specificly inhibits 
the activity of the viral DNA polymerase (Wahren and Oberg, 1979). 
Experiments described above have shown that the large stimulation of IEPTKl 
activity in DNA transfection studies is primarily associated with the late 
phase of the HCMV replicatLve cycle. These metabolic inhibitors were used to 
investigate at which phases the factor which stimulates expression from the 
transfected IE promoter was synthesised. 
Even in the presence of PFA, HCMV infection induced a large stimulation 
of expression from the transfected IE promoter at 72h p. i. (Table 3: 6). PFA 
did, however, suppress the HCMV-induced stimulation of expression from 
IEPTKl by approximately 50% (Table 3: 6) which indicates that although the 
virus-encoded trans-activator is produced during the early phase its 
activity is further enhanced after virus DNA replication. 2-Deoxy-D-glucose 
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appeared to inhibit the stimulation of expression from IEPTK1 by HCMV 
infection to a greater extent than PFA; it should be noted, however, that 
2-deoxy-D-glucose had a marked cytotoxic effect on the infected cells. 
The growth factor induced by HCMV infection of fibroblasts has been 
shown to be heat stable (Gonczol and Plotkin, 1984). The data contained in 
Table 3: 6 shows that pre-incubating the HCMV seed virus at 560C for 30 min 
prior to infection abolishes the stimulation of IEPTKl expression in 
transfected cells. This result indicates that the stimultion of IEPTKl 
expression is was not caused by the HCMV-induced growth factor. 
Treatment TK activity 
(cpm) 
6,809 
HCMV 101,142 
HCMV + PFA 47,818 
(100 tig/ml) 
HCMV + Deoxyglucose 13,766 
(10. ) 
HCMV preincubated 5,620 
at 56 OC for 30 min 
Table 3: 6: The effect of various treatment on the ability of HCMV 
infection to stimulate expression from IEPTKl in transfection 
experiments. Duplicate samples were assayed three times each, the 
average calculated and the value obtained from assaying TK 
extraction buffer (8,466) subtracted. Results are expressed as an 
average of TK-enzyme activity in cpm/10 41 of cell extract. HCMV 
infections were performed at a m. o. i. of 1 p. f. u. /cell and samples 
harvested 72h p. i. 
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3: 9 HCMV IE Gene Expression in CeUs Transfected With IEP11assaterm 
It has been reported that the major IE gene product, either directly or 
indirectly, represses transcription from its own promoter (Stenberg and 
Stinski, 1985). The proposed autoregulation of the major IE gene during 
productive infections provides a possible mechanism to explain why HCMV 
infection stimulates expression from the major IE promoter (in IEPTKl) in 
transfected cells (section 3: 4). In transfection experiments, DNA associated 
with precipitated calcium phosphate crystals was applied to cell monolayers 
(section 2: 4). A feature of this methodology is that when a single plasmid 
is used the transfected cells receive a very large number of copies of that 
plasmid (Loyter et al., 1982). It is possible that the large copy number of 
the transfected IE promoter may saturate essential cellular transcription 
factors and thus inhibit expression from the HCMV major IE gene following 
virus infection. Hypothetically, in the absence of repressor synthesis, 
expression from the transfected IE promoter could be stimulated by 
HCMV-encoded trans-activators. 
In order to monitor expression from transfected plasmids in individual 
cells a reporter gene was used which could be detected immunologically. 
IEP11assaterm, kindly provided by Dr C. Clegg, consists of the structural 
gene of the lassa virus nucleocapAd protein expressed under the control of 
the HCMV IE promoter (identical to the promoter element in IEPTK1) plus a 3' 
polyadenylation signal, also derived from the HCMV major IE gene, inserted 
into a pUC7 based vector (Fig 3: 13). To determine whether the HCMV major IE 
gene is expressed in cells containing high concentrations of the IE promoter 
the plasmid IEP11assaterm was transfected into MRC5 cells which were then 
infected with HCMV. Immunofluorescence was used to assay for the expression 
of both the lassa virus nucleocapsid protein and the HCMV major IE protein 
in the same cell. Expression of the lassa virus nucleocapsid protein w as 
detected using a speci: ELc hyperim mune sera raised in guinea pig as the first 
antibody and fluorescein-conjugated goat anti-guinea pig IgG as the second 
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antibody; this produces a green cytoplasmic fluorescence in IEPllassaterm 
transfected cells as shown in Fig 3: 14a. The nucleocapsid protein is also 
detected in the cytoplasm of cells infected with lassa virus. Expression of 
the HCMV major IE polypeptide in viru&-infected cells was detected using the 
monoclonal antibody L-14 (Rice et al., 1984) as the first antibody and 
rhodamine-conjugated goat. anti-mouse antibody as the second; expression of 
the IE antigen produces the red nuclear fluoresence in HCMV infected cells 
seen in Fig 3: 14b. 
Vector: 
IEPIlElerm 
-299 -28 +1 +69\ +2757 +2820 +3053 
1 ilmý 1 r"TR- T wm'6ý 11 0 ý1ý -, 
TAIATAA' V3 x C4 -0 T CA xw x 
AAIAAA 
cn M 
0 3 
' t. 3 
Iz < x 
-IEPilassaterm 
Fig 3: 13: Construction of IEP11assaterm. The vector IEPlIEterm was 
kindly provided by Dr A. Akrigg. The polyadenylation signal (+2757 to 
+3053 with respect to the transcriptional start site) was excised from 
EHB2 (see Fig 3: 1) with BamHI/Sstl and cloned into the same unique 
sites in M13mpll. IEPlIEterm was produced by excising the IE promoter 
from IEPl- and the IE polyadenylation signal from the M13mpll 
recombinant both on EcoRI/HindIII fragments and ligating them together 
into pUC7. IEP11assaterm, kindly provided by Dr C. Clegg, was produced 
by excising the lassa virus nucleocapsid gene from pLS120 (Clegg and 
Oram, 1985) on a BamHI fragment and cloning it between the BamHI sites 
in IEPlIEterm as shown. The BamHI fragment from pLS100 contains 
approximately 100bp of sequence 51to the translation initiation codon 
and approximately 40bp of sequence 3' of the translation termination 
codon. 
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Fig 3: 14: HCMV IE gene expression in cells transfected with 
IEPIlassaterm DNA. MRC5 cells in 50 mm diameter petri dishes were 
transfected with 5 4g of IEPIlassaterm DNA. 18h post transfection the 
cells were washed once with TBS, once with complete media and incubated 
a further 6h. The monolayer was then infected with HCMV at a m. o. i. of 
10 p. f. u. /cell. Cells, grown on glass coverslips, were removed 6h p. i. 
and immunofluorescence carried out as described in the text and in 
section 2: 2. The figure illustrates the same field photographed (a) 
with a green filter to show the cytoplasmic fluorescence produced by 
the lassa virus nucleocapsid protein, (b) with a red filter to show the 
nuclear fluorescence produced by the HCMV major IE antigen and (c) a 
double exposure with first the red and then the green filter which 
shows the same cell can express both antigens. 
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Cells transfected with IEP11assaterm and infected with HCMV can express 
both the lassa virus cytoplasmic antigen and the HCMV nuclear IE antigen 
simultaneously (Fig 3: 14c). Clearly the HCMV major IE gene product is 
expressed in cells transfected with IEP11assaterm and, therefore, presumably 
also in cells transfected with IEPTK1. Consequently the stimulation of 
expression from the IE promoter in transfected cells by HCMV infection 
cannot be attributed to the major IE polypeptide, the proposed repressor of 
the IE promoter, not being synthesised. 
3: 10 The Relationship Between The Concentration of The IE Promoter in Transfected 
Cells and its Stimulation by Infection With HCMV 
When introduced into cells by DNA transfection, expression from the IE 
promoter was unexpectedly found to be stimulated between 24-72h p. L by a 
-de 
. 
novo synthesised, HCMV-encoded trans-activator (sections 3: 4,3: 5 and 3: 6). 
Stenberg and Stinski (1985) recently proposed that the HCMV major IE 
polypeptide itself is involved in negatively regulating IE transcription. 
Im munofluorescence studies (section 3: 9) have shown that the major IE 
polypeptide is expressed following HCMV infection of cells transfected with 
the IE promoter. The high copy numbers of the IE promoter in transfected 
cells, therefore, does not completely saturate transcription factors 
necessary for the expression of the major IE gene product from the viral 
genome. It is possible, however, that high concentrations of the transfected 
IE promoter may be sufficient to saturate the HCMV-induced repressor of IE 
transcription (RIT). The copy number of the IE promoter in transfected cells 
can be lowered simply by reducing the concentration of the plasmid 
containing the IE promoter in transfection mixtures. The relationship 
between the concentration of the IE promoter in transfected cells and its 
stimulation by infection with HCMV was therefore investigated. 
Lowering the concentration of IEPTKI DNA used in transfection mixtures 
produced a concomitant decrease in the level of constitutive expression 
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detected from the IE promoter in transfected cells (Table 3: 7). The direct 
relationship between the concentration of the IEPTKl plasmid and the level 
of expresson from the reporter gene supports the observation that the IE 
promoter was not completely saturating essential transcription factors in 
transfected cells within the range of concentrations used (section 3: 9). 
However, three-fold increases in the concentration of IEPTKl DNA transfected 
into cells resulted in only an approximately two-fold increases in 
expression from the IE promoter. In uninfected cells the rate of expression 
from the IEPTKl would appear to be dependent not only on the concentration 
of the IE promoter but also on some constraint exerted on the availibility 
of cellular factors required for effIcient expression. 
Amount of IEPTK1 IEPTK1 
in Transfection 
mix (gg DNA) 
IEPTKl Stimulation 
+ HCMV by HCMV 
10 18,371 840,979 x 45 
3 8,840 205,534 x 23 
1 4,013 56,685 x 14 
0.3 2,497 23,093 x9 
0.1 2,023 3,866 x 1.9 
0.03 2,239 4,049 x 1.8 
0 736 -- 
Table 3: 7 Relationship between the concentration of IEPTKl DNA in 
transfections and stimulation of expression from the IE promoter by HCMV infection. Duplicate samples -were assayed three times 
each, the average calculated and the value obtained by assaying TK 
extraction buffer (3051) subtracted. Results are expressed as 
cpm/10 pl of cell extract. Samples giving values over 100,000 cpm 
were diluted and reasssayed to be brought into the linear range of 
the reaction. Each transfection mixture containing 20 pg of DNA, 
the remainder being made up by the pUC8, was split into four equal 
portions. 5 pg of DNA was applied to each 50 mm diameter petri 
dish containing MRC5 cells. HCMV infection was performed using a 
m. o. i. of 4 p. f. u. /cell and samples harvested 72h p. i. (96h p. t. ). 
Although the results of this experiment again showed that expressLon 
from the transfected HCMV IE promoter was stimulated by infection with HCMV, 
as the concentration of IEPTK1 DNA per transfection was lowered so was the 
relative stimulation of expression from the IE promoter by HCMV infection 
(represented by the stimulation index in Table 3: 7). The level of 
stimulation was 45-fold with 10 ýig IEPTK1/transfection, 23-fold with 3 ýig 
and 14-fold with 1 jig. At a concentration of IEPTK1 DNA per transfection of 
0.3 ýig or lower, the level of TK enzyme activity in transfected cells was 
not sufficiently above background values for the enzyme assay to be 
signiRcant. It was noticable that three-fold increases in the amount of 
1--EPTK1 DNA transfected also resulted in approximately three-fold increases 
in the level of IE gene expression in HCMV-infected cells. Expression from 
the transfected IE promoter, in infected cells, therefore appeared to be 
limited by the concentration of the DNA template. 
The results obtained were consistent with the hypothesis that high 
concentrations of the transfected IE promoter were saturating the RIT 
function in HCMV-infected cells. However, due to the limited sensitivity of 
the system used to assay expression from the IE promoter it was not possible 
to determine whether HCMV infection would repress expression from the IE 
promoter if the concentration of IEPTKl DNA used in transfections was 
reduced sufficiently. In an endeavour to provide a more sensitive assay for 
IE promoter activity the experiment was repeated, this time using CAT in 
place of TK as the reporter gene. The bacterial CAT gene is widely used to 
monitor expression from eukaryotic promoters because an extremely sensitive 
assay has been devised to measure its activity (section 2: 23) and, since 
eukaryotic cells do not encode an equivalent of CAT, the background levels 
in the assay are extremely low. The plasmid IEPIcatIEterm, provided by Dr A. 
Akrigg, contains the CAT structural gene under the control of the HCMV IE 
promoter (identical to the IE promoter element in IEPTK1) and a 3' 
polyadenylation signal also obtained from the HCMV major IE gene (Fig 3: 15). 
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Vector: 
IEPlIEterm 
-299 -28 . 2? 57 -2020 -M3 
TAPJAA ýIlmmiýll AAFAAA 
-3 
- 
ýz 
.13- 
x 
IEPlcatlEterm 
Fig 3: 15: Construction of IEPlcatIEterm. The plasmid, IEPlcatIEterm, 
provided by Dr A. Akrigg, was produced by excising the CAT structural 
gene from the plasmid pCAT (kindly provided by Dr D. Gaffney) on a 
BamHI fragment which was then cloned between the BamHI sites in the 
vector IEPlIEterm as shown in the diagram. The construction of 
IEPlIEterm is described in Fig 3: 13. 
The results of the CAT assay shown in Fig 3: 16 indicate that at high 
DNA concentrations (10 and 3 ýLg per transfection) expression from 
IEPlcatIEterm was stimulated 72h p. L with HCMV. At a concentration of 1 pg 
IEPlcatIEterm DNA per transfection HCMV infection did not appreciably affect 
the level of expression and at lower concentrations (0.3,0.1 and 0.03 Pg 
of IEPlcatIEterm DNA per transfection) infection with HCMV caused a 
significant reduction in expression from the IE promoter. When 10 jig of 
JEPTKl DNA and 0.1 ýig of IEPlcatIEterm were co-transfected into MRC5 cells 
infection with HCMV no longer repressed but stimulated expression from 
IEPlcatIEterm (Fig 3: 16). The results of these experiments indicate that 
when the IE promoter is introduced into MRC5 cells in low copy numbers it is 
susceptible to an HCMV-induced repressor of IE gene expression, but when it 
is present in high copy numbers the transfected IE promoter is no longer 
repressed by virus infection but is stimulated by an HCMV-induced 
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YTTTTTTIR'ITH 
: 10 :31 : 0-3: 0-1 : 003: 0-1 :0 
10 
HC MV 
IEPlcatlEterm 
IEPTK1 
IEPIcatIEterm 
(jig DNA) 
IEM1 
(gg DNA) 
HCKV CAT AC7IVM 
(C. P. m. /lig protein) 
CAT ACTIVM 
- CONTROL 
(C. P. m. /Pg protein) 
10 0 506.5 503.0 
10 0 + 832.1 828.6 
3 0 247.7 244.2 
3 0 + 415.0 411.5 
1 0 286.7 283.2 
1 0 + 231.7 228.2 
0.3 0 220.5 217.0 
0.3 0 + 70.2 66.7 
0.1 0 97.5 94.0 
0.1 0 + 49.3 46.3 
0.03 0 48.8 45.3 0.03 0 + 14.0 10.5 
0.1 10 7.1 3 6 0.1 10 + 22.9 . 19.4 
0 0 3.5 
Fip, 3: 16: Titration of the concentration of IEPIcatIEterm DNA in 
transfection experiment; the effect of HCMV infection on CAT 
expression. Transfection mixtures containing 10,3,1,0.3,0.1 or 0.03 
4g of IEPIcatIEterm DNA were added to MRC5 cells as indicated in the 
figure. One transfection mixture also contained 10 4g of IEPTKI DNA. 
The DNA content in each transfection mixture was made up to 20 4g by 
the addition of pUC18 vector DNA. 5' ag of DNA from each transfection 
mixture was added to two 50 mm diameter petri dishes, one of which was 
subsequently infected with H01V at a m. o. i. of 4 p. f. u. /cell. Cells 
were harvested 72h p. i. (96h p. t. ). - indicates samples taken from 
uninfected cells and + samples taken from infected cells. The 
acetylated products of the reaction, I-acetyl chloramphenicol (1) and 
3-acetyl chloramphenicol (3), are labelled. The sample containing 0 
IEPIcatIEterm was a negative control performed using an extract 
prepared from untransfected MRC5 cells. In quantifying the results the 
value obtained for this control was subtracted from all others. 
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trans-activator. Although infection with HCMV was able to reduce the level 
of expressLon from expression from IEPlcatIEterm DNA, in none of the samples 
was expression from the transfected IE promoter totally repressed (Fig 
3: 16). It was observed in immunofluorescence experiments, similar to those 
described in section 3.9, that following a high m. o. L with HCMV only 52% 
of MRC5 cells transfected with the plasmid IEPllassaterm expressed the HCMV 
major IE antigen 6h p. L as compared with 787q of untransfected control 
cells. In view of the inefficiency with which HCMV infects cells exposed to 
DNA transfection, it is perhaps not surprising that only limited repression 
of expression from IEPIcatIEterm could be detected. 
While the repression of expression from IEPlcatIEterm produced by 
infection with HCMV was reproducible, the concentration of IEPlcatIEterm per 
transfectLon at which repression could be detected was dependent on the 
efficiency of transfection. At a concentration of 0.3 jig per transfection, 
expression from the plasmid IEPlcatIEterm is inhibited by infection with 
HCMV whereas at the same concentration IEPTKl expression was stimulated 
nine-fold by virus infection (Fig 3: 16; Table 3: 7). The different results 
obtained in these two experiments may be attributable sLmply to a difference 
in transfection efficiency. However, although the promoter elements of the 
two plasmids are identical IEPlcatIEterm contains an additional 233bp of 
sequence from the 3' end of the major IE gene. The presence of this 
downstream element is known to affect expression from the IE promoter. The 
plasmids IEPlcatIEterm and AccHincat are essentially identical except that 
the polyadenylation signal in AccHincat is derived from SV40 (Fig 3: 17a), 
but in transient DNA transfection experiments expression from IEP1catIEterm 
is consistently fLve-fold higher than that from AccHincat (A. Akrigg, 
personal communication). The mechanism by which the the 3' end of the IE 
gene stimulates expression has yet to be determined. The possiblity that the 
HCMV IE gene downstream sequence may be involved in negatively regulating 
expression from the IE promoter was therefore investigated. 
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a) PROMOTER CAT -EMýLAj2ENYLATItIN -2-, -QN LL 
IEPIcatlEterm . 
IE IE 
AccHincat m1E SV40 
SV2catlEterm SV 40 IE 
SV2cat SV40SV40. 
RSVcat RSV LTR SV40 
Fig 3: 17: Effect of HCMV infection on expression from the plasmids 
IEP1catIEterm, AccHincat, SV2cat, SV2catIEterm. and RSVcat in 
transf ection experiments. (a) Schematic representation indicating the 
relevant details of the plasmids used. IEPlcatIEterm, AccHincat and 
SV2catIEterm were kindly provided by Dr A. Akrigg, The construction of 
IEPlcatIEterm, is described in Fig 3: 15, AccHincat was produced by 
replacing the SV40 promoter from Mcat (excised by digestion with 
AccI and HindIII) with the IE promoter from IEPl (on an EcoRI/HindII 
fragment). SV2catIEtdrm was produced by replacing the SV40 
polyadenylation site in Mcat with the HCMV IE polyadenylation signal 
in IEPlcatIEterm using convenient ECORI site in both plasmids. Details 
of the construction of Mcat and RSVcat is given by Gorman et al. 
(1982a; 1982b). (b) Transfection mixtures containing 10 pg or 0.3 gg of 
IEPlcatIEterm, AccHincat, SV2cat, SV2catIEterm or RSVcat DNA were 
prepared; the final DNA content being made up to 20 ýLg with pUC18 DNA. 
For each transfection 5 pg of DNA was added to two 50 mm diameter petri 
dishes containing MRC5 cells, one of which was infected with HCMV (4 
p. f. u. /cell) 24h later. Cells were harvested 72h p. i. and assayed for 
CAT activity. Enzymes assays for cells transfected with 0.3 ýig SV2cat, 
SV2catIEterm and RSVcat were incubated at 37 0C for 2h, other samples 
were incubated at 37 0C for 30 min. Films were exposed for different 
times (16h or 5 days) during autoradiography in order to optimise the 
detection of reaction products. Negative controls were prepared from 
untransfected MRC5 cells. In quantifying the results the value obtained 
for this control was subtracted from all others. N. D. indicates no 
detectable enzyme activity. 
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PLASMTD AMOUNT PER HCMV CAT ACTIVITY CAT ACTTVM 
TRANSFECTION - CONTROL 
(jig DNA) (c. p. m. /4g protein) (c. p. m. /4g protein) 
IEPIcatIEterm 10 2481 2466 
IEPIcatIEterm 10 + 4319 4309 
AccHincat 10 608 593 
AccHincat 10 + 2695 2680 
Mcat 10 29 
Mcat 10 + 642 627 
SV2catIEterm 10 106 91 
SV2catlEterm 10 + 630 615 
IEPIcatIEterm 0.3 557 542 
IEPIcatlEterm 0.3 + 534 519 
AccHincat 0.3 86 71 
AccHincat 0.3 + 73 58 
None - 
- 
15 
------ --------- 
RSVcat 
------ 
0.3 
------ --------- 
80 
---- 
ND 
RSVcat 0.3 + 1521 1436 
Mcat 0.3 106 21 
Mcat 0.3 + 243 158 
SV2catIEterm 0.3 135 50 
SV2catlEterm 0.3 + 237 152 
None 85 
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The relevant features of the plasmids IEPlcatIEterm, AccHincat, 
SV2catIEterm, Mcat and RSVcat are described in Fig 3: 17a. At a 
concentration of 10 ýLg of each plasmid per transfection HCMV infection 
stimulated expression from IEPlcatIEterm, AccHincat, SV2catIEterm and Mcat 
while a concentration of 0.3 ýig per transfection HCMV infection stimulated 
expression from RSVcat, Mcat and SV2catIEterm but not from IEPlcatIEterm 
or AccHincat. HCMV encoded trans-activator functions therefore stimulated 
expression from the SV40 early promoter and the RSV promoter, both of which 
contain enhancer elements, when they were transfected at either high or low 
DNA concentration. 
At a concentration of 10 4g per transfection mixture, constitutive 
expression from IEPlcatIEterm was more than four-fold higher than that from 
AccHincat. HCMV infection, however, had a relatively stronger stimulatory 
effect on expression from AccHincat than from IEPlcatIEterm. When used at a 
concentration of 0.3 ýtg per transfection mixture, a small reduction in 
expression from IEPlcatIEterm and AccHincat was detected following infection 
with HCMV. This effect was reproducible. It is not clear from these 
experiments, in which CAT was used as the reporter gene, why infection with 
HCMV did not repress expression from IEPTKl when used at a concentration of 
0.3 ýtg per transfection. It is possible that a regulatory region within the 
TK structural gene was responding to stimulation by HCMV-encoded 
trans-activating functions. Alternatively, transfections with IEPTKl DNA may 
have been exceptionally efficient so that, even when its concentration was 
reduced in transfection mixtures, the copy number of the plasmid taken up by 
cells was stOl high enough to prevent HCMV-induced transcriptional 
repression. 
The results of this and sLmilar experiments suggest that an IE 
promoter-regulatory region (between bases -299 to +72) present in 
IEPlcatIEterm and AccHincat was necessary for HCMV-Induced repression of IE 
promoter activity whereas the IE gene downstream sequence, contained in 
146 
IEPlcatIEterm and SV2catIEterm but not AccHincat and Mcat, was not 
essential for repression. 
3: 11 Competitive Co-transfection Experiments to Investigate Repressor-Binding By 
The Major IE Promoter 
The results of experiments described in section 3: 10 indicated that the 
repressor of IE gene expression, which is active during the early and late 
phases of the HCMV replicative cycle, interacts either directly or 
indirectly with the IE promoter-regulatory element between bases -299 to +69 
(section 3: 10). When cells were transfected with high concentrations of the 
IE promoter HCMV infection was unable to negatively regulate expression from 
the IE promoter, indeed expression was stimulated by HCMV-induced 
trans-activators (section 3: 10). These results were interpreted as 
indicating that high concentrations of the IE promoter in transfected cells 
may be saturating the RIT function during HCMV infection. When 0.1 ýIg of 
IEPlcatIEterm DNA was co-transfected with 10 gg of IEPTK1 DNA then HCMV 
infection was observed to stimulate expression from IEPIcatIEterm (Fig 
3: 16), co-transfection with large amounts of IEPTK1 DNA therefore prevented 
HCMV infection repressing expression from IEPlcatIEterm. This apparent 
ability to compete out the HCMV-induced repressor in co-transfection 
experiments potentially provided an experimental system to identify 
sequences within the IE prom oter-regulatory region, or elsewhere, which 
interact with the repressor. 
A series of recombinant plasmids containing short segments of the IE 
promoter were generated as decribed in Fig 3: 18a. HCMV Hind]Ir fragment Z, 
in the plasmid, HlD2, contains the IE promoter in IE coding region 4 (Oram et 
al., 1982; Wilkinson et al., 1984; Fig 1: 6) and pMD102 contains the SV40 
early promoter (Everett et al., 1983). In each transfection 19.7 Pg of the 
test plasmid was mixed with 0.3 pg of IEPlcatIEterm DNA and 5 ýIg of DNA 
applied to two 50 mm diameter dishes containing MRC5 cells. The effect of 
infection with HCMV on IEPlcatIEterm expression was studied (Fig 3: 18b). The 
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Fig 3: 18a: Inactivating repression of the the major IE promoter in 
co-transfection experiments. The map locations of cloned DNA fragments 
derived from the major IE promoter-regulatory region which were used in 
co-transfection experiments are shown. The vector IER is described in 
Fig 3: 7. pO. 38, kindly provided by Dr A. Akrigg, contains the LiLlILHeLaI 
fragment (position -299 to -63) cloned into the SmaI site in pUC18. 
pAat2 and pAat3 were produced by cloning AatII fragment (-321 to -404 
and -404 to -457) into the unique AatII site in pKM21b. IEPl-aat was 
generated by religating AatII cleaved IEPl which deleted sequences 
between -135 to +69 and a small portion of pUC8 vector DNA. Similarly 
pO. 38-aat was produced by religating AatII cleaved pO. 38; the HOW 
cloned inserts in IEP1-aat and pO. 38-aat are identical. pAatNco 
contains the AatII/NcoI fragment (-321 to -222) cloned between the 
unique AatII ýn_d NcoI sites in pMTL21b and SstA contains the SstI 
fragment (-15 to +714) cloned into the unique SstI site in pUC19. 
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Fig 3: 18b: Inactivating repression of the major IE promoter in 
co-transfection experiments. 0.3 4g of IEPIcatIEterm DNA and 19.7 ýig of 
the competing plasmid were used in each transfection. As before, for 
each transfection 5 4g of DNA was added to two 50 mm diameter petri 
dishes containing MRC5 cells, one of which was subsequently infected 
with HCMV (4 p. f. u. /cell). Cells were harvested at 72h p. i. and assayed 
for CAT activity. 20 41 of cell extract was added to the CAT assay 
which was incubated for 2h at 37 0C except for the cells transfected 
with 20 4g of IEPIcatIEterm DNA in which case 5 41 of cell extract was 
used and the assay incubated at 37 C for 40 min. Negative control 
samples were prepared from untransfected MRC5 cells. In quantifying the 
results the relavent value obtained for this control was subtracted. 
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COMPETING HCMV CAT ACTIVITY CAT ACTIVITY 
PLASMID - CONTROL (c. p. m. /lig protein) (c. p. m. /gg protein) 
pUC18 524 480 
pUC18 + 340 301 
IEPI 54 15 
IEP1 + 303 264 
pO. 38 178 139 
pO. 38 + 313 274 
pAat2 43 4 
pAat2 + 131 92 
pAat3 122 84 
pAat3 + 347 308 
IEPl-aat 90 51 
IEPl-aat + 214 175 
pO. 38aat 86 47 
pO. 38aat + 169 130 
pAatNco 240 201 
pAatNco + 589 550 
SstA 363 324 
SstA + 308 269 
HindIIIZ 205 166 
HindIIIZ + 154 115 
pMD102 155 116 
pMD102 + 120 81 
pAT153 892 853 
pAT153 + 631 592 
None 39 
IEPlcatIEterm 192 185 
IEPlcatIEterm + 819 812 
Fig 3: 18b: Continued. 
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results obtained with the control samples were consistent with previous 
observations; HCMV infection stimulated expression from the reporter gene 
when IEP1catIEterm comprised 100% (20 jig/20 pg) of transfected DNA and 
resulted in a small reduction in expression when IEP1catIEterm comprised 
only 0.3 pg/20 ýLg of transfected DNA. Constitutive expression from 
IEP1catIEterm was higher when it was co-transfected with the plasmid 
vectors, pUC18 and pAT153, than it was when co-transfected with any of the 
plasmids containing cloned eukaryotic prom oter-regulatory sequences (Fig 
3: 18b). While transfection frequencies do vary with different DNA 
preparations, the magnitude of the differences observed in this experiment 
suggests that the co-transfecting DNA fragments were competing with 
IEPlcatIEterm for cellular transcription factors. 
Expression from IEP1catIEterm was stimulated by virus infection when 
co-transfected with IEP1, pO. 38, pAat2, pAat3, IEPl-aat, pO. 38-aat and 
pAatNco (all of which contain sequences upstream of the transcriptional 
start site) but not when co-transfected with Sst A, LiLndBI Z. or pMD102 (Fig 
3: 18). Co-transfection with three distinct non-overlapping DNA fragments, 
delineated by the Aat][I sites in the IE promoter-regulatory region at -135, 
-321, -404 and -457, caused expression from the co-transfected IE promoter 
to be induced by virus infectLon. The 53bp (in pAat3) and the 83bp (in 
pAat2) Aat1I fragments are particularly notable because neither sequence is 
present in pIEPlcatIEterm. The IE prom oter-regulatory region contains a 
complex series of 16,18,19 and 21bp direct repeats but none of these 
repeats is present in all of the fragments which confer-red inducibility on 
the IE promoter in the co-transfection experiments (Fig 3: 18a). Boshart, et 
2L. (1985) observed that a series of non-overlapPing DNA fragments 
in the 
HCMV IE promoter between -118 to -524 possessed enhancer activity. 
The 
reduction in the level of constitutive IEPlcatIEterm expression when - 
co-transfected with fragments from the IE promoter-regulatory region may 
be 
due to competition by these fragments for enhancer-binding proteins. 
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The possiblity that during productive infections transcriptional 
repression of the major IE gene may be mediated through its enhancer 
elements will be considered in the discussion. It is relevant to note, 
however, that although co-transfection with Hind11I Z or the SV40 early 
promoter (pMD102; which contains an enhancer element) reduced the 
constitutive level of expression from IEPlcatIEterm, it did not result in 
expression from IEP1catIEterm being stimulated by virus infection. 
As in cells transfected with a high copy number of IEPTK1 DNA (section 
3: 10), in these co-transfection experiments HCMV infection is probably 
stimulating expression from the reporter gene by providing an excess of 
transcription factors to the IE promoter. It is notable that in none of the 
co-transfection experiments, in which HCMV infection stimulated expression 
from IEPlcatIEterm, was the level of CAT activity significantly higher than 
that detected in pUC18- or pAT153-IEPlcatIEterm transfected cells in which 
expression had been repressed by virus infection. 
It has recently been proposed that the HSV-1 Vmw 175 polypeptide 
represses transcription from HSV-1 IE gene by binding directly to a sequence 
close to the transcriptional start site. Since co-transfection with SstA did 
not result in HCMV infection stimulating expression from IEPlcatIEterm, 
sequences downstream of position -15 do not appear to be important in the 
transcriptional repression of the HCMV major IE promoter. 
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3: 12 Chnmetrri-rinn or tile Abundnnt IICMV Early Trnnnr-ript 
In exce= of 60', b of IICMV-encoded cytoplasmic poly (A)+ RNA isolated 
from infected calls during the early phase hybridises with the HCMV Pstl 
fragment C. a DNA fragment which contains most of both the IR L and IRS 
regions (Fig 3: 19). More detailed experiments, In which early RNA was 
hybridized with Southern transfers of the HCMV cloned gene bank digested 
with re--triction endonuclemes, Indicated that abundant early transcription 
was localised In the region of a 1.5kb EcoRT1Bnm11I fragment (0.008-0.014 and 
0.812-0.818 map units; Fig 3: 19) present In both the TR L and IR L (WfUdnson, 
1983). 
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ipq: rhysical m4p of the HOW genome showing the 
tions of 11indIII restriction endonuclesse cleavage sites 
(OrAm Pt al.. T-982) and the region within Pstl C encoding the 
2.7kb -a3-rly RNA. The region of DNA whict; -has been sequenced (Crevmw4y And Wilkinson. 1987) and the map location of 
H13mpll(1/39) and M13mpll(1/34) are indicated. 
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Cytoplasmic poly (A)+ RNA was isolated from HCMV infected MRC5 cells 2h 
and 72h p. L and under IE and early phase conditions (section 2: 3). The 
purified RNA preparations were electrophoresed in a form aldehyde-agarose gel 
and transfer-red to nitroce-Ilulose membranes (Thomas, 1980). Fig 3: 20a shows 
that when the Northern transfer was probed with a recombinant clone 
containing fstl fragment C an RNA species of 2.7kb was detected in IE, early 
and late phase RNA preparations but not in RNA prepared 2h p. L The 2.7kb 
transcript, which is synthesised in very sm. all amounts under IE conditions 
(Fig 3: 20a), had previously been identifLed as a minor IE RNA (Wilkinson, 
1983). It is possibe that the 2.7kb RNA is transcribed during the IE phase 
as a consequence of incomplete inhibition of protein synthesis by 
cycloheximide resulting in a IimiEed level of early phase transcription. 
When total HCMV DNA was used as the hybridisation probe the 2.7kb RNA was 
found to be the major early phase cytoplasmic transcript (Fig 3: 20b). 
Although the concentration of the 2.7kb RNA in infected ceBs increases 
considerably during the transition from the early to the late phase of gene 
expression it is no longer the predominant transcript because of the 
efficient expression of HCMV late genes (Fig 3: 20b). 
The mapping and structural analysis of the 2.7kb early RNA was 
supported by the determination of the nucleotide sequence of the gene 
(performed by Dr P. J. Greenaway). The complete nucleotide sequence of the 
strain AD169 major early gene is contained in appendix 3 (Greenaway and 
Wilkinson, 1987). 
Fig 3: 20: Analysis of HCMV transcrýption at different stages 
of the replicative cycle. Cells were infected with HCMV and 
cytoplasmic poly (A)+ RNA isolated after infection for 12h in 
the presence of 100 ýig/ml cycloheximide, 2h p. i., after 
infection for 24h in the presence of 100 ýig/ml PFA and 72h 
p. i. RNA samples (1 ýIg) were electrophoresed in 1% 
agarose-formaldehyde gels and the fractionated material 
transferred to nitrocellulose membranes. Membranes were 
hybridised with radioactive probes prepared from (a) the 
plasmid pT23 (containing HCMV PstI fragment C) and (b) HCMV 
DNA. 
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McDonough et al. (1985) showed that between a region 0.63kb upstream 
and -1.85kb downstream -of the EcoRI site (Fig 3: 19) the major early gene is 
not spliced. These experiments have been repeated and their results 
confirmed (results not shown). Problems were encountered in nuclease 
protection experiments due to artifactual but reproducible cleavage of 
RNA/DNA hybrids at distinct points. The nucleotide sequence data indicates 
that these artifactual cleavage sites occur in sequences containing long 
tracts of A and T(U) residues, e. g. between bases 5004 to 5035 on the 
sequence presented in appendix 4 (Greenaway and Wilkinson, 1987). The 3' 
terminus of the gene was mapped to 265bp downstream from the BamHI site 
detailed in Fig 3: 19. A consensus polyadenylation signal (AATAAA; Proudfoot 
and Brownlee, 1976) is present in the appropriate position upstream (bases 
5742 to 5747; appendix 4) from the proposed 3' terminus of the gene. The 
position of the 5' end of the gene was initially less clear. Although 
nuclease protection experiments indicated transcription was initiated 0.6kb 
upstream of the EcORI site (Fig 3: 19) the possibility of an undetected 
upstream exon was suspected for a number of reasons. Firstly, if translation 
was initiated at the first 5' proximal AUG codon the proposed RNA would 
encode a polypeptide of only seven amino acids. Secondly, there is a 
reasonable homology to the consensus splice acceptor sequence (Mount, 1982) 
close to the proposed transcriptional start site (CTTCCCCAGA between bases 
3276 to 3285 in appendix 4). Finally, the sequence upstream of base 3277 did 
not contain obvious consensus promoter elements. 
To test for the presence of an additional upstream exon in the major 
early gene a primer extension experiment was performed. The recombinant M13 
clone M13mpll(1/39), provided by Dr P. J. Greenaway, spans the 
transcriptional start site and contains approximately 0.5kb of HCMV 
nucleotide sequences upstream from base 3403. A 106n radiolabeUed ssDNA 
primer complementary to the 2.7kb early RNA, extending from the Xma HI 
cleavage site at base 3330 to base 3403 (plus 33n of M13 vector sequence), 
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was prepared from M13mpll(1/39) as described in section 2: 20 and hybridised 
with early and late phase total cytoplasmic RNA. Reverse transcriptase 
extended the primer only an additional 49n, (Fig 3: 21) to base 3281. It was 
concluded that the major HCMV early gene does not contain an upstream exon. 
The 2.7kb early RNA is therefore not spliced and its trancriptional 
initiation site is near base 3281. 
The transcriptional initiation site was precisely mapped in S1 nuclease 
protection experiments. A radiolabelled single stranded DNA hybridisation 
probe spanning the transcriptional start site was prepared as described in 
section 2: 19 using the M13 clone M13mpll(1/39); the same M13 clone used for 
the primer extension experiment. Early and late phase RNA both protected a 
126n Sl resistant fragment (Fig 3: 21) and it was therefore concluded that 
transcription of the 2.7kb RNA was initiated 126bp upstream from the end of 
the insert cloned into M13 (base 3403) at base 3277. 
Twenty-seven base pairs upstream of the designated transcriptLonal 
initiation site at base 3277 (+l) is the sequence which most closely 
resembles the consensus for a TATA box; ATATAAAA (base 3251 to 3258). An 
analysis of the HCMV early promoter revealed a 17bp sequence homology, 
centered on the TATA box, with the corresponding regions of the HSV-1 gD 
Fig 3: 21: Primer extension and S-1 nuclease analysis using the 
recombinant clone M13mpll(1/39). Tracks 1-4 and 18-21 are 
nucleotide sequence tracks for M13mpll(1/39) run as molecular 
weight standards. Tracks 5-11 are primer extension analyses from 
the XmaIII cleavage site at base 3330 using 10 gg of E. coli tRNA 
(track 5), total cytoplasmic RNA from uninfected MRC5 cells 
(tracks 6-8), early phase RNA (track 9) and late phase RNA (tracks 
10,11. ) from HCMV-infected cells. The major band common to all 
tracks is the single-stranded primer molecule. The extended 
fragment of 49n can only be observed in tracks 9-11. Tracks 12-17 
are S-1 nuclease protection analyses in which ssDNA complementary 
to the entire cloned insert in M13mpll(1/39) was hybridised with 
10 pg of total cytoplasmic RNA from uninfected Hela cells (track 
12), uninfected MRC5 cells (tracks 13,14), and early phase (track 
15) and late phase (tracks 16,17) from infected cells. The 
nuclease protected fragment can only be observed in tracks 15-17. 
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(Everett, 1983) and a human heat shock protein (hsp 70; Wu, 1984) gene 
promoters (Table 3: 8). The 2.7kb early promoter does not contain any of the 
direct or inverted repeats associated with the IE gene nor does it contain 
the consensus core sequence for an enhancer (TGGAAA W eiher et aL, 1983) or TTT; 
the binding site of the transcription factor Sp-l (GGGCGG). One imperfect 13 
bp repeat (TCAGTCCGAATGA) was present between bases 2983 to 2995 and 3003 to 
3014 and one perfect 9bp direct repeat (AAACCGTAT) was present between bases 
3131 to 3139 and 3147 to 3155. The latter repeat is also part of a longer 
15bp imperfect repeat. The GC and AC-rich regions which are present upstream 
from the TATA box of the HCMV major early gene have also been identLELed in 
the same relative position in other herpesvirus early promoters (Everett, 
1983); no direct sequence homology has been identified however. The GC-rich 
sequence between bases 3222 to 3246 may possibly be functionally important 
as the analogous region of the HSV-1 gD promoter has been shown 
experimentally to be required for efficient expression (Everett, 1984). 
An analysis of the nucleotide sequence of the HCMV early gene shows the 
major early RNA to contains multiple stop codons in all three reading 
frames. Assuming that an AUG is required to initiate translation the longest 
ORF would encode a polypeptide of only 170 amino acids. It is possLble that 
the HCMV major early RNA transcript does not encode a polypeptide 
(Greenaway and Wilicinson, 1987). 
Human hsp70 promoter TA TA A A A CG CcA G G GG 
-30 -15 
HOW 2.7 kb early promoter TA TA A A A ACG CA G G GG TTTAG 
26 -6 
HSV-1 gD promoter 
TA A A A A-G CA G G GG T-TAG 
23 -7 
Table 3: 8: Corresponding homologous regions in the human hsp 
70, HCMV 2.7kb early and the HSV-l gD gene promoters. 
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Fig 3: 22: The construction of the plasmids pVUTK1,0.7TK1,1/34TK1 and 
0.7-1T3_4TK1. (a) pVUTKl was constructed by excising the complete HSV-l TK 
gene from the plasmid pM2 (Wilkie et al., 1979) on a PvuII fragment 
(approximately 2kb) and inserted into t-he unique HincII site in pUC19. (b) 
0.7TK1. The HincII/E&aI fragment (position -600 to -63) was excised from 
the IE promo-t-er in IEP2, blunt-ended by treatment with T4 polymerase and 
inserted into the SmaI site in pUC18 to generate the plasmid pO. 7. The TK 
gene was excised from pVUTK1 by digestion with EpnIýXbaI, the DNA fragment 
blunt-ended using T4 polymerase and inserted into the HincII site in pO. 7. 
The enhancer element in 0.7TK1 is inverted relevant to its orietation in 
the major IE gene. (c) 1/34TK1. The HCMV DNA fragment 1/34 produced by DNA 
sonication was cloned into the SmaI site in M13mpll (Dr P. J. Greenaway, 
personal communication). A DNA fragment containing 1/34 was excised from 
M13mpll(1/34) by digestion with BamHI/EcoRI and cloned between the Bam. HI 
and EcoRI sites in pUC18 generat7i7n-g- the plasmid pl/34. The plasmid PVUTK5 
is identical to pVUTKl except that the TK gene was inserted in the 
opposite orientation into pUC19. The TK structural gene was excised from 
pVUTK5 by digestion with a&lII/EcoRI and inserted between the EcCRI and 
SstI sites in pl/34 generating the plasmid 1/34TK1*. Finally restriction 
endonuclease cleavage sites upstream of the HCMV early promoter were 
removed by digestion with HindII/BamHI, blunt-ending using the Klenow 
polymerase and religating to produce the plasmid 1/34TK1. (d) 0.7-1/34TKI. 
1/34TKl* was digested with BamHI/HindIII and pO. 7 digested with 
HindIII/SstI. The BamHI site upstream of the enhancer was ligated to the 
BamHI site of the early promoter. The HindIII and SstI sticky ends were 
then blunt-ended using T4 polymerase and ligated together to generate the 
plasmid 0.7-1/34TKJ. The majority of work involved in constructing these 
pi mids was performed by Dr A. Akrigg. LamHI (f), ýelII (9), EcoRI 
(), I! qaI (Hg), HincII (H), ILindIII (4. ), EDnI (K), LstI (7), Lvujj (P), 
Im I (S), ýstI (V) and XbaI (X) restriction endonuclease cleavage sites 
are shown. 
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3: 13 Activation of Expression From The HCMV Early and The HSV-1 TK Promoters 
By Virus Infection 
The characterisation of the HCMV major early gene provided a basis from 
which to devise further experiments to study the transition from HCMV IE to 
early phase gene expression. In particular, a knowledge of the DNA sequence 
of the early gene facilitated the cloning of reporter genes downstream and 
under the control of the early gene promoter. The recombinant phage 
M13mpll(1/34), generated during the nucleotide sequence analysis of the HCMV 
major early gene (Greenaway, personal communication), contains a cloned 
insert extending from approximately -500 to precisely +97 (base 3377; 
appendix 3) with respect to the transcriptional start site of the 2.7kb 
early RNA as determined in section 3: 12. The plasmid 1/34TK (constructed by 
Dr A. Akrigg) contains the HCMV early promoter excised from M13mpll(1/34) 
and inserted upstream from the TK structural gene in a pUC19 based plasmid 
as described in the legend to Fig 3: 22c. It should be noted that the HCMV 
leader sequence cloned into 1/34TK1 contains a potential translational 
initiation codon at +89 which may influence TK expression. The promoter 
sequence in 1/34TK1 is shown in Fig 3: 23. 
The level of TK enzyme activity detected in uninfected MRC5 cells, 
transfected with the plasmid 1/34TK1, was similar to background levels of 
the assay which indicates that there was little constitutive expression from 
the early promoter. However, expression from 1/34TK1 was stimulated 
significantly by infection with HCMV (Table 3: 9; Fig 3: 23). During the 
course of the infection expression from 1/34TK1 increased gradually to reach 
its maximum level during the late phase (Table 3: 9; Fig 3: 23). There was a 
significant delay of bet*een 8 to 12h following infection before an increase 
in expression from the transfected promoter was detected. This lag period 
could not overcome by increasing the m. o. L of HCMV (results not shown). The 
HCMV early promoter appears to be regulated in a similar manner in infected 
cells whqther introduced by DNA transfection or virus infection. In HCMV 
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Ch=GACTG ATTCGTWrA OMACTG= CATCCCrMh ATGACGAhGA AGATOTIGAA 
CrGTG3AGAG Trr=ir TrAATAA= ChTACCACAT McrMhrrr ATATCMTr 
TrAGGATGAT GACrATAGrA TRACTCTGM GAACAAATAT ClkTACGrrAA TCACrMAG 
TrACCCC= A(EAAAAGAh MTrAG= MlICAhGCkT AGrCAGOCGA AMATACAGC 
AATAGCrMr TrACAACGTG TrCITrrrrA ChTrAIr. W GTGCLTrGCr TrrrATACAC 
ACAIIGGAGAC AGAG=Cr CAGCCCTTM CACCACAACr CCCrrrrrCr AAhCCGrAV; 
TGCrCCAAAC CC; rAT=Cr CATCGTCACG IGWTACCK TG33ACCCCr TrMGXXA 
ChCCTCrrrC C=ACCCA ACGCG7CAGC CCGC=r. CAGAGCrACC ATATAMAAC 
+1 
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GC=AAIM =03C7= CMI W-= TCCX; AarAT aGOSAC. AA= G= 
-ioo -ioo -; Oo 
HCMV 2-7kb RNA Early 
Promoter 
Fig 3: 23: Stimulation of expression from the transfected HCMV major early 
promoter by infection with HOW and HSV-1. The nucleotide sequence of the 
promoter-regulatory region (from approximately -500 to precisely +97) 
cloned into 1/34TK1 and its position relative to the TK structural gene 
are shown. 0,1/34TKI transfected cells; X, 1/34TKJ transfected 
HCMV-infected cells; 1/34TKI transfected HSV-1 infected. 
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024 8 16 24 48 
infected cells, measurements of the levels of the 2.7kb RNA in the cytoplasm 
were unable to detect the transcript at 2h p. L, show it to be present in 
only trace amounts under IE conditions and at 8h pi. but in increasing 
abundance subsequently (sectLon 3: 12; McDonough et aL, 1985). 
A short region of DNA sequence ho m ology is shared by the HCMV early and 
the HSV-1 gD promoters (Table 3: 8). In view of this homology, an attempt was 
made to activate expression from the HCMV early promoter by infecting 
1/34TK1-transfected cells with HSV-1 TK-. Expression from the transfected 
HCMV early promoter was not significantly enhanced by HSV-l infection, 
although there was a very small transient increase in expression between 12 
and 24h pi. (Table 3: 9; Fig 3: 23). The inability of HSV-l infections to 
stimulate expression from 1/34TKI is unlikely to be a property of the 
reporter gene, since it was derived from HSV-1. Consequently, it would 
Time 1/34TK1 1/34TK1 + HSV-1 1/34TK1 + HCMV 
(h p. i. ) 
0 1,674 
2 2,280 2,176 2,219 
4 2,131 2,197 1,865 
8 1,622 2,841 1,885 
16 2,369 5,183 6,119 
24 2,782 5,211 23,053 
48 3,571 2,810 53,178 
Table 3: 9: Effect of virus infection on expression from the 
transfected HCMV early promoter. All samples were taken from 
1/34TK1 transfected cells. Results of the TK enzyme assay are 
expressed as c. p. m. /10 41 cell extract. Duplicate samples were 
assayed three times each, the average value calculated and the 
value obtained by assaying TK extraction buffer (2,679) 
subtracted. Cells were infected with HCMV or HSV-l at a m. o. i. of 
5 p. f. u. /cell. 
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HSV-1 TK gene promoter by infection with HCMV 
pVUTK1 transfected cells; X pVUTK1 
HCMV-infected cells; 0, pVUTK1 transfected HSV-1 
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appear that either the HCMV early promoter does not respond to HSV-1 
encoded trans-actLvators or that the short HCMV leader sequence is 
preventing expression. 
In DNA transfection experiments, HSV-1 infections stimulated expression 
from the HCMV major IE promoter but not the HCMV major early promoter 
(section 3: 4, this section). This inability of HSV-l to activate expression 
from the HCMV major early promoter implied that the two herpesviruses may 
use different mechanisms to regulate early phase gene expression. It was 
therefore decided to investigate the effect of infection with HCMV on a 
HSV-1 early promoter. The plasmid pVUTKl (kindly provided by Dr A. Akrigg) 
contains the HSV-1 TK gene under the control of its own early promoter (Fig 
3: 22a). 
The levels of TK act: Lvity detected in pVUTK1-transfected and in 
untransfected ceUs were sLmilar (Table 3: 10), constitutive expression from 
the TK gene was therefore very low. Stimulation of expression from the 
Time pVUTK1 pVUTK1 pVUTK1 
(h p. i. ) + HSV-1 + HCMV 
0 5,007 
3 3,648 2,485 4,062 
8 4,048 78,583 3,206 
24 3,510 97,354 32,282 
48 4,419 78,388 157,355 
96 7,922 - 147,369 
0 
Table 3: 10: Effect of virus infection on expression from the 
transfected HSV-1 -rK promoter. All samples were taken from 
pVUTK1 transfected cells. Results of the TK enzyme assay 
are expressed as cpm/10 pl of cell extract. Duplicate samples 
were assayed three times each, the average calculated and the 
value obtained by assaying' TK extraction buffer (4,002) 
subtracted. Cells were infected with HSV-1 TK or HCMV at a 
m. o. i. of 5 p. f. u. /cell. 
165 
70 
60- 
50 
CD 
T- 
X 
. 40 
3C 
*Z 
0 
cz 
llý 
i- 2C 
ic 
Time p. i. (h) 
Fig, 3: 25: Effect of increased m. o. i. on HCMV stimulation of expression 
from the transfected HSV-1 TK promoter. All samples were from 
pVUrKl-transfected cells. 0 uninfected; X, infected with 5 
p. f. u. /cell HCMV and A, infected with 35 p. f. u. /cell HOW. 
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transfected TK promoter by infection with HSV-1 TK- was not detected 3h p. L 
but at 8h, 24h and 48h p. i. TK enzyme actLvity in cell extracts was greatly 
enhanced (Table 3: 10; Fig 3: 24). By 96h p. L the HSV-1 infection had 
destroyed the monolayer. 
HCMV infection induced efficient expressLon from the transfected HSV-1 
early promoter but not until 24-48h p. L (Table 3: 10; Fig 3: 24). A similar 
lag period was also observed between HCMV infection and the virus-induced 
stimulation of expression from the -transfected HCMV major IE (section 3: 4) 
and major early (this section) promoters. In an attempt to overcome this lag 
period ceUs transfected with pVUTKl were infected with a very high input 
m. o. L of HCMV (Table 3: 11; Fig 3: 25). Although the level of TK expression 
at 21h, 48h and 72h p. L was appreciably higher when the m. o. L with HCMV 
was increased from 5 to 35 p. f. u. /cell, there was no detectable stimulation 
of TK expression at 8h p. L (Fig 3: 25). 
Time pVUTK1 pVUTK1 pVUTK1 
(h p. i. ) +5 PFU/cell + 35 PFU/cell 
HCMV HCMV 
0 3,513 
4 2,768 1,396 1,821 
8 998 1,159 55 
21 1,355 6,527 11,848 
48 2,470 43,816 67,964 
72 1,621 46,289 20,258 
Table 3: 11: The effect on expression from the HSV-1 TK 
promoter of moderate and high m. o. i. with HCMV. All samples 
were from pVUTK1-transfected cells. Results of the TK enzyme 
assay are expressed in c. p. m. /lo pl of cell extract. 
Duplicate samples were assayed three times each, the average 
calculated and the value obtained by, assaying TK extraction 
buffer (4,490) subtracted. 
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In DNA transfection experiments while HCMV infection was able to 
stimulate expression from an HSV-1 early promoter, HSV-l infection was 
unable to stimulate expression from the HCMV major early promoter. HSV-1 
infection was, however, able to stimulate expression from the HCMV major IE 
promoter (section 3: 7) and its own TK promoter (this section) appreciably 
more rapidly than HCMV in experiments performed in parallel, using the same 
plasmid constructs and the same cell system. 
3: 14 Activation of Expression From The HCMV Major Ear1V Promoter in Cis 
BV an Enhancer 
The HCMV major IE gene contains one of the strongest characterised 
enhancer elements (Boshart et al., 1985). A 537bp DNA fragment, containing 
the enhancer region from the major IE gene, was inserted upstream of the 
HCMV major promoter in 1/34TK1 (as described in the legend to Fig 3: 22d) to 
determine whether expression from the 1/34TK1 could be activated solely by 
stimulating transcription from the early promoter. The 537bp IE enhancer 
element was also inserted into the plasmid pVUTK1, upstream of the TK gene, 
as a positive control to confirm that the enhancer was functional. (Fig 
3: 22). The plasmids 0.7-1/34TK1 and 0.7TK1 were constructed in collaboration 
with Dr A. Akrigg. 
In order to maximise the transfection frequency, Hela cells, rather 
than MRC5 cells, were transfected with the plasmids pVUTK1,0.7TK1,1/34TK1, 
0.7-1/34TK1 and IEPTK1. The presence of the 537bp enhancer element, in 
. 
2k, 
stimulated expression from both the HSV-1 TK and HCMV early promoter (Table 
3: 12). Even wherl stimulated by the IE enhancer element, the level of 
expression from the HSV-1 and HCMV early promoters was significantly less 
than that obtained using the intact HCMV IE promoter (IEPTK1 in Table 3: 12). 
These results demonstrated that detectable levels of expression from 
1/34TK1 can be obtained by stimulating transcription from the early 
promoter. In an attempt to map HCMV trans-activator<s), the plasmid 1/34TK1, 
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and analogous constructs containing the C AT reporter gene, have been 
co-transfected with recombinant plasmid containing HCMV IE genes. These 
experiments have been unable to demonstrate trans-activation of the HCMV 
early promoter (results not shown). It has recently been suggested that the 
leader sequence of the 2.7kb early transcript may exert some form of 
post-transcriptional control over expression, possibly by inhibiting the 
passage of ribosomes through the leader (Geballe et al., 1986b). It is clear 
from the results in table 3: 10 that expression from 1/34TK1 is not 
absolutely dependent on an HCMV early gene product inter-acting with the 
leader sequence to permit translation. Although the presence of the upstream 
initiation codon within the HCMV leader sequence did not prevent translation 
of the TK enzyme, it may act to attenuate the level of its expression. 
Plasmid TK Enzyme 
Activity 
pVUTK1 1,836 
0.7pVUTK1 109,756 
1/34TK1 8,501 
0.7-1/34TKi 57,025 
IEPTK1 357,444 
Table 3: 12: Cis-activation of expression from the HSV-l TK 
and the HCMV major early promoters by an enhancer element 
derived from the HCMV major IE gene. The plasmid 
constructions are described in Figs 3: 3 and 3: 22. Hela cells 
in 100 mm diameter petri dishes were transfected with 20 ýig 
of plasmid DNA. Cells were scraped off the petri dishes in 
0.5 ml of PBS, pelleted by low speed centrifugation and 
resuspended in 100 pl of TK extraction buffer. The results of 
the TK enzyme assays are expressed as cpm/10 pl of cell 
extract. Duplicate samples were assayed three times each, 
the average calculated and the value obtained by assaying an 
extract from untransfected cells (28,648) subtracted. 
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Discli---ýd 
The nuclease mapping technique of Berk and Sharp (1977) was used to 
precisely m ap the 5' and 3' ter mini of the HCMVm ajor IE gene and the exact 
location of four exons. The structural mapping of the IE gene permitted the 
amino acid sequence of the major IE polypeptide to be deduced from the DNA 
sequence (Akrigg 
. 
2t ! 21:, 1985; appendix 2). Translation is initiated within 
the second exon 966 bases downstream of the transcriptional start site 
which, after making allowance for the 5' proximal intron, indicates the 
1.95kb major IE mRNA has a leader sequence of 139n. 
The molecular weight of the HCMV major IE polypeptide, as calculated 
from the predicted amino acid sequence, is 55,001 daltons (strain AD169) and 
not 64K as reported previously (Stenberg 
. 
2t ýý, 1984; Akrigg et ýý, 1985). 
The discrepancy was due to a failure to compensate for the loss of H20 
molecules during peptide bond formation. Since the polypeptide is 
phosphorylated its final molecular weight following post translational 
processing will be slightly greater than 55,001 daltons but still 
considerably less than molecular weight estimations made by SDS-PAGE 
(approximately 75K; Blanton and Tevethia, 1981; Cameron and Preston, 1981; 
Gibson, 1981a; Wilkinson et al., 1984). The presence of high concentrations 
of proline, an --helix breaker, at both termini may contribute towards the 
protein's anomolous migration in SDS-PAGE; similar discrepencies in 
molecular weight estimations have also been reported for other proline-rich 
herpesvirus proteins (Watson et al., 1982; Frink et al., 1983; McGeoch et 
jLL, 1986; Perry Lt 2L, 1986). The major IE polypeptide is mainly 
hydrophilic, particularly at the glutamic acid/aspartic acid-rich 
carboxy-terminal end, and carries a net negative charge which is consistent 
with its experimentally determined isoelectric point of approximately pH 5.9 
(Gibson, 1983; Stenberg et 2ý, 1984). 
The structural organisation of the major IE genes of HCMV strains AD169 
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and Towne are very sLmilar (Stenberg et jaL, 1984: Akrigg et j2L, 1985; this 
thesis). The 5' ends of the mRNAs are apparently identical and the 3' 
terminus of the strain AD169 gene is located only lbp downstream of that 
reported for strain Towne. There are only three nucleotide differences in 
the coding sequence of the two strains which produce two amino acid changes 
in the encoded proteins: the 68th amino acid is glutamine and arginine and 
the 394th amino acid is valine and alanine in strains AD169 and Towne 
respectively. The similarity between the IE polypeptide amino acid sequence 
of the two strains was unexpected since their electrophoretic, mobilities on 
SDS-PAGE indicated a difference of approximately 3K in their apparent 
molecular weights (Cameron and Preston, 1981; Gibson, 1981a). The anomolous 
migration of the major IE polypeptides of strains AD169 and Towne in gels 
is probably caused by an SDS-resistant conformational property bestowed by 
the high proline content of the two proteins. The two amino acid differences 
between the proteins may produce conformational changes (in the presence of 
SDS) which disproportionately affect their electrophoretic migration. 
Exonuclease protection experiments precisely mapped the 5' end of the 
IE gene and thereby identLEied the promoter-regulatory region of the major 
IE gene. The extensive nucleotide sequence homology between the IE genes of 
strains AD169 and Towne extends into the promoter where there are only 13 
base differences in the reported sequences (Thomsen et aL, 1984; Akrigg 
. 
2t 
al., 1985). The DNA sequence of the HCMV IE promoter contains a number of 
remarkable features. In addition to a consensus TATA box between bases -23 
to -29 the promoter contains a complex mixed series of imperfect direct 
repeats which consist most notably of three copies of a 21bp repeat, four 
copies of a palindromic 19bp repeat, four copies of a 18bp repeat and three 
copies of a 16bp repeat. Due to the palindromic nature of the 19bp repeat 
there is potential for the formation of a variety of stem loop structures 
within the IE promoter (Thomsen et aL, 1984; Akrigg et . 
21., 1985). 
The HCMV IE promoter has been shown Lperimentally to contain an 
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exceptionally strong enhancer which has been mapped between bases -118 to 
-524 (Boshart, et aL, 1985). Enhancer elements are defined as cis-acting 
regulatory elements which potentiate transcriptional initiation from nearby 
genes relatively independent of distance or orientation (Weiher et aL, 
1983). The activity of enhancer elements is mediated through their 
interaction with diffusable transcription factors (Scholer and Gruss, 1984). 
Deletion studies indicated that the HCMV major IE promoter contains a series 
of elements each of which independently exhibits enhancer activity in an 
SV40-based 'enhancer trap'. The efficiency with which the different 
sub-, elements from the IE enhancer region stimulated expressLon was 
increased when they were combined (Boshart et aL, 1985). The core enhancer 
consenus sequence TGG 
AAA identified by Weiher et. al. (1983), which is TTT 
contained in three of the four copies of the 18bp repeat, was however shown 
not to be essential for enhancer activity (Boshart. et al., 1985). 
The IE promoter also contains three CAAT box homologies (in 3 of the 4 
copies of the 19bp repeat), four potential binding sites for the 
transcription factor Sp-1 (GGCGGG or CCCGCC; Gidoni et al., 1984) and five 
experim entally-deter mined binding -sites (TGGN 5 GCCAA) for nuclear factor I 
(NFl). Hennighausen and Fleckenstein (1986) have shown that NF1 binds 
specifically (Lin 2jjEo) to five sites surrounding the IE promoter, four are 
located far upstream between bases -620 to -725 but the binding site with 
highest affinity for NF1 is located inside the first intron at approximately 
base +350. 
Following virus infection the HCMV major IE gene is expressed in 
differentiated but not in undifferentiated human embryonal carcinoma (EC) 
cells (Gonczol et al., 1984). In chromatin extracted from HCMV-infected 
undifferentiated EC cells Nelson and Groudine (1986) identified five DNAase 
hypersensitive sites within the enhancer region, one near the TATA box and 
two adjacent to the NFl-binding site in the first intron. In chromatin 
purif: Led from differentiated EC cells additional DNAase hypersensitive sites 
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were detected near the transcriptional start site and between bases -650 to 
-975, the latter region contains the upstream region associated with 
NFl-binding (Nelson and Groudine, 1986). Although the binding of NF1 to 
sequences upstream from the IE promoter is associated with transcriptional 
induction in EC cells there is currently no evidence to indicate NF1 has a 
regulatory role in IE gene expression. Indeed, in transient DNA transfection 
experiments transcription and transcriptional repression of the IE promoter 
(e. g. in IEPTKI and IEPlcatIEterm) can take place in the absence of both the 
upstream and downstream NFI-binding s: Ltes. 
The transcription of the 1.95kb major IE RNA and probably the majority 
of RNA species derived from IE coding region 2 is initiated from the major 
IE promoter (Stenberg et 2, ý, 1985). The efficient expression of this 
transcriptional unit during the first 6h p. i. is ensured by the presence in 
the IE promoter of the strongest enhancer element which has yet been 
identified (Boshart et al., 1985). The HCMV major IE gene contains an 
exceptionally efficient constitutive promoter, in transient DNA transfection 
experiments expression from IEPlcatIEterm is approximately 20 fold and 40 
fold stronger than that from similar constructs based on the RSV LTR 
promoter and the SV40 early promoter respectively (Akrigg and Wilkinson, 
unpublished data; section 3: 11). A different version of the HCMV IE 
promoter, linked to a polyadenylation signal sequence derived from SV40, was 
found to be approximately four-fold more efficient than the RSV promoter in 
driving expression of bovine growth hormone (Pasleau et. aL, 1985). 
Expression from the HCMV IE promoter is similarly much more efficient than 
that from the SV40 and RSV promoters in established cell lines; indeed the 
HCMV promoter has been decribed as being the "system of choice for 
high-level expression with mammalian vector systems" (Foecking and 
H ofstetter, 1986). 
In a series of transient DNA transfection experiments (using the 
plasmid constructs IEPTKI, IEPTK2, AccHincat and IEPlcatIEterm) the level of 
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expression from the major IE promoter was found to be further enhanced by 
infection with HCMV. This virus-induced stimulation of expression from the 
IE promoter was not anticipated since during HCMV infections of permissive 
cells in tissue culture transcription from the IE promoter is repressed 
after 6h pi. (Nelson and Groudine, 1986). Expression of HSV-1 IE genes is 
known to be stimulated by a transcriptional trans-activator which is carried 
in the virion (Campbell et al., 1984). Experiments were therefore performed 
to investigate whether the HCMV major IE promoter was also being stimulated 
by a component of the virion. The level of expression from the reporter gene 
was measured in cells transfected with IEPTKl which were (i) mock-infected, 
(Ji) infected with u. v. -inactivated HCMV and (iii) infected with viable 
HCMV. These experiments showed that u. v. -irradiation abolished the majority, 
but not all, of the virus-induced stimulation of expression from the IE 
promoter. Inhibitors of HCMV DNA replication (e. g. PFA) were also shown to 
reduce the extent HCMV stimulated expression from the transfected IE 
promoter; a result which is consistent with the contention that the 
transfected IE promoter was stimulated by a de novo synthesised HCMV-encoded 
gene product. Expression from the transfected HCMV IE promoter was therefore 
stimulated both by a de novo synthesised, virus-induced trans-activator 
and, to a much lesser extent, by a component of virus infection which was 
resistant to u. v. light. 
Two other groups have recently shown that, in the enforced absence of 
virus-encoded protein synthesis, HCMV infections stim ulate expression fro m 
the major IE promoter. Using a continuous cell line containing integrated 
copies of the HCMV major IE promoter (linked to the chicken ovalbumin gene), 
Stinski and Roehr (1985) observed that the amount of RNA transcribed from 
the IE promoter increased following infection with HCMV in the presence of 
anisomycin. In a similar experiment Spaete and Mocarski (1985b) transfected 
a plasmid containing the IE promoter linked to bacterial p-galactosidase 
(the reporter gene) into permissive cells which were then infected with 
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HCMV in the presence of cycloheximide. Expression from the reporter gene, 
measured following cycloheximide-release in the presence of actinomycin D, 
was found to be stimulated by HCMV infection. 
Although these three independently-conducted experiments all indicated 
that HCMV infections stim ulate expression fro m the IE pro m oter in the 
absence of de novo virus-encoded protein synthesis, it does not necessarily 
follow that the stimulation is caused by a vixion trans-activator analogous 
to HSV-1 Vmw65. It is possible that events involved in virus adsorption and 
penetration may produce metabolic changes within cells which either enhance 
transcription or relieve transcriptional repression from the IE promoter. 
For example, by merely binding to its surface receptor HSV-l stimulates 
transcription from a subset of cellular genes (Kemp Lt . 
21:, 1986). Results 
obtained in a number of recent studies are consistent with there being a 
labile cellular protein which interacts with the 'HCMV IE promoter to 
suppress its transcription. Boom et al. (1986) produced a rat ce-Il line 
containing IE coding regions 1 and 2 of strain AD169 stabily integrated into 
the cellular geno m e. In im m unofluorescence studies only approximately 1% of 
the transformed cell line was observed to express the major IE antigen at 
detectable levels. However, when the cell line was exposed for a short 
period (3h) to an inhibitor of protein synthesis or given a heat shock, 
synthesis of the major IE nuclear antigen was induced in up to 20% and 80% 
of cells respectively. Administering a heat shock to cells prior to 
infection with HCMV has also been shown to increase the percentage of Vero 
cells which express the IE antigen from 6.4% to 25.3% (Zerbini et al., 1985) 
and, in permissive cells, to both shorten the eclipse phase and increase the 
plaquing efficiency of the virus (Zerbini et al., 1986/87). It is possible 
that virus adsorption and penetration may induce a 'heat shock' or similar 
response which inactivates a cellular factor which represses HCMV IE 
transcription. 
Campbell and Preston (1987) observed that while PRV apparently does not 
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encode a virion trans-inducing factor (TIF), expression from the PRV IE gene 
was stimulated by HSV-1 TIF. A1 5bp direct repeat within the PRV IE 
regulatory region exhibits sequence homology with the 18bp repeat in the 
HCMV IE promoter (which contains the enhancer 'core' consensus sequence) and 
the HSV-1 TAATGARATTC sequence, which has been shown to be involved in 
TIF-mediated transcriptional stimulation (Bzik and Preston, 1986; Campbell 
and Preston, 1987), (Table 4: 1). Campbell and Preston (1987) suggested that 
in HCMV and PRV the presence of multiple copies of the "positive control 
sequence" may promote enhancer activity whereas in HSV-1 efficient IE gene 
expression is dependent on TIF stimulating transcription. The enhancer 
fcorel consensus sequence which is contained in the HCMV 18bp repeat is also 
part of a sequence which is conserved between the SV40 enhancer (Boshart et 
al., 1985), an enhancer ele m ent in the kappa im m unoglobulin gene (Sen and 
Baltimore, 1986) and the HIV LTR (Nabel and Baltimore, 1987), (Table 4: 1). 
It has recently been proposed that negative regulation of transcription 
fro m the HCMVm ajor IE pro m oter, during virus infections, m ay be m ediated 
GNTAATGARATTC 
GGCCAATGAGATTGT 
GGCCAATGGGATTTY 
ccAAACGGG ACT TTCCAA GTT 
GGG ACT TTCCA 
GGG ACT TTCCA 
HSV-1 Consensus 
PRV -420 to -435 
PRV Consenus 
HCMV 18 bp Consensus 
SV40 Enhancer 
HIV Enhancer 
GGG ACT TTCCA Kappa Ig Enhancer 
Table 4: 1: Homology between the HCMV 18bp repeat and other 
promoter elements. 
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by the major IE gene product itself. Stenberg and Stinski (1985) transfected 
COS-I cells with a plasmid containing the entire HCMV major IE gene and a 
mutated form of the same plasmid in which a DNA fragment encoding 145 amino 
acids at the carboxy-ter minus of the major IE polypeptide had beeen deleted. 
The level of expression of both the major IE RNA and protein were observed 
to be appreciably less in cells transfected with the plasmid containing the 
wild-type IE gene than it was in cells transfected with the mutated plasmid. 
Furthermore, co-transfection with the wild-type IE gene resulted in a 
reduced level of expression from the mutated form. From these results it was 
deduced that the major IE polypeptide acts in trans to suppress 
transcription from its own promoter and that this autoregulation involved 
the carboxy-terminal end of the major IE polypeptide. The major IE protein, 
however, does not appear to bind directly with DNA although it has been 
reported to associate "preferentially with chromatin" (Stinski et al., 
1983). Im m unofluorescence studies sho w the HCMVm ajor IE antigen to be 
distributed evenly throughout the nuclei rather than being preferentially 
associated with replicating co'mplexes of viral DNA, as has been reported for 
the autoregulatory HSV-1 Vmw175 IE polypeptide (Randall and Dinwoodie, 
1986). Although the HCMV major IE protein is associated with the nucleus, 
the limited biochemical data available suggest it may not bind specifically 
to HCMV DNA (section 1: 18). 
The HCMV-induced stimulation of expression from the IE promoter in 
IEPTK1-transfected cells contrasts with the situation during productive 
infections where transcription from the IE promoter is repressed from 6h 
p. i. The anomolous behaviour of the IE promoter in transfected cells was the 
subject of a systematic investigation. The inability to repress expression 
from the transfected IE promoter implied that the HCMV-induced repressor of 
IE transcription (RIT) was not interacting effectively with its receptor. 
Since the IE prom oter-regulatory region in IEPTK1 extends only from bases 
-299 to +69, it was hypothesised that the cis-acting regulatory -signal 
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required for IE transcriptonal repression may not be contained in IEPTK1. 
The IE prom oter-regulatory sequence was therefore extended to 1.7kb upstream 
of the transcriptional start site in the plasmid IEPTK2. HCMV infection, 
however, was stM found to stimulate expression from the extended promoter. 
The result of this and similar experiments indicated that the inability of 
HCMV infections to repress expression from the transfected major IE promoter 
was not due to the absence of a repressor-binding sequence. 
The second possibility considered was that the putative repressor, the 
major IE polypeptide, might fail to be synthesised in cells transfected with 
a plasmid containing the IE promoter. It was envisaged that high copy 
numbers of the transfected IE promoter may compete with low copy numbers of 
the major IE promoter on the HCMV genome (introduced by infection) for 
essential transcription factors and thus prevent expression of the major IE 
polypeptide. Hypothetically, in the absence of its repressor, the 
transfected IE promoter could then be stimulated by HCMV-encoded 
trans-activators. Cells transfected with the plasmid IEP11assaterm, which 
contains the lassa virus nucleocapsid protein under control of the HCMV 
major IE promoter, were able to simultaneously express both the lassa virus 
antigen and, following HCMV infection, the HCMV major IE antigen. It was 
therefore demonstrated that the presence of high copy numbers of the IE 
promoter in transfected cells did not, following subsequent virus infection, 
prevent expression of the HCMV major IE antigen. 
Although the presence in cells of high copy numbers of the transfected 
IE promoter did not prevent HCMV gene expression, following virus infection, 
it could still have been sufficient to saturate the RIT function and thereby 
permit expression from the transfected IE promoter to be stimulated by 
HCMV-encoded trans-activators. In order to test this hypothesis, the copy 
number of the IE promoter introduced into cells was lowered simply by 
serially reducing the concentration of IEPTK1 or IEP1catIEterm used in DNA 
transfections. As the concentration of IEPTKI used per transfection was 
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lowered so was the relative stimulation of expression from the IE promoter 
induced by virus infection. However, a three-fold increase in copy number of 
the IE promoter in transfected cells produced only an approximately two-fold 
increase in TK activity detected in uninfected cells as compared with an 
approximately three-fold increase in infected cells. This indicated that 
although the level of TK activity detected in uninfected cells was 
proportional to the concentration of transfected IEPTK1 DNA, competition for 
a limiting cellular factor also appeared to be restricting expression as the 
concentration of IEPTK1 DNA was increased. In HCMV-infected cells, on the 
other hand, a linear relationship existed between the concentration of 
transfected IEPTK1 DNA and the amount of TK activity detected in transfected 
cells. HCMV infection could, therefore, apparently overcome the constraints 
imposed on expression by limiting cellular factors. 
- Although the relative stimulation of expression from IEPTK1 DNA by HCMV 
infection was less when lower copy numbers of the plasmid were used, HCMV 
infection was not observed to repress expression from IEPTK1. In similar 
serial dilution/transfection experiments performed with the plasmid 
IEPlcatIEterm, HCMV infection did repress expression from the transfected IE 
promoter. The activity of an HCMV-induced repressor was clearly unmasked by 
reducing the concentration of IEPlcatIEterm DNA used in transfections. The 
inability to detect HCMV-induced repression of IEPTKl expression may be due 
to the assay for TK activity being less sensitive than that for CAT 
activity. Alternatively, the TK structural gene may in some way affect 
expression from the IE promoter in IEPTK1-transfected cells. The possibility 
that the polyadenylation site from the IE gene, which is present in 
IEPlcatIEterm but not in IEPTK1, was required for repression of the IE 
promoter was tested using a series of plasmid constructs containing all four- 
possible combinations of the HCMV major IE promoter or the SV40 early 
promoter with either the SV40 or HCMV IE polyadenylation signal driving 
expression of the CAT gene. While the DNA fragment containing the HCMV IE 
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polyadenylation signal specif-Lcally increased expression fro m the HCMV 
promoter (A. Akrigg, personal communication; Fig 3: 17), it was not essential 
for repression of the IE promoter. A sequence in the HCMV IE gene between 
positions -299 and +69 therefore contains a cis-acting -signal which responds 
to an HCMV-induced repressor. 
The identity of the sequence within the IE promoter involved in 
transcriptional repression was further investigated in a series of 
competitive co-transfection experiments. The rationale behind these 
experiments was based on the assumption that when the IE promoter was 
present in low copy numbers in transfected cells RIT repressed its 
expression, but when the IE promoter was present in high copy number the RIT 
function was saturated and HCMV-encoded trans-activators stimulated its 
expression. Large amounts of subc1oned DNA fragments from the IE promoter, 
and elsewhere, were therefore co-transfected with low concentrationsl of 
IEPlcatIEterm DNA in order to distinguish the DNA fragments, which by 
binding with the repressor, would enable HCMV-encoded trans-activators to 
stimulate expression from the IE promoter. The situation in the 
co-transfected cells, howeVer, transpired to be more complex. 
When the plasmid IEPlcatIEterm was co-transfected with IEP1, pO. 38, 
pAat2, pAat3, IEPl-aat/0.38-aat, Hindl1I Z or pMD102 the level of CAT 
expression from the major IE promoter was appreciably reduced. An internal 
standard, ie. a reporter gene under the control of different promoter, was 
not used in these experiments because of the possibility that it could, 
potentially, also compete for RIT. However, since the presence of the 
co-transfected plasmids reduced the level of expression from IEPlcatIEterm 
both consistently and (in some cases) very substantially, it was considered 
extremely unlikely that the effect could be due entirely to variations in 
the transfection frequency. The observed reductions in constitutive 
IEP1catIEterm expression were probably caused by the co-transfected plasmids 
competing for enhancer-binding proteins. Using a similar DNA transfection 
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protocol, Scholer and Gruss (1984) observed that pSV2cat plasmid. DNA became 
saturating for available transcription factors at a concentration of 1 ýig 
per 25 ýtg of total DNA applied to 10 cm petri dishes of CV-1 cells. In 
competitive co-transfectLon experiments, using homologous and heterologous 
promoter elements, the cellular transcription factor which was most readily 
saturated by high concentrations of SV2cat DNA interacted with the enhancer 
region (Scholer and Gruss, 1984; Scholer et al., 1985). Serial dilution of 
IEPlcatIEterm DNA in transfection experiments indicated that it also began 
to saturate available transcription factors when used at a concentration of 
between 0.3 to 1.0 ýig per transfection. 
The plasmids IEP1, pO. 38 and pMD102 have all been shown experimentally 
to contain enhancer elements (results not shown; Everett et al., 1983). 
Since co-transfection with pAat2, pAat3, IEPl-aat/0.38-aat, pAat/Nco and 
HindBI Z also reduced constitutive expression from IEPlcatIEterm, the 
result provides indirect evidence that these cloned fragments may also all 
contain enhancer elements. The Sst-A fragment, which probably does not 
contain an enhancer, was least effective in reducing constitutive 
expression. The smallest cloned DNA fragment which competed effectively for 
transcription factors was only 59bp (contained in pAat3) but included a 
complete copy of the 18bp repeat and two partial copies of the 19bp repeat. 
The result obtained with pAat3 supports the observation of Stinski and Roehr 
(1985) that the 18bp and 19bp repeats contribute towards efficient 
expression from the IE promoter. It is interesting to note that the SV40 
promoter, which shares homology with the 18bp repeat (Fig 4: 1), also 
competes with the HCMV IE promoter for transcription factors. The extent to 
which plasmids containing different prom-oter-regulatory elements competed 
with IEP1catIEterm DNA for transcription factors was observed to vary 
considerably. It is possible that more than one enhancer-binding protein may 
be present in limiting concentrations and/or that some of the competing 
plasmids have different affinities for the same transcription factor. 
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The original aim of the competitive co-transfection experiments was to 
identify cis-acting sequence elements involved in repressing rather than 
enhancing HCMV IE transcription. In competition experiments, HCMV infection 
stimulated expression only when IEPlcatIEterm was co-transfected with 
plasmids containing upstream promoter elements derived from the HCMV major 
IE gene. Co-transfection with these fragments, however, also reduced the 
level of constitutive expression from the IE promoter. Indeed, the 
HCMV-induced levels of expression in these samples were lower than levels 
detected in pUC18 or pAT153/IEPlcatIEterm co-transfected cells in which 
expression was repressed by HCMV infection. In cases where HCMV infection 
stimulated expression from IEPlcatIEterm, it was probably accomplished by 
increasing the availability of transcription factors which had been 
saturated by the competing plasmid. In competitive co-transfection 
experiments, HCMV encoded trans-activators appeared to be unable to 
stimulate expression from IEPlcatIEterm above its maximum constitutive level 
in uninfected cells. 
Since expression from the SV40 early and RSV promoters (both of which 
contain enhancer elements) was stimulated by HCMV infection, even when they 
were transfected at a low DNA concentration (0.3 ýtg/20 gg of total DNA), the 
RIT function would appear to have some degree of promoter specificity in its 
action. Co-transfection with the plasmid pMD102 (which contains the SV40 
promoter) reduced the level of constitutive expression from IEPlcatIEterm, a 
result which implies that the SV40 promoter was competing with the HCMV IE 
promoter for enhancer-binding proteins. Although HCMV appears to increase 
the availability of transcription factors in infected cells, virus infection 
did not stimulate CAT expression in IEP1catIEterm/pMD102 co-transfected 
cells. It would appear that while upstream promoter sequences from the major 
IE gene are able to compete out both enhancer-binding proteins and the RIT 
function (thus making IEP1catIEterm inducible by HCMV infection), the SV40 
promoter may compete only for enhancer-binding proteins. 
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During the course of productive HCMV infections in tissue culture cells 
transcription from the IE promoter is repressed from 6h p. L which implies 
that the negative effect on transcription of RIT is dominant over the 
positive influences of the enhancer or HCMV-induced trans-activators. Even 
if the IE promoter is being expressed inefficiently the HCMV-induced 
repressor should dominate the effects of trans-activators, indeed this is 
the case in cells transfected with IEPlcatIEterm and pMD102 or HindII Z. 
The results of the co-transfectLon experiment are therefore consistent with 
RIT binding to and being saturated by sequence common to pAat2, pAat3, 
pAatNco, pO. 38-aat/IEPl-aat and pO. 38. Although the IE promoter contains a 
mixed series of tandem repeats, none are shared by all the fragments which 
conferred inducibility on the IE promoter. It is possible that RIT may 
interact, either directly or indirectly, with more than one sequence 
element. The competitive co-transfection experiments indicated that RIT 
recognises at least three discrete regions in the IE promoter between bases 
-135 and -457 delineated by the AatlI sites at -321 and -401. 
It would be 
interesting now to chemically synthesise the 16,18,19 and 22bp repeats and 
experimentally determine the effect each repeat had on both constitutive and 
HCMV-induced expression from the IE promoter in competitive co-transfection 
experiments. Potentially, the results of this experiment could differentiate 
promoter elements involved in enhancing and repressing transcription from 
the IE promoter. 
The adenovirus Ela gene products have been shown to specifically 
repress transcription from promoters containing enhancer elements and to 
activate transcription from adenovirus early promoters and some cellular 
genes (Borrelli et al., 1984; Svensson and Akusjarvi, 1984). Adenoviruses 
carrying deletions in the Ela gene are host range mutants which can 
replicate only in a few cell types including 293, Hela and teratocarcinoma 
cells (Imperiale et al., 1984). 293 ceUs contain an integrated copy of the 
Ela gene which provides a helper function in trans while teratocarcinoma 
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cells, and possibly also Hela cells, are thought to constitutively express 
functions which have virtually identical properties to transcriptional 
activator and repressor activities induced by the Ela gene products 
(Imperiale et aL, 1984; Hen et aL, 1986). Although productive HCMV 
infections are restricted to cells of human origin most types of mammalian 
cells will, following infection, express IE and at least some early viral 
genes (DeMarchi, 1983c). Hela cells, 293 cells (LaFemina and Hayward, 1986), 
undifferentiated EC cells (Gonczol et aL, 1984) and lymphocytic stem cells 
(Braun and Reiser, 1986; Reiser et aL, 1986) are notable exceptions in 
which even HCMV IE genes are not expressed. HCMV DNA is taken into the 
nuclei of undifferentiated EC and 293 cells following infection but is not 
replicated (Gonczol et al j 1984; LaFemina and Hayward, 1986). However, 293 
(unpublished results), Hela (section 3: 2) and EC cells (J. Sinclair, 
personal communication) will all express the major IE gene when it is 
introduced by DNA transfection. In transfected ceUs high copy numbers of 
the IE promoter may be saturating the cellular (Ela-like) repressor. 
Although RIT may be more specific than the Ela gene product in its action, 
both repressors act on DNA elements associated with enhancer activity. HCMV 
and adenovirus may both negatively regulate transcription by activating 
similar cellular repressor functions. However, it is also possible that the 
HCMV major IE polypeptide interacts directly with its own promoter to 
suppress transcription. 
Although the site of HCMV latency in vivo has yet to be established, 
recent clinical and laboratory studies suggest it may lie within a 
subpopulation of lymphocytes (section 1: 25). In vitro HCMV replication in T 
lymphocyte was detected only after cell growth had been stimulated with 
interleukin 2 (Reiser et al., 1986) and in bone marrow stem cells only after 
they had been precultured. It is possible that lymphocytic stem cells may 
contain an enhancer-specific transcriptional repressor similar to the 
Ela-like function in EC cells. When lymphocytes are stimulated to grow in 
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vitro, they may also undergo a differentiation step in which the repressor 
of HCMV IE gene expression becomes inactive. In latently infected cells this 
may induce virus replication. 
An alternative mechanism for the re-activation of HCMV from lymphocytes 
is suggested by recent work on HIV. Mitogenic activation of lymphocytes has 
been shown to stimulate the binding of a protein (NF-kappaB) to an enhancer 
sequence present in both the kappa immunoglobulin gene and the HIV LTR 
resulting in transcriptional stimulation (Sen and Baltimore, 1986; Nabel and 
Baltimore, 1987). The binding of NF-kappaB to the enhancer stimulates 
transcription from adjacent promoters and, in the case of HIV, this 
stimulation may be involved in reactivating virus from latently infected 
lymphocytes. The DNA sequence recognised by NF-kappaB is also contained in 
the 18bp repeat present in the HCMV IE enhancer region (Nabel and Baltimore, 
1987; Table 4: 1). By analogy, the induction of NF-kappaB activity could 
potentially also stimulate HCMV IE gene expression in latently infected 
lymphocytes and thereby reactivate virus infection. 
The reactivation of HCMV infections in im m unosuppressed individuals is 
an important clinical problem particularly in transplant recipients and AIDS 
patients. A greater understanding of the mechanisms involved in regulating 
HCMV IE gene expression may provide valuable insight into both how the 
latent infections are established and, also, how subsequently the virus is 
able to reactivate. 
During the early phase of the replicative cycle HCMV encodes a single 
high abundance 2.7kb RNA and an unspecified large number of additional low 
abundance RNAs (Wathen and Stinski, 1982; unpublished results). The 2.7kb 
early RNA, which is not spliced (McDonough et al., 1985; section 3: 13), is 
transcribed from a gene contained within both copies of the strains AD169 
and Towne long repeats but is present as a single copy in the UL region of 
strain Davis (DeMarchi, 1981; Wathen and Stinski, 1982; Wilkinson, 1983). 
The relatively rapid and efficient synthesis of this transcript suggested 
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that it may encode an important function. The 2.7kb HCMV major early gene 
was therefore studied in more detail. 
The 5' end of the 2.7kb early gene was identifLed by a combination of a 
primer extension and Sl nuclease analysis. Assuming translation is initiated 
at an AUG codon and that coding assignments are normal the longest ORF 
associated with the gene would encode a polypeptide of 170 amino acids. 
Translation of the predicted polypepti-de would be initiated fro m the fourth 
AUG codon downstream from the transcriptional start site, the previous three 
initiation codons all being associated with very short ORFs. 'False' 
initiation codons have been shown to be present in the leader sequences of 
other herpesvirus genes, e. g. the thymidylate synthase gene of HVS (Bodemer 
et Eý, 1986). The predicted polypeptide would be basic, have an 
exceptionally high proline content (14%) and contain two potential 
0-glycosylation sites within hydrophilic domains. The early promoter plus 
either 135bp or 95bp of leader sequence has been cloned upstream of the 
reporter genes a--galactosidase and TK respectively (Spaete and Mocarsk4 
1985b; section 3: 14). Efficient expression was obtained from both these 
constructs following HCMV infection of the transfected cells (Spaete and 
Mocarski, 1985b; section 3: 14). Ribosomes must therefore recognise the 
'leader sequence' of the 2.7kb RNA and remain attached to the RNA at least 
until after the first short ORF (8 amino acids). The sequence adjacent to 
the proposed translational initiation codon for the 170 amino acid ORF 
(CACCCAUGC), however, is not in good agreement with the consensus sequence 
(C CA CCAUGG) identifLed by Kozak (1984) with respect to the key bases at G 
positions -3 and +4. Attempts to identify the protein predicted by the 170 
amino acid ORF in vitro by hybrid selected translation, by analysing 
1 35 SI-methionine and [3 HI-proline pulse-labelled proteins in infected tissue 
culture cells by SDS-PAGE and in prokaryotic expression systems have been 
unsuccessful (WiUdnson and Greenaway, unpublished results). Additionally, 
an analysis of the 170 amino acid ORF using the "Testcode" algorithm devised 
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by Fickett (1982) indicated there is only a 40% probability of the ORF 
being used. The possibility that the proposed ORF is not used and that the 
2.7kb early RNA does not encode a functional polypeptide cannot be ruled 
out. 
A characteristic property of HCMV is its relatively long replicative 
cycle, in the same permisgive cell system HSV-1 and HCMV have an eclipse 
phase lasting 6h and 4 days respectively (Smith and DeHarven, 1973). The 
initial events following infection, however, occur rapidly with the 
expression of HCMV nuclear antigens being detected within lh p. L 
(Michelson-Fiske et al., 1977). Blanton and Tevethia. (1981) were able to 
detect the synthesis of early polypeptides between 4-6h p. L in 
im m uno precipitation experiments and Geballe et al. (1986a) identiaed two 
mRNA encoding predominantly late phase proteins (the abundant 65K tegument 
protein and the 48K DNA-binding protein) as early as 4h p. L The transition 
from IE to early phase gene expression therefore occurs by 4h p. L 
The nucleic acid sequence and structural analysis of the HCMV major 
early gene provided the basis to investigate the transition fro m IE to early 
phase gene expression. DNA/RNA hybridisation experiments showed that 
although the 2.7kb early RNA was synthesised in low abundance under IE 
conditions, it was not detected in cytoplasmic RNA extracted from cells 2h 
p. i. The 2.7kb RNA was synthesised in trace amounts by 8h p. L but by 24h 
p. L it was present in high concentrations and was the predominant viral 
transcript. Although classed as an early transcript the 2.7kb RNA continued 
to be synthesised in even higher abundance during the late phase. 
Expression from the HCMV early promoter was measured in DNA 
transfection studies using the plasmid 1/34TK1 in which the 2.7kb major 
early gene promoter regulates expression from the HSV-l TK structural gene. 
The results obtained using the HCMV early promoter in transfection 
experiments were consistent with the DNA/RNA hybridisation data. Although 
constitutive expression from 1/34TK1 is extremely low, efficient expression 
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was detected following infection with HCMV. Even when a high m. o. L was 
used, however, activation of expression from the transfected early promoter 
was not detected until after 8h p. L Although the transfection studies did 
not detect stimulation of early gene expression until 8h p. L the transition 
from IE to early phase gene expression occurs earlier. While the TK enzyme 
assay is extremely sensitive, it was necessary in these experiments to use 
HCMV-permissive human fibroblasts which have a low transfection frequency 
relative to Hela cells. It may be that expression from the transfected early 
promoter was stimulated by HCMV-encoded trans--activators before 8h p. L at a 
level too low to be detected above background. 
HCMV infections were able to stimulate expression from all the 
transfected promoters which were tested; ie. the HCMV major IE the SV40 
early, the RSV LTR, the HSV-1 TK (early) and the HCMV major early 
promoters. Time course experiments showed that, as with the HCMV early 
promoter, ! 2. -ans-activation of the HCMV major IE (artificially) and the HSV-1 
early promoters was not detected before 8h p. i. In experiments performed in 
parallel, however, infection with HSV-1 efficiently stimulated expression 
from the transfected HCMV major IE and HSV-1 early promoters by 8h p. L 
HSV-1 infections were unable to significantly stimulate expression from the 
transfected HCMV early promoter. Spaete and Mocar-ski (1985b) have recently 
reported similar results with the HCMV IE and early promoters while O'Hare 
and Hayward (1984) have shown that infection with simian CMV stimulates 
expression from the HSV-1 TK promoter. 
The lag period between infection and detectable stimulaton of 
expression from transfected promoters was approximately 8h longer with HCMV 
than with HSV-1 infections. This 'lag period' is neither a property of the 
cell, since MRC5 cel1s were used throughout these experiments, nor HCMV 
early promoters since the effect was also observed using the HCMV IE and 
HSV-1 early promoters. Although post-transcriptLonal regulation of HCMV RNA 
processing has been described (DeMarch% 1983a; Geballe et al., 1986a) 
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hybridisation data using both whole cell and polysomal RNA suggest the 
control is primarily exerted at the transcriptional level (DeMarchi et al., 
1980; DeMarchi, 1984). The gradual activation of early phase and 
consequently the protracted nature of HCMV early phase gene expression 
appears to be a fundamental property of HCMV transcriptional activation. A 
HCMV trans-activator has been mapped within strain AD169 HindDI fragment E 
(Everett, 1984), which contains IE coding regions 1,2 and 3. In 
co-transfection experiments, however, Everett (1984) described the 
transcriptional stimulation from the HSV-l gD promoter by the major IE gene 
alone as being "barely detectable". The identifLcation of HCMV 
trans--activator functions will be central to our understanding of HCMV gene 
regulation and ultimately also virus pathogenicity. The characterisation of 
the HCMV major early gene and the fusion of its promoter to suitable 
reporter genes, such as in 1/34TKI, permits the activity of HCMV 
trans-activators to be assayed, in co-transfection experiments, using a 
homologous system. This system should enable the HCMV trans--activator genes 
to be mapped and characterised in more detail. 
It has recently been suggested that HCMV also exerts control over early 
phase gene expression at the translational level. Geballe et al. (1986b) 
cloned a sequence spanning the transcriptional start site of the 2.7kb early 
gene into the major IE leader sequence and showed that the cloned insert 
delayed the stimulation of expression from the transfected IE promoter 
following infection with HCMV. This result was interpreted by the authors as 
indicating that the "5' leader sequence" from the 2.7kb early RNA may 
contain a cis-acting signal which delayed translation and consequently, with 
respect to expression, changed the temporal class of the gene from IE to 
early. It has been shown in this study, however, that in HCMV-infected cells 
the stimulation of the transfected IE promoter, by de novo synthesised HCMV 
trans-activators, was artificial and that under such conditions the observed 
stimulation of expression from the IE promoter already exhibits kinetics 
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similar to those of an early promoter. Additionally, expression from the 
early promoter, together with the relevant portion of the 'leader sequence' 
can be stimulated in cis by the IE enhancer element in DNA transfection 
experiments; thus translation of the 2.7kb early RNA is therefore not 
absolutely dependent on any ýe novo-synthesised HCMV-encoded gene product. 
It is possible that the AUG codon within the 'leader sequence' of the early 
gene may be attenuating translation from the downstream reporter gene. A 
reduction in the level of total expression, by the effects of attenuation, 
could appear as a delay in HCMV-induced expression since the initial effects 
of the trans-activators may not be distinguishable above background levels 
in the assay. 
Finally, the ability of HSV-1 to stimulate expression from the HCMV IE 
but not the HCMV early promoter was unexpected in view of the sequence 
homology identified between the HSV-1 gD and the HCMV early promoters. Mosca 
et al. (1987) have recently demonstrated that HSV-1 stimulates expression 
from the simian CMV (strain Colburn) IE promoter and showed that this 
stimulation was dependent neither on a component of the HSV-1 virion nor a 
function of Vmwl75. The HSV-1 IE polypeptide VmwllO can stimulate 
transcription from heterologous promoters in transfection experiments but is 
unable to extensively activate HSV-1 early phase gene expres8ion in the 
absence of a functional Vmw175 protein during virus infections (see section 
1: 26). It has been suggested that- the major function of VmwllO in infected 
cells may be to stimulate the transcription of HSV-1 IE genes (OHare and 
Hayward, 1985b). It is therefore possible that in HSV-1 infected cells 
VmwllO may be able to stimulate transcription from the transfected HCMV 
major IE promoter but not the HCMV major early promoter. The HSV-1 Vmw175 
protein has been shown to bind specifLcally to sequences in HSV-1 IE genes 
to negatively regulate HSV-1 IE transcription (Faber and Wilcox, 1986). The 
apparent inability of HSV-1 Vmw175 to stimulate expression from the HCMV 
early promoter may reflect a degree of specificity in activator function of 
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Vm w175. 
The basic morphology of herpesvirions is sustained throughout the group 
and has, historically, been the primary basis for their classification. In 
recent years the grouping of all herpesviruses into the single family, the 
Herpesviridae, has been supported by the results of DNA sequence analyses. 
Many of the genes involved in replication, cleavage and packaging of virus 
DNA as well as genes encoding structural vir: Lon polypeptides have been 
conserved, to varying extents, between different members of the 
Harpesviridae (Baer et al., 1984; Spaete and Mocarski, 1985a; Cranage et 
al., 1986; Davison and Scott, 1986; Kouzarides et aL. 1987a; 1987b; and 
references within). The homologies which have been identified are consistent 
with the Herpesviridae being comprised of a single group of related viruses 
derived from a com mon ancestor. 
This study has concentrated primarily on the IE and early phases of 
HCMV gene expression. Like HSV-1, HCMV operates a cascade system of gene 
regul. ation which is conventionally divided Rito three phases; IE, early and 
late. However, a more detailed analysis identiELes differences in the way 
the two viruses regulate gene expression. It has been known for some time 
that while infection with HSV-1 suppresses cellular macromolecular 
synthesis, in HCMV-infected cells it is stimulated. The efficient expression 
of HSV-1 IE genes is dependent on transcriptional stimulation in trans by a 
component of the virion (TIF) and the IE polypeptide Vmw11O (synthesised de 
novo), whereas efficient expression of the HCMV major IE gene and its 
associated transcriptional unit appears to depend primarily on the 
stimulation of transcription in cis by an extaordinarily strong enhancer 
element (Boshart et aL, 1985). Although infection with u. vAnactivated 
HCMV produced a slight stimulation in expression from the major IE promoter 
in DNA transfection experiments, there is currently no firm evidence that 
HCMV virions contain an analogue of the HSV-1 TIF. 
In both HCMV and HSV-1 infected cells, IE gene expression is negatively 
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regulated at the transcriptional level (Nelson and Groudine, 1986; O'Hare 
and Hayward, 1985b). The HSV-1 IE protein, Vmw175 has been shown to suppress 
transcription through its interaction wit ha conserved sequence adjacent to 
the transcriptional start site of HSV-1 IE genes (Pizer et al., 1986; 
Muller, 1987). While it has been proposed that the HCMV major IE protein 
also autoregulates its own expression (Stenberg and Stinski, 1985), results 
obtained in competitive co-transfection experiments suggested that negative 
regulation of the HCMV major IE promoter is mediated through cis-acting 
sequences associated with its enhancer elements. 
The transition from the IE to the early phase of gene expression occurs 
by 4h p. L in both HCMV and HSV-1 infected cells. However, the stimulation 
of early phase transcription is a much more gradual process in HCMV-infected 
cells. Results obtained in this study indicate that the relatively slow rate 
of HCMV early phase gene activation is due neither to a property of 
HCMV-permissive cells nor HCMV early promoters. InfectLon with HCMV was 
also observed to stimulate expression from a wider range of promoters in 
transfectLon experiments. The different properties of HCMV and HSV-1 
trans-activators suggest that their mode of action may not be identicaL 
The Herpesviridae is divided into three sub-families primarily on the 
basis of the biological properties of its members, e. g. host range, growth 
rate and lesions produced in vivo (section 1: 1). While HSV-1 IE genes share 
homology with IE genes in other alphaherpesviruses (Davison and Wilkie, 
1983; Davison and Scott, 1986), the HCMV major IE gene has not been shown to 
exhibit homology with any of the characterlsed herpesvirus IE genes nor with 
the EBV genome. Herpesvirus IE gene products are generally associated with 
the regulation of gene expression. It is interesting to speculate that some 
of the characteristic properties of the herpesvirus sub-families may be 
attributable to their different mechanisms of regulating gene expression. 
Members of the betaherpesvirinae are charateristically slow-growing and have 
a restricted host range. The slow growth of HCMV may well be due to the very 
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gradual trans-activation of early and late gene expression, while its 
restricted host range appears to be related to an inability to efficiently 
activate transcription from the virus genome in non- and semi-permissive 
cell system (DeMarchi, 1984). The potential for the enhancer element in the 
major IE gene to be involved in the modulation of latency has already been 
discussed. The mechanisms involved in regulating herpesvirus gene expression 
may ultLmately prove to be crucial not only in determining their biological 
properties but also as determinants of pathogeni--ds. 
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